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ABSTRACT 
 
Synthesis of Through-bond Energy Transfer Cassettes and Their Encapsulation  
in Silica and Calcium Phosphate Nanoparticles. 
 (December 2009) 
Jiney Jose, B.S., U.I.C.T, Mumbai, India; M.S., Texas A&M University.  
Chair of Advisory Committee: Dr. Kevin Burgess 
 
Water-soluble fluorescent probes with emission in the 600-800 nm region have 
significant potential in biological applications such as cell imaging. Most fluorescent 
probes however suffer from limited fluorescence brightness in aqueous media due to 
aggregation and self-quenching. Their photostability for an extended period of time is 
also a concern. One way of improving their photophysical properties is to encapsulate 
them in a protective matrix to form fluorescent nanoparticles.  
 
We have synthesized a set of six through-bond energy transfer cassettes which emit in 
the 600-800 nm region with Fluorescein or BODIPY as donor and benzophenoxazine 
dye Nile Red or cyanine dye Cy5 as acceptor. Their photophysical properties in organic 
and aqueous media were evaluated. These cassettes were encapsulated in silica or 
calcium phosphate nanoparticles (20 nm in diameter) to improve their solubility, 
brightness, and photostability in aqueous media. We also synthesized some water-
soluble benzophenoxazine based fluorophores and the impact of different water-soluble 
groups on their emission characteristics in aqueous media was studied. Selected 
fluorophores were used for in vitro cellular imaging studies. 
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CHAPTER I 
 
INTRODUCTION 
1.1 Cell Imaging 
Advances in imaging techniques have allowed researchers to gain a better understanding 
of the functions of cells, tissues and even individual biomolecules like proteins. 
Development of techniques such as laser-scanning microscopy, fluorescence resonance 
energy transfer (FRET), multiphoton microscopy, and epifluorescence microscopy has 
allowed imaging of cells at resolutions previously thought to be unattainable.1 
Observation of fluorescently labeled biomolecules in live cells can reveal their 
interaction with each other, which is useful in cell signaling studies and also for high 
throughput screening of drugs. Although a great number and range of fluorescent 
proteins are currently available, improving them to meet the ever-expanding needs of 
cell biologists is quite challenging.2 Most fluorescent proteins emit light in the green to 
yellow region of the spectrum and only very few emit in the red region, which is a 
prerequisite for live cell imaging application.   On the other hand there are numerous 
reports on small molecule organic fluorescent probes, which are much brighter and easy 
to access via chemical synthesis.3-6 Fluorescent probes emitting in the 600-800 nm range 
have attracted much attention because (i) cellular auto fluorescence in this region is 
minimal and (ii) hemoglobin, water and lipid have minimum absorbance in this region. 
Fluorescence imaging is widely used in various research fields due to its fine temporal 
and spatial resolution and the ease of performing imaging studies with simple 
instruments and experimental setup.7 
 
 
 
____________ 
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The light in the near infrared region can penetrate deep inside tissues and is therefore 
suitable for in vivo imaging because light scattering by dense media is much reduced, 
resulting in deeper penetration of light. The signal to noise ratio is also maximized due 
to less auto fluorescence in this region.  
 
Among the extensive array of fluorescent probes, which is available for cellular imaging 
studies, there is none that works with every cell type. The difference in membrane 
permeability, intracellular compartmentalization and photostability has made it difficult 
to extend the applications of probes from mammalian cells to plant cells, bacteria and 
yeast.8 A careful examination of probe design with respect to their biocompatibility will 
help in development of new versatile probes, which may have broad utility. Fluorescent 
probes not only allow real-time monitoring of events, but also provide spatial 
information about the monitored event.  For such studies it is often desirable to 
simultaneously observe several fluorescently tagged components in a biochemical 
mixture, ie multiplexing.9 This can be achieved by exciting all the tags using the same 
laser source.  However excitation using a single source is difficult because dyes that 
absorb near the excitation source will absorb more light than dyes that absorb farther 
away from the source.  This results in diminishing emissions from the dyes excited with 
a single source.  Combinations of dyes arranged to maximize FRET have been used to 
overcome this problem.10,11  A variety of near-infrared fluorophores based on FRET 
have been developed, which are largely being used in detecting early cancers or 
inflammatory process in mouse cells.12,13 
1.2 Fluorescence Resonance Energy Transfer (FRET) 
 As early as the 1920s the transfer of electronic excitation energy between well separated 
atoms or molecules was reported.14 The simplest case is that of two atoms separated in 
space and the electronic excitation of one results in excitation of the other. This 
excitation could occur by emission of one photon of light by the first atom and 
reabsorption of this quantum by the second atom.  Such transfers are rarely observed and 
were proven not to be the case by Cario and Franck in 1922 in their experiments on 
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fluorescence of atoms in vapor phase.15 In their experiments they irradiated a mixture of 
mercury and thallium vapors with mercury light and obtained the emission spectra for 
both the atoms.  Since thallium atoms do not absorb mercury light, energy transfer from 
excited mercury atoms can excite them.  Therefore a transfer by reabsorption of light is 
not possible in this case. The transfer of excitation energy happens over a larger distance 
than observed in normal collision transfer.  There are a number of other examples of 
such excitation transfer.   
 
Perrin et al. reported the first observation of such excitation transfer in solution in 
1929.16 One example is described below.  A solution containing both perylene (acceptor) 
and chloroanthracene (donor) in varying ratio was prepared.  A decrease in 
chloroanthracene fluorescence was observed when both components were at the same 
concentration, which means a definite transfer of excitation energy is taking place 
between the donor and acceptor molecule.  The transfer occurs over the mean 
intermolecular distances between the donor and acceptor.  This excitation transfer is 
independent of both the volume of solution and viscosity of the solvent and is 
characterized by a decrease in donor fluorescence lifetime. 
 
The mechanism of excited energy transfer can be explained with the help of Figure (1.1) 
where during the absorption process, the donor is excited to a higher vibrational level of 
its first exited state.  The donor can fall to a lower vibrational level of the same excited 
state by a non-radiative transition.  During the deactivation process when the donor 
returns to the ground state, it is possible that the energy of deactivation may exactly 
coincide with possible absorption transition in an acceptor molecule that is in the vicinity 
of the deactivated donor molecule.  With sufficient energetic coupling an excitation 
energy transfer between the donor and the acceptor molecule takes place.  This type of 
energy transfer is referred to as “resonance transfer”.17,18 The energy transfer takes place 
before emission from the donor molecule takes place and requires coupling between the 
electronic systems of both donor and acceptor.  This limits the distance over which such 
  4 
an energy transfer can occur.  There is also literature precedent, which shows such 
energy transfer occurring between electronic systems of the same molecule. 
 
D
D*
A
A*
coupled transitions
radiative transitions.
non-radiative transitions.
transfer transitions.
 
Figure 1.1. Simplified energy level diagram of energy transfer between a donor (D) and 
an acceptor (A). 
 
This kind of excitation transfer process, when applied to fluorescent molecules can be 
defined as exciting a fluorescent molecule which is in proximity to a second fluorophore, 
resulting in emission occurring from the second fluorophore with minimal or almost no 
fluorescence seen from the excited molecule. This phenomenon is termed as 
Fluorescence Resonance Energy Transfer (FRET).  For FRET to occur the distance 
between both fluorophores should be less than 10 nm.  FRET was first reported by 
Professor Theodor Förster in 1946.19 The excited fluorophore can be termed as a donor 
and the molecule emitting light can be termed as an acceptor.  The energy transfer which 
takes place between the donor and acceptor which is separated by a distance r, is given 
by: 
KT(r) = QDκ2/τD r6 (9000(ln10)/128π5Nη4)0∫∞FD(λ)εA(λ)λ4dλ........................................(1) 
  5 
Where QD = quantum yield of donor in the absence of the acceptor κ2 = orientation 
factor (range from 0 to 4, usually assumed to be 0.67 for dynamic random averaging). κ2 
= 4 if the transition dipoles of the donor and acceptor are perfectly parallel and 0 when 
they are orthogonal. τD = lifetime of donor in the absence of the acceptor. N = 6.02 x 
1023. η = refractive index of the medium (usually assumed to be 1.4 for biomolecules in 
aqueous solution).  The rate of energy transfer is inversely proportional to the sixth 
power of the distance, r, between the donor and the acceptor. The overlap integral J (λ) 
can be given as  
J (λ) = 0∫∞FD(λ)εA(λ)λ4dλ................................................................................................(2) 
The extent of overlap between the emission spectrum of the donor and the absorbtion 
spectrum of the acceptor is given by above equation.  FD(λ) is the normalized emission 
spectrum of the donor. εA(λ) is the extinction coefficient of the acceptor at wavelength  
λ. 
The Förster radius, Ro, is the distance r, at which the rate of energy transfer is equal to 
the rate of decay of the donor (1/τD) in the absence of the acceptor.  Ro is the distance at 
which FRET is 50 % efficient. At r = Ro, KT = (1/τD).  Equation 1 can be written as  
Ro = (9000(ln10) QDκ2/128π5Nη4) 0∫∞FD(λ)εA(λ)λ4dλ.......................................……..(3)  
Ro is typically in the range of 20 to 60 Ao for organic fluorophores. 
Knowing Ro, one can calculate the ET rate by: 
 1
!D
Ro
r
kT =
6
………………………………………………………………………….(4) 
The efficiency of energy transfer, E, is the fraction of photons absorbed by the donor that 
are transformed to the acceptor.  E is given by 
E =
kT
!D
-1 + kT …………………………………………………………………………...(5) 
this is the ratio of the energy transfer rate to the total decay rate of the donor. 
The efficiency of energy transfer can be calculated from the emission intensity of the 
donor in the absence and presence of the acceptor.20 
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In order for FRET to occur overlap of emission of the donor fragment with the 
absorbtion of the acceptor is essential.  This is a constraint, which limits the combination 
of dyes that can be used for multiplexing.   
1.3 Through Bond Energy Transfer 
Through-bond energy transfer systems consist of a donor and acceptor part connected 
via a conjugate linker that does not allow them to be planar.  This nonplanar geometry 
allows rapid energy transfer from the donor to the acceptor part.  Through-bond energy 
transfer is mechanistically different from Förster basis for FRET, which requires overlap 
of emission of the donor fragment with the absorbtion of the acceptor.  There are two 
mechanisms proposed for the observed energy transfer. Dexter21 and superexchange 
energy transfer.22  As compared to Förster  energy transfer, Dexter energy transfer is a 
short range phenomenon and requires the interaction between an excited donor orbital 
with an orbital of the acceptor in the ground state.  Superexchange energy transfer can 
take place over a longer distance since energy is relayed through bonds connecting the 
donor and the acceptor (Figure 1.2). 
 
n
hv
donor acceptor
hv'
through-bond and through-space
energy transfer
! electron conjugated linker
hv
donor acceptor
hv'
 nonconjugated linkage
through-space energy transfer
a b
 
Figure 1.2. Concept of (a) through-space and (b) through-bond energy transfer. 
 
Thus appropriately designed through-bond energy transfer cassettes could absorb 
photons via a donor part and transfer the energy rapidly through the conjugated linker to 
the acceptor fragment that emits at a longer wavelength.  There is no known constraint 
on the difference between the donor absorbtion and acceptor emission wavelength in this 
scheme since no overlap is required for energy transfer to occur.  Thus it is possible to 
design dyes that can absorb strongly at short wavelengths and emit brightly at longer 
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wavelengths. When the fluorescence Stokes’ shift (the wavelength separation between 
absorption and fluorescence maxima) is small, which is usually the case in most organic 
fluorophores, it is difficult to maximize the excitation and detection of fluorophore and 
at the same time isolate the fluorescence signal from scattered excitation light. This 
problem can be completely overcome in through-bond energy transfer cassettes because 
the donor absorbtion wavelength is far apart from the acceptor emission wavelength.   In 
summary, through bond energy transfer cassettes have the potential to increase the 
resolution and fluorescence intensities obtained from several probes excited by a laser 
source operating at a single wavelength. 
 
Our group has expertise in designing such through-bond energy transfer cassettes.23-28  
Previous members have designed four energy transfer cassettes as shown in Figure 1.3 
and studied their photophysical properties (Figure 1.4).29  Excitation of these cassettes at 
488 nm produces fluorescence characteristic of only the acceptor component, which 
proves 100 % energy transfer efficiency between the donor and the acceptor.  The 
fluorescence intensities of 1-4 when excited at the donor component were compared to 
emission of molecule that resembles only the acceptor part.  Cassettes were shown to 
fluoresce more brightly than the acceptor proving efficient energy transfer. 
 
O OHO
OH2N NH2
O
O
-O2C
donor part
conjugate linker
acceptor part
for attachement to
biomolecule
O OHO
OMe2N NMe2
O
O
-O2C
O OHO
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O
O
-O2C
N
OH2N NH2
Br
OMe2N NMe2
Br
ON N
Br
!max emis.= 534 nm
1 2
582 nm
3
605 nm
O OHO
ON
O
O
-O2C
N
4
616 nm
ON N
Br
5 6 7 8  
Figure 1.3. Through-bond energy transfer cassettes and acceptors synthesized by our 
group. 
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Figure 1.4. (a) absorbance of cassettes 1-4 in EtOH and (b) Fluorescence of equimolar 
EtOH solutions of 1-8 excited at 488 nm. 
 
For the above-mentioned cassettes to be useful in cellular imaging, they should be 
soluble in aqueous media.  To enhance their water solubility either the donor or acceptor 
should have water-soluble functional groups. Our group recently published a water-
soluble through-bond energy transfer cassette, which showed approximately 80 % 
energy transfer in aqueous media.30 This cassette was successfully used for intracellular 
imaging studies of COS-7 cells.  
 
Our work with benzophenoxazine dyes showed that their water-soluble variant 
fluoresces in the 600-700 nm region with good quantum yields.31,32 This property makes 
them useful as an acceptor fragment for synthesis of water-soluble cassettes. In chapter 
two we will explain the synthesis of water-soluble analogues of benzophenoxazine dyes. 
The effect of different water-soluble groups on the photophysical properties of these 
dyes, particularly on quantum yield, was evaluated. The synthesis and photophysical 
properties of cassettes based on water-soluble benzophenoxazine dyes are discussed in 
Chapter III.  
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1.4 Fluorescent Nanoparticles 
With the advent of cellular imaging technologies, the need for brighter and near infrared 
fluorophores has increased.2 Organic fluorophores can be synthetically fine tuned to emit 
in the near infrared region with sufficient water-solubility. There are few literature 
reports on water-soluble bright fluorophores and their brightness is heavily dependent on 
the surrounding media.31,33,34 Cellular imaging studies are done at physiological pH and 
most organic fluorophores fluoresce with reduced efficiency in the cellular environment, 
mainly due to aggregation and quenching by cellular entities.33 More demanding 
biological applications such as single molecule detection and studying protein-protein 
interaction puts restrictions on the extent to which organic fluorophores can be used. 
One of the most significant drawbacks is their low photostabilities in aqueous media, 
which makes detection of signal over extended periods of time difficult.35  
 
Semiconductor quantum dots discovered by Louis E. Brus at Bell Labs, proved to be a 
very good alternative to organic fluorophores due to their extreme brightness and size 
dependent emission characteristics.36 Quantum dots are 20 times brighter and 100 times 
more photostable than organic fluorophores and have a particle size range between 20-
100 nm. It’s emission is dependent on particle size with large nanoparticles emitting in 
the near IR region of the spectra. Most quantum dots are synthesized from heavy metals 
like cadmium and selenide and therefore suffer from cytotoxicity issues.37-39 It is 
insoluble in water and must be coated with a polymer to make them water-soluble before 
introducing into cells, which increases their hydrodynamic radius. Recently cadmium- 
free quantum dots were reported but their cytotoxicity has yet to be completely 
evaluated.40 Under cellular imaging conditions cadmium leaches out from the quantum 
dots, because the energy of UV irradiation is sufficient to break the covalent chemical 
bond of cadmium selenide.  It also suffer from “blinking” which is the dark state of these 
particles and is a drawback for single molecule tracking studies. 
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Weisner et al has published extensively on fluorescent silica nanoparticles, which 
involves encapsulations of organic fluorophores in silica.41,42 The particle size of silica 
nanoparticles fall in the sub 50 nm region and are therefore useful for cellular imaging 
studies.  Silica is chemically stable and protects the encapsulated dye molecules from the 
external environment. These nanoparticles are 20 times brighter than the constituent dye 
itself.42 The photostability of the encapsulated dye is shown to improve dramatically 
compared to the dye itself. Their small size makes them dispersible in aqueous media 
and they remain stable without aggregation for months. The silica surface is easily 
functionalizable and therefore such surface modified silica nanoparticles can be used for 
attachment to biomolecules.43 The silica nanoparticles are nontoxic at biologically 
relevant concentrations and can be used in a broad range of imaging applications such as 
visualization of capillaries and macrophages, and real time imaging of tumor 
metastasis.44 When used at concentration less than or equal to 0.1 mg/mL no cell death 
was reported over a period of 8 h.45 We have tried to encapsulate some of our through-
bond energy transfer cassettes in silica, which will be discussed in part one of Chapter 
IV. 
 
Calcium phosphate nanoparticles is another interesting and simpler method to 
encapsulate organic fluorophores to enhance their photophysical properties in aqueous 
media.46 Like silica, calcium phosphate shields the encapsulated dye from the external 
environment and therefore enhances their photophysical properties. These are 15-25 nm 
particles and are therefore optimal for cellular imaging studies. The surface of these 
nanoparticles can be decorated with carboxylic acid groups by which they can be 
attached to biomolecules or they can be further modified with groups such as glycols to 
improve their water-solubility.  They are stable for months at physiological pH and only 
dissolve below pH 5.5.47 This property makes it useful in delivering cargoes like 
therapeutic agents for treatment of various diseases like cancer, wherein controlled 
release of the drug at the specific target is important for efficient diagnosis and 
treatment. Calcium phosphate is bioresorbable and calcium is the most abundant metal 
  11 
found in the human body. There is no reported cell cytotoxicity of calcium phosphate 
nanoparticles and therefore it is easy to work with. Calcium phosphate nanoparticles 
present an attractive tool for diagnostic imaging for both in vivo and in vitro studies. A 
detailed study of these particles with respect to encapsulating hydrophobic cassettes is 
illustrated in part two of Chapter IV. 
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CHAPTER II 
 
 
SYNTHESIS OF WATER-SOLUBLE FLUORESCENT PROBES  
 
 
2.1 Introduction 
There are many application of fluorescent probes as a suitable diagnostic and 
imaging agent. Therefore the demand for probes that can perform imaging has also 
increased. These probes are mainly used as markers for cell organelles and also for 
conjugation to protein molecules for protein-protein interaction studies which 
requires them to be inherently water-soluble. A vast majority of fluorescent probes 
reported in the literature are only sparingly soluble in aqueous media, which reduces 
their fluorescence output in a cellular environment. In recent years a number of 
water-soluble fluorescent probes have been reported and their application for cellular 
imaging studies evaluated.48-50 The presence of different water-soluble groups 
improves fluorescence output of these probes in aqueous media by preventing 
aggregation induced quenching. Much of these studies are carried out on 
rhodamines,51 cyanines,52 and BODIPY53 derivatives. There exists an opportunity to 
extent these studies to other family of fluorescent probes such as benzophenoxazines, 
perylenes, and squarines which are traditionally used as functional materials such as 
organic light emitting diodes (OLED).54 Here in we describe our efforts towards 
synthesized water-soluble benzophenoxazine derivatives for cellular imaging studies.  
 
2.2 Benzophenoxazine Derivatives 
Benzophenoxazine dye, Nile Red is a solvatochromic dye (solvent dependent 
emission).32 It is a liphophilic stain extensively used for detection of intracellular 
lipid droplets.55,56 Its emission is shifted to lower wavelengths in nonpolar solvents 
and to higher wavelengths in polar solvents. Its emission in the 600-700 nm region 
makes it a useful probe for cellular imaging,1 but it suffers from two major 
drawbacks; (i) it is completely insoluble in aqueous media and (ii) it is 
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nonfluorescent in aqueous media due to aggregation. We hypothesized that 
introduction of water-solubilizing groups would improve its water-solubility and 
fluorescence in aqueous media. There are very few reports of water-soluble 
benzophenoxazine dyes in the literature.57,58 We had previously reported two water-
soluble analogues which showed good quantum yields in water.31 Herein we report 
the effect of different water-soluble groups on the photophysical properties of these 
dyes in aqueous media. 
 
Most organic fluorescent probes are inherently flat and self organize into supramolecular 
clusters in aqueous media due to aggregation resulting in reduced fluorescence 
efficiency. Relatively low fluorescence or complete quenching of fluorescence in 
solutions where aggregation is predominant is due to the fact that excited energy in these 
systems is usually dissipated in non-radiative processes.59,60 Photophysical properties of 
fluorescent probes in aqueous media are markedly different compared to that in organic 
media. This can be attributed to the greater difference in polarity between fluorescent 
probes and water. Surfactants such as the Triton® series help in reducing the polarity 
difference and enhancing fluorescence. A more attractive means is to synthetically 
incorporate groups which will make fluorescent probes intrinsically water-soluble. 
Water-soluble groups such as sulfonic acids and carboxylic acids are widely used for this 
purpose.61,62 Carboxylic acid groups also serve as a suitable handle for attachment of 
fluorescent probes to various biomolecules. Other groups such as polyethylene glycols, 
phenols, phosphonates are also utilized to impart water-solubility.52,63,64 Recent reports 
from the Romieu group have emphasized post synthetic modification of organic dyes to 
impart water-solubility.33,53 This method is particularly useful for introduction of 
multiple sulfonic acid groups and is a viable alternative to elaborate synthetic routes 
most commonly used to introduce such groups. A similar strategy to introduce multiple 
carboxylic acids and hydroxyl groups is explored in this work. 
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2.2.1 Results and Discussion 
2.2.1.1 Syntheses of Benzophenoxazine Dyes 
The synthesis of dye 13 was started from the dicarboxylic acid derivative of 3-
aminophenol, 9 (Scheme 2.1). The starting material was prepared form a previously 
reported procedure.31 Esterification of compound 9, followed by nitrosation and 
condensation with 1,6-dihydroxy naphthalene in the presence of a catalytic amount of 
hydrochloric acid yielded dye 12. The nitroso compound was used without additional 
purification due to its unstable and hygroscopic nature. Alkylation of 12 followed by 
removal of t-butyl group with trifluoroacetic acid afforded 13 in 45 % yield. Surprisingly 
dye 1 with only one carboxylic acid was soluble in water. The diethylester groups also 
helps in imparting solubility to the dye. The 2-hydroxy Nile Red, with a carboxylic 
handle at 2- position is reported to be soluble in water but its quantum yield is not 
mentioned.65 
 
Scheme 2.1.  Synthesis of dye 13. 
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Sulfonic acid dye 20 (Scheme 2.2) was prepared from nitroso compound 17.64,66 3-
Aminophenol 14 was mono-alkylated to obtain ethyl derivative 15 in 70 % yield. 
Treatment of 15 with 1,3-propane sultone yielded water-soluble sulfonated aminophenol 
16 in 60 % yield. Nitrosation of 16 yielded nitroso compound 17 which was used for 
further reaction without any purification. Purification was not attempted due to the 
instability of nitroso compound 17. Reaction of 17 with 1,7- dihydroxy naphthalene in 
DMF at 140 ºC yielded 20 in 71 % yield. A similar dye is reported in the literature but its 
photophysical properties in aqueous media were not measured.57 The presence of a 
phenolic group and a sulfonic acid group makes dye 20 highly water-slouble. 
 
Scheme 2.2.  Synthesis of dye 20. 
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Dyes 25, 27 and 28 incorporate water-soluble groups shown in Figure 2.1. Trizma base 
21 is widely used as a buffer (pH 8.4) in immunohistochemical staining and is very 
soluble in water.67 Compound 21 also acts as a useful substrate for incorporating 
multiple carboxylic acid groups which we assume will further improve water-solubility 
and serve as a handle for attachment to biomolecules. Treatment of 21 with acrylonitrile 
followed by acid hydrolysis yielded 22 in quantitative yield.68 The random orientation of 
21 and 22 will prevent π-stacking of dyes and help reduce aggregation in aqueous media. 
On the other hand, oligoethylene glycol linkers are known to improve water-solubility. 
Our group has expertise in synthesis of oligoethylene glycols using “click” chemistry.69 
We used a similar strategy to prepare linker 23 in gram quantities. Linker 23 was 
prepared by Dr. Yuichiro Yueno. 
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Figure 2.1. Water-soluble groups used in this study. 
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Scheme 2.3. Synthesis of water-soluble group 22. 
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2-Hydroxy Nile Red 24, prepared by following a reported proceudure3 was alkylated 
with oligoethylene glycol linker 23 followed by removal of PMB group in TFA/CH2Cl2 
to afford 25 in 58 % yield. We had previously reported the synthesis of water-soluble 
dye 26, which has a quatum yield of 0.33 in pH 7.4 buffer. Activation of the carboxylic 
acids of dye 26, followed by reaction with corresponding amines 21 and 22 yielded dyes 
27 and 28 in 59 and 28 % yield respectively. A longer reaction time was required for 
synthesis of dye 28 and we attribute this to the steric bulk of the water-soluble group 22. 
Both dyes 27 and 28 were purified on medium pressure liquid chromatography using 
reverse phase C-18 column and CH3CN/H2O as eluent. 
 
Scheme 2.4.  Synthesis of dye 25. 
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Scheme 2.5.  Synthesis of dye 27 and 28. 
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2.2.1.2 Photophysical Properties of Benzophenoxazine Dyes 
All dyes showed good solubility in water, pH 7.4 phosphate buffer and EtOH. The 
abosrbance and fluorescence spectra of all dyes in EtOH and pH 7.4 phosphate buffer 
are shown in Figure 2.2 and Figure 2.3 respectively. Absorbance and fluorescence is 
red shifted by a value of 20-30 nm in pH 7.4 compared to  their corresponding values 
in EtOH. This red shift is primarily due to the solvatochromic nature of 
benzophenoxazine dyes. The Stokes’ shift of these dyes, the difference in wavelength 
(nm) between the absorbtion and emission maxima in pH 7.4 and EtOH varies 
between 78-99 nm. The large stoke shift makes it possible to excite these dyes at a 
lower wavelength and obtain fluorescence output at a higher wavelength which can 
be readily distinguished from the light source used to excite the dye. Most 
fluorophores have small Stokes’ shifts and it is often difficult to avoid the mutual 
inteference between the excitation and emission wavelength. This draw back reduces 
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the sensitivity of such fluorophores in bioimaging studies. Benzophenoxazine dyes 
such as the ones synthesized, with large Stokes’ shifts can be used to overcome these 
drawbacks.  
 
Among the water-soluble groups used, carboxylic acid shows a greater effect on 
quantum yields than sulfonic acid and oligoethylene glycol linker (Table 2.2) in pH 7.4 
and also in EtOH (Table 2.1). The carboxylic acid dye 13 has a quantum yield of 0.33 as 
compared to sulfonic acid dye 20, which has a quantum yield of 0.17. The quantum 
yields of these dyes in EtOH varied from 0.47-0.73. The quantum yields obtained for 
dyes in pH 7.4 shows a significant improvement compared to 2-hydroxy Nile Red dye 
24 which is almost non-fluorescent in pH 7.4. The different water-soluble groups used 
have a positive influence on the solubility and quantum yield of dyes in aqueous media, 
but to different extents. Groups such as carboxylic acids, which tend to disrupt the 
planarity of the dye molecules thereby preventing pi stacking seem to improve 
photophysical properties to a greater extent in aqueous media. Twisted intramolecular 
charge transfer70 which is prominent in benzophenoxazine dyes tends to be lower in 
aqueous media due to H-bonding of water with the lone pair of electrons on nitrogen.  
This can only be prevented if the dye is completely isolated from water by casting them 
in a rigid matrix like silica.71 Efforts in this direction will be an alternative means to 
improve their photophysical properties. The full width at half maxima values, which is a 
measure of aggregation is in fact lower in pH 7.4 (Table 2.2) for all dyes compared to 
their value in EtOH (Table 2.1). This reflects their reduced tendency to aggregate in 
aqueous media. 
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Figure 2.2.  Normalized UV absorption and fluorescence emission spectra of dyes in 
EtOH. Concentration for absorption measurement: 10-6 M; concentration for 
fluorescence measurement: 10-7 M. 
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Figure 2.3.  Normalized UV absorption and fluorescence emission spectra of dyes in pH 
7.4 (0.1 M sodium phosphate buffer). Concentration for absorption measurement: 10-6 
M; concentration for fluorescence measurement: 10-7 M. 
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TABLE 2.1.  Spectroscopic properties of dyes in EtOH. 
 
dye λabs 
(nm) 
ε 
(M-1cm-1) 
λem. 
(nm) 
fwhm 
(nm) 
Φa 
      
13 522 15400 621 65 0.73 
20 545 16200 639 66 0.60 
25 548 11740 631 60 0.48 
27 530 9900 620 65 0.47 
28 544 10200 622 67 0.63 
a Standard used for quantum yield measurement: rhodamine 6G in EtOH (Φ : 0.94), 
quantum yield and extinction coefficients (at 10-6 M) were repeated three times. 
 
 
TABLE 2.2.  Spectroscopic properties of dyes in pH 7.4. 
 
dye λabs 
(nm) 
ε 
(M-1cm-1) 
λem. 
(nm) 
fwhm 
(nm) 
Φ 
      
13 554 14300 640 60 0.33a 
20 581 15200 667 65 0.17b 
25 572 15250 658 53 0.26a 
27 554 7900 643 60 0.32a 
28 566 8300 654 63 0.28a 
Standard used for quantum yield measurement: arhodamine 101 in EtOH (Φ : 1.0), 
bsulforhodamine in EtOH (Φ : 1.0), quantum yield and extinction coefficients (at 10-6 M) 
were repeated three times. 
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2.2.1.3 Cellular Imaging Studies using Benzophenoxazine Dyes 
The subcellular localization of the Nile Red derivatives was studied in Clone 9 cells.  
When the cells were incubated with the hydrophobic 2-hydroxy Nile Red 24, no specific 
labeling was observed and both the mitochondria and the golgi were labeled (Figure 
2.4a).  On the other hand, Nile Red derivatives 25 and 27 targeted different organelles 
(Figure 2.4b and 2.4c).  Compound 25 specifically stained the mitochondria, while probe 
27 accumulated in the golgi.  The localization of 27 in the golgi was confirmed by 
comparing the staining pattern of 27 to the one of BODIPY TR ceramide complexed to 
BSA, a marker for golgi. Nile Red derivatives 13, 20 and 28 did not enter the cells under 
normal conditions.  This is probably because they are negatively charged.  In an attempt 
to import those dyes inside the cells, 28 was mixed with Pep-1 (1:3 mol ratio) and the 
cells incubated with this complex.  After 30 min incubation at 37 °C, the probe could be 
observed inside the cells, but was sequestered in lysozomes (Figure 2.4d). Dr. Aurore 
Loudet performed cellular imaging studies. 
 
 
 
Figure 2.4. Images of Clone 9 cells treated with (a) 2-hydroxy Nile Red 24 (b) dye 25 
(c) dye 27 and (d) dye 28. 
  24 
 
2.2.2 Conclusion 
In conclusion we have prepared five water-soluble dyes with good quantum yields to 
study the effect of different water-soluble groups on their photophysical properties in 
aqueous media. The yields of these dyes were moderate to good and can be easily 
reproduced. In some cases the syntheses can be scaled up to gram quantities without 
much synthetic effort. These water-soluble dyes can be readily purified on a reverse 
phase column without significant loss in yield. Photophysical properties do not seem to 
vary much with different water-soluble groups even though carboxylic acids seem to 
improve quantum yields better than sulfonic acids. This is due to the ability of such 
groups to disrupt π stacking in aqueous media. The large Stokes’ shift of the water-
soluble dyes compared to commercially available dyes makes them useful in 
applications such as in vitro imaging studies. Selected dyes 25 and 27 specifically 
stained the mitochondria and the golgi apparatus respectively proving their applicability 
for bioimaging studies. 
 
2.3 Water-soluble Nile Blue Derivatives 
Nile Blue, 29 (Figure 2.5), is a fluorescent probe that has been known for over 110 
years.32,72  In polar media its absorption and emission maxima shift to the red, indicative 
of stabilized charge separation in the excited state; consequently, this dye has been used 
to monitor events that depend upon solvent polarity.73-75 It has also been used for 
fluorescence resonance energy transfer (FRET) studies.76,77 Nile Blue tends to have a 
higher affinity for cancerous cells than healthy ones,78 and it is a photosensitizer for 
oxygen;79,80 these two properties together can be useful in photodynamic therapy.81 
However, two properties of Nile Blue in aqueous media are limiting for many 
applications, specifically: (i) low solubility; and, (ii) low quantum yield.   
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Figure 2.5. Photophysical properties of Nile Blue 29 in different solvents. 
 
Some work has been published on Nile Blue derivatives with improved water 
solubilities.82-85  Aggregation of inherently flat, lipophilic aromatic dyes is disfavored 
when they are functionalized with water-soluble substituents, and their quantum yields 
can improve as a result.  Consequently, Nile Blue derivatives bearing hydrophilic groups 
can have improved solubilities and fluorescence outputs.   Probes 30 and 31 are the most 
interesting probes to arise from these studies (Figure 2.6).82  Their quantum efficiencies 
are improved by as much as a factor of ten.  However, they have no carboxylic acid 
handle for attachment to biomolecules, and the sharpness of their emissions broaden as 
the solvent is changed from methanol to water, perhaps indicative of aggregation.  Other 
work involves incorporation of groups that offer only incrementally enhanced water 
solubilities,83 lack of quantum yield data,84 and/or no experimental procedures for the 
syntheses.84,85  
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Figure 2.6. (a) Reported water-soluble Nile Blue derivatives 30 and 31 and (b) Nile 
Blue derivatives synthesized in this work 32 and 33. 
 
This work reports the syntheses of the 2-hydroxy Nile Blue derivatives 32 and 33, and 
compares their fluorescence properties with those of 30 and 31.  For both probes, the 2-
hydroxy substituent was incorporated to enhance water solubility, and the other 
hydrophilic groups are situated on both ends of the molecule to reduce the potential for 
aggregation.  Not all possible applications of these dyes require functional groups for 
attachment to biomolecules, but many do, and compounds 33a and 33b were designed 
for that purpose. 
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2.3.1 Results and Discussion 
2.3.1.2 Synthesis of Nile Blue Derivatives (32 and 33) 
The western part of targets 32 and 33 were formed from functionalized nitrosophenols; 
these were prepared as outlined in Scheme 2.2 (compound 17) and Scheme 2.6 
(compound 34).  Nitroso compound 34 was formed via nitrosylation of phenol 9, a 
starting material previously used in these laboratories for syntheses of Nile Red 
derivatives.86 Both the aminonaphthol components 36 required for the eastern half of 
these molecules were made via alkylation reactions.  Compound 36a was obtained via 
alkylation with propane sultone (Scheme 2.7a).  The triethylene glycol derivative 37 was 
conveniently made in a few steps from the parent diol, then this was used to N-alkylate 
5-amino-2-naphthol as shown (Scheme 2.7b).87-89   
 
Scheme 2.6. Synthesis of nitroso aminophenols. 
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Scheme 2.7. Synthesis of water-soluble aminonaphthol components (a) and (b) 
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Previous syntheses of Nile Blue derivatives required relatively high temperatures and/or 
strong acids.  Compounds 32 and 33 were made via condensation at a relatively low 
temperature (90 °C) without addition of any additional acids.  The blue products were 
isolated via MPLC on a reverse phase C18 column (Scheme 2.8). 
 
Scheme 2.8. Synthesis of water-soluble Nile Blue derivatives (a) without carboxylic 
acid handle and (b) with carboxylic acid handle. 
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2.3.1.2 Photophysical Properties of Nile Blue Derivatives 
Electronic spectra (Figure 2.7) of the dyes were recorded in methanol, as a representative 
polar organic solvent, in 0.1 M phosphate buffer at pH 7.4 (PB, Table 2.3), in the same 
buffer but with 3 % Triton X-100 (TX), and in 0.1 M pH 9 borate buffer (BB).  Only 32a 
and 33a were soluble in MeOH; data for 32b and 33b could not be obtained in this 
medium.  The effects of adding Triton X-100 to the medium are ambiguous; this reagent 
changes the solvent polarity, but also might prevent aggregation effects.74,90,91  In borate 
buffer at pH 9.0 the phenolic hydroxyl of the dyes will be predominantly in the anionic 
form. The quantum yields of the dyes are much lower in pH 9 borate buffer compared to 
the ones in pH 7.4 phosphate buffer. This reduced quantum yield at higher pH can be 
attributed to the instability of the dyes in basic environment. 
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TABLE 2.3.  Spectroscopic properties of the Nile Blue derivatives in different solvents. 
 
dye λabs 
(nm) 
ε 
(M-1cm-1) 
λem. 
(nm) 
fwhm 
(nm) 
Φa solvent 
       
32a 628 14400 662 47 0.56 MeOH 
32a 630 42400 671 52 0.14 PBb 
32a 631 51200 669 49 0.24 TXc 
32a 630 28400 670 56 0.02 BBd 
33a 629 58800 666 50 0.32 MeOH 
33a 630 30300 670 58 0.10 PBb 
33a 629 64100 669 56 0.11 TXc 
33a 631 34500 670 73 0.02 BBd 
32b 629 33600 671 55 0.14 PBb 
32b 628 44400 670 47 0.23 TXc 
32b 630 21800 672 51 0.13 BBd 
33b 632 38100 673 56 0.13 PBb 
33b 631 14700 672 54 0.26 TXc 
33b 630 38000 670 54 0.08 BBd 
2982 635 4000 675 115 0.01 water 
3082 633 36000 675 86 0.10 water 
3182 637 11000 677 93 0.03 water 
aStandard used for quantum yield measurement: Nile Blue in MeOH (Φ: 0.27), quantum 
yield and extinction coefficient (at 10-6 M) experiments were repeated three times; bpH 
7.4 phosphate buffer; c3 % Triton X-100 in pH 7.4 phosphate buffer; dpH 9.0 borate 
buffer. 
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All the dyes under any of the conditions described above, had absorption maxima 
between 628 – 632 nm; consequently, there is little variation of this parameter with 
solvent polarity.  Extinction coefficients for the molecules, however, ranged from 10,100 
– 64,100.  For 32a, 33a, and 32b the maximum values corresponded to the media that 
includes Triton X-100; such enhancement effects have been observed for fluorescent 
dyes,90,91 including Nile Blue.74  Variations in the extinction coefficients for 33b were not 
as wide as for the other dyes, and the absolute values were less.  Fluorescent emission 
maxima for the dyes varied between 662 – 673 nm.  The fact that in MeOH, compounds 
32a and 33a had fluorescence emission maxima that were within 9 nm of the values in 
aqueous buffers means that the solvatochromic effects for these two materials are much 
less than for Nile Blue.  Further, lack of significant variations between the emission 
wavelengths in the various buffers indicates that increased pH change from 
physiological levels, and lipophilic co-solvents have little affect on these dyes.  
Sharpness of fluorescent emissions are expressed in terms of full width at half maximum 
peak heights (fwhm; where smaller is sharper).  All the dyes 32 and 33 emitted with 
sharper fluorescence peaks than Nile Blue 29 or the more water-soluble forms 30 and 31 
(data shown in Table 2.3 for these dyes is taken from the literature reference).  Further, 
in aqueous media the quantum yields for these emissions were in all cases better for 32 
and 33 relative to Nile Blue and its derivatives 30 and 31.82 
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FIGURE 2.7.  Absorption (dashed lines) and fluorescence (solid lines) at 2 x 10–6 M, of: 
a dyes 32a, 33a in methanol; b dyes in phosphate buffer (pH = 7.4); c dyes in 3% Triton 
X-100 in phosphate buffer (pH 7.4); and d in borate buffer (pH = 9.0).  All dyes excited 
at their corresponding λmax. 
 
Figure 2.8 outlines experiments performed to explore aggregation of the dyes in aqueous 
media.  Plots of the normalized UV absorbance versus concentration reveal that the λmax 
abs for compound 32a at 4µM occurs at 671 nm, with an inflection on the blue side of the 
peak at approximately 600 nm (Figure 2.8a).  This inflection point grows as the 
concentration of the dye was increased; at 16 µM there are two distinct absorption 
maxima, and at higher concentrations, the shorter wavelength absorption becomes 
dominant.  Figure 2.8 b shows that at concentrations of up to 4.0 µM the absorbance of 
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32a varies in a near linear way with concentration.  Above that concentration, the 
absorbance deviated markedly from linear concentration dependence.  Overall, these 
data may be interpreted to mean that the dye is aggregating at concentrations above ca 
4.0 µM.  Similar analyses using UV absorption indicate that dye 32a deviates from Beer-
Lambert behavior above this concentration.  Probably the dyes are forming fluorescent J-
aggregates at concentrations above ca 4.0 µM, rather than the non-fluorescent H-forms. 
Similar analyses for dyes 32b, 33a, and 33b (Figures 2.8 c – h) indicate very similar 
behavior.  Concentration versus absorbance studies indicate these materials tend to 
aggregate above 4.0 µM. 
 
Finally the Nile Blue derivative, 33a was used to label ovalbumin via activation of the 
dye-dicarboxylic acids (N-hydroxysuccinimide and N,N’-diisopropylcarbodiimide in 
DMF) followed by addition of this activated probe to protein in 0.1M NaHCO3 solution 
(pH 8.3).  The dye:protein ratio was calculated25 to be 1.1 when 5 eq. of dye was used; 
this corresponds to 22 % labeling efficiency.  This sample was used to obtain the 
spectral data shown in Figure 2.9a.   The wavelengths for the absorption and 
fluorescence maxima for the free dye 33a and the 33a-ovalbumin conjugate were 
observed to be almost identical, but the fluorescence intensity was much less for 33a-
ovalbumin conjugate. 
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FIGURE 2.8. Aggregation studies at various concentrations for dyes (32a-b, 33a-b). 
Normalized absorption for various concentrations (µM) in pH 7.4 phosphate buffer (plot 
a, c, e, g) and plot of absorbance intensity vs. concentration (plot b, d, f, h). 
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One application of Nile blue derivatives is to measure protein concentrations; this is 
possible because the fluorescence intensities of Nile blue derivatives tend to increase 
with protein concentration.  However, one limitation of this application is the poor water 
solubility of Nile Blue derivatives.  In this work, the Nile Blue derivative 33a was mixed 
with with increasing concentrations of ovalbumin in pH 6.8 phosphate buffer.   The 
fluorescence data for that set of experiments are shown in Figure 2.9b.  The fluorescence 
intensity of 33a was increased when the protein was added.  These increases were small, 
but the concentrations of ovalbumin were only varied between 3 – 12 µM, ie also small 
changes in protein concentration that are hard to detect.  Further, unlike in some 
previous work with lipophilic Nile Blue derivatives, use of the water-soluble form 33a 
circumvented the need for any detergent additives. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9. Absorption and fluorescence spectra of covalently and non-covalently 
bonded dye-protein conjugates.  a: Absorbance (blue) and fluorescence (red) spectra of 
33a-ovalbumin in 0.1 M phosphate buffer (pH 7.4).  b: Fluorescence spectra of 33a (5 x 
10–7 M) and blue: 0, green: 3.0, orange: 6.0, and red: 12.0 µM ovalbumin in phosphate 
buffer (pH 6.8), λex = 630 nm.  Inset: Variation in the fluorescence intensity of 33a vs. 
ovalbumin concentration. 
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2.3.2 Conclusion 
The Nile Blue derivatives reported here have sharper fluorescence emissions (fwhm 30 
nm less), and improved quantum yields in pH 7.4 phosphate buffer relative to the known 
water-soluble Nile Blue derivatives 30 and 31.  They are formed via condensation 
reactions that do not require added acids or very harsh reaction conditions (DMF, 90 
°C); this is in marked contrast to the syntheses of most other Nile Blue derivatives.  
Preparative HPLC purification of the products was not necessary: they were isolated via 
reverse phase medium pressure liquid chromatography (MPLC) using acetonitrile/water 
eluant.  The phenolic OH functionalities of dyes 32 and 33 almost certainly increase the 
water solubilities of these compounds.  Alternatively, the phenolic group provides a 
potential avenue for further derivatization of the dyes (eg via triflation and 
organometallic couplings, or for attachment of a handle to enable dyes 32 to be 
conjugated to proteins).   Three other groups that promote water solubilities were 
included in these studies: a sulfonic acid, dicarboxylic acids, and a triethylene glycol 
fragment.  Despite this, the fluorescence properties of the dyes, and presumably their 
aggregation states at elevated concentrations, did not vary significantly.  All the dyes 
showed little tendency to aggregate below 1 - 4 µM; this characteristic would tend to 
make them useful for biochemical studies when used in relatively dilute solutions, but 
would exclude applications where quantitation is required at higher concentrations.  
Probably the most useful spectroscopic parameter of the dyes is their fluorescence at 
relatively long wavelengths, 670-680 nm, in aqueous media.  Probes that emit above 650 
nm are relatively few, yet they tend to be the most useful ones for tissue and intracellular 
imaging applications.92,93 
 
Many applications of Nile Blue require it to be water-soluble. Nile Blue acts as an 
electron mediator for the oxidation of the 1,4-dihydronicotinamide, NAD(P)H cofactors 
and can be used for detection of NAD(P)H.94 Upon interaction with NAD(P)H the 
fluorescence of Nile Blue is quenched due to reduction of Nile Blue by NAD(P)H.95 
Most studies use commercially available sparingly water-soluble Nile Blue and therefore 
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a surfactant or additive has to be used to enhance solubility of Nile Blue in aqueous 
media. The water-soluble Nile Blues described in this section can improve detection of 
such metabolites in an aqueous environment. Detection of trace amount of aluminum in 
food samples is performed using a kinetic method involving slow oxidation of Nile Blue 
with potassium bromate.96 This oxidation reaction is catalyzed by aluminum and 
therefore can be used as a tool for analyzing the presence of aluminum in food samples. 
The reaction is carried out in aqueous acidic media and therefore a hydrophilic Nile Blue 
analogue can greatly enhance the sensitivity of such measurements. Nile Blue 
derivatives are used for detection of nanomolar concentration of toxic metals such as 
Hg(II) in aqueous media as a low cost alternative to other detection methods.97 In spite 
of their low quantum yields (0.1), water-soluble analogues of Nile Blue are preferred to 
the water insoluble non fluorescent ones for sensing and detection studies. 
 
2.4 SNAP Tag 
Site specific labeling of proteins in vivo with fluorescent probes helps to study their 
functions and understand protein-protein interactions in live cells or tissues. Currently 
the methods available to achieve site specific labeling involve either genetically 
modifying the protein of interest by introducing an unnatural amino acid using nonsense 
codon suppression technology98,99 or expressing them as a fusion protein with a 
polypeptide or protein to which a fluorescent label is attached.100 While genetic 
modifications are limited to proteins which are expressed in exogenous hosts, fusion 
proteins often result in oligomerisation. Attachment of organic functional groups to 
specific locations on the protein using chemical reactions is another alternative for 
protein labeling but suffers from the fact that proteins may not be stable to all reaction 
conditions and most of these reactions involve modification of cysteine or lysine 
residues which are very abundant in most proteins and therefore affect specificity.101 
Introduction of organometallic intermediates, which target less common amino acids like 
tryptophan and tyrosine seems to have somewhat overcome the problem of specificity, 
the broad applicability of these reactions are still to be ascertained.102,103 
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O6-benzylguanine derivatives commonly referred to as SNAP-Tags in literature, have 
gained prominence in recent years due to their small size and ability to selectively label 
biomolecules.104,105 It is based on the human form of DNA repair protein O6-
alkylguanine-DNA alkyltransferase (AGT). The function of AGT is to remove alkyl 
groups from guanine bases of DNA to prevent mutations during cell division. The 
removal of alkyl group is achieved by formation of a covalent thioether bond with the 
alkyl group by the cysteine residue. The discovery by Johnsson et al., that AGT can 
undergo reaction with any chemical moiety when attached to the guanine base through a 
benzyl group, triggered a widespread interest in using them as potential cellular imaging 
agents.106 The labeling is based on the irreversible reaction of DNA alkyltransferase with 
O6-benzylguanine derivative to which a fluorophore is attached (Figure 2.10). The 
reaction results in transfer of the fluorophore to the cysteine residue of AGT. This 
reaction allows any fluorescent tag with a suitable handle to be transferred to a protein of 
interest, which is attached to AGT. There is no known dependence of reaction rate with 
the type of fluorescent probe used. Wild type AGT (207 amino acids) can be mutated by 
removing 30 C-terminal residues without significantly altering its activity towards 
benzylguanine. This mutation is necessary to avoid reaction of AGT with alkyl groups 
on alkylguanine residues. Removal of amino acid residues also makes AGT much 
smaller than auto fluorescent proteins. 
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Figure 2.10. Reaction mechanism for SNAP-tag essay. 
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Figure 2.11 shows a list of the most commonly used fluorescent probes for synthesis of 
SNAP-tag. All probes are commercially available and emit in the 500-620 nm region. 
Presence of acetyl groups promote cell permeability, as the efficiency of labeling is 
dependent on the cell permeability of the substrate. In some cases the benzyl guanine is 
modified by addition of ester groups on guanine to promote permeability.107 
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Figure 2.11. Commonly used SNAP-tag fluorescent labels. 
 
The general strategy for syntheses of SNAP-tags is shown in Scheme 2.9.108 6-
Chloroguanine is activated by treatment with N-methylpyrolidine and the activated 
guanine is coupled with trifluoro-N-(4-hydroxymethyl-benzyl)-acetamide to form the 
corresponding protected benzylguanine derivative. Deprotection of protected 
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benzylguanine derivative and coupling with activated fluorophores yields the SNAP-tags 
in 2-10 % yield. The low stability of the activated fluorophores results in poor yields in 
the coupling step. 
 
Scheme 2.9. General strategy for syntheses of SNAP-tags. 
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Recently Blake Peterson et al. have reported SNAP-tag based on Pennsylvania Green 
derivatives, which exhibit substantially higher cell permeability than similar Oregon 
Green derivatives (Figure 2.12).109 Their work shows that a small change in molecular 
substitution of a carboxylate group in Oregon Green to a methyl group in Pennsylvania 
Green greatly enhances the cell permeability and therefore biological activity of O6-
benzylguanine derivatives. Transient transfection of CHO cells with nuclear localized 
AGT-H2B fusion protein showed strong nuclear fluorescence upon labeling with O6-
benzylguanine-Pennsylvania Green but only weak nuclear fluorescence signal when 
labeled with O6-benzylguanine-Oregon green under same reaction conditions. 
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Figure 2.12. Structures of O6-benzylguanine-Pennsylvania and Oregon green. 
 
2.4.1 Results and discussion 
A major problem encountered in cellular imaging studies is the inherent auto- 
fluorescence of cells in the 400-600 nm region, which sometimes results in false 
positives and should be avoided. The way to overcome this problem is to synthesize 
probes, which emit in the 600-800 nm region. Nile Red and its derivatives fluoresce 
around 630-640 nm and its emission is solvent dependent, with a bathochromic shift in 
more polar solvents like water. There is no reported SNAP-tags based on Nile Red 
derivatives in the literature probably due to the absence of a handle such as carboxyl 
group which can be used to attach it to benzylguanine. We had earlier reported synthesis 
of a dicarboxylic acid derivative of Nile Red.31 In collaboration with Covalys 
Biosciences AG, Switzerland, we prepared Nile Red-SNAP-tag, which was used for 
labeling studies (Figure 2.13). Transfection of CHO cells with AGT26-his fusion protein 
and treatment with Nile Red-SNAP-tag shows distinct fluorescence indicating that the 
compound is entering the cell (Figure 2.14). Most of the label seems to be trapped in the 
cytosol and no fluorescence was observed from the nuclei. 
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Figure 2.13. Nile Red based SNAP-tag derivative. 
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Figure 2.14. (a) SDS Gel shows Nile Red-SNAP-tag is reactive towards SNAP26-his 
(line A and B); (b) labeling of CHO-K1 cell line with Nile Red-SNAP-tag. Green spots 
shows labeling with Nile Red-SNAP-tag and blue is DAPI stain (control for nuclear 
staining). 
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These results prompted us to modify the structure of the Nile Red derivative to improve 
its nuclear permeability. The modified Nile Red derivative 13 was used to synthesize 
benzylguanine derivatives 13a, 13b, and 13c (Figure 2.15). Transfection of CHO cell 
lines CHO-K1 and CHO-NLS with AGT26-his fusion protein and treatment with 13a, 
13b, and 13c again gave distinct fluorescence indicating that the compound is entering 
the cell but was trapped in either vesicles and in some cases mitochondria (Figure 2.16 
and 2.17).  Further studies are required to synthesize a SNAP-tag based on Nile Red 
derivative, which can selectively label nuclei. 
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Figure 2.15. SNAP-tag based on Nile Red with different benzylguanine derivatives. 
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Figure 2.16. Labeling of CHO-K1 cell line with SNAP-tags (a) 13a (b) 13b (c) 13c. 
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Figure 2.17. Labeling of CHO-NLS cell line with SNAP-tags (a) 13a (b) 13b (c) 13c. 
 
2.4.2 Conclusion 
We have synthesized water-soluble derivatives of benzophenoxazine dyes and studied 
their photophysical properties in aqueous media. There are only a few water-soluble 
benzophenoxazine dyes reported in the literature and the ones that are published do not 
give full photophysical properties in aqueous media.57,61 The quantum yields of these 
dyes in pH 7.4 phosphate buffer were in the range of 0.1-0.33, which is a great 
improvement from the corresponding insoluble ones. Aggregation studies on these dyes 
  46 
shows that they have fewer tendencies to aggregate in the 1 - 4 µM range which tends to 
make them useful for biochemical studies when used in low concentration. Most 
applications dealing with organic fluorophores involve dilute concentrations and 
therefore the above mentioned range in which the dyes are in the non-aggregated state is 
not a serious drawback in using them. Selected dyes 25 and 27 specifically stained the 
mitochondria and the golgi apparatus respectively proving their applicability for 
bioimaging studies. There is no reported use of benzophenoxazine dyes for cellular 
imaging studies. Dye 13 was used to synthesize benzylguanine derivatives of SNAP-tag 
for cell imaging and was observed to enter cells efficiently. 
 
Presence of a phenoxazine core in chemotherapeutic drugs such as actinomycin D 
(Figure 2.18) suggests that the phenoxazine derivatives may possess anticancer 
activities. In vitro and in vivo studies on various cancerous cell lines have shown the 
antitumor activities of water-soluble phenoxazines.110 In light of these findings, it would 
be interesting to study the antitumor activity of the synthesized water-soluble 
benzophenoxazine dyes. 
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Figure2.18. Structure of actinomycin D, a chemotherapeutic drug. 
 
Our motivation to synthesize benzophenoxazine dyes was not only to make them water-
soluble but also to use them as a possible acceptor fragment in through-bond energy 
transfer cassettes. The syntheses of such cassettes are reported in the Chapter III.  
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CHAPTER III 
 
ENERGY TRANSFER CASSETTES 
 
3.1 Through-bond Energy Transfer Cassettes 
Through-bond energy transfer (TBET) cassettes consist of two fluorophores, a donor 
absorbing at a lower wavelength and an acceptor emitting at a longer wavelength 
connected by a conjugate linker in such a manner that the entire molecule is not 
completely planar. Such cassettes could be particularly useful in biotechnology for 
multiplexing experiments in which several outputs are to be observed from a single 
excitation source. The advantage of such a system over traditional FRET based systems 
is that there is no known requirement of overlap between the donor emission and the 
acceptor absorbance. Therefore in principle any two fluorophores can be linked together 
to observe a single fluorescence output from the acceptor. Initial work from our lab 
proved that such systems are synthetically viable and can be constructed without much 
difficulty.29,111 These TBET cassettes showed good photophysical properties and highly 
efficient energy transfer in organic media. In order to broaden their utility for cellular 
imaging studies these cassettes need to be water-soluble. Some water-soluble cassettes 
were reported from our group and was used for monitoring three-component interactions 
in vitro and in living cells.112  
 
3.1.1 Results and Discussion 
We intend to shift the emission of such TBET cassette systems further to the near IR 
region of the spectrum and make them water-soluble either by decorating them with 
water-soluble groups such as carboxylic acids and sulfonic acids or by encapsulating 
them in silica or calcium phosphate nanoparticles, which can then be dispersed in water. 
We chose to work with benzophenoxazine dye Nile Red and cyanine dye Cy5 as 
acceptors which emit in the 600-700 nm region. Figure 3.1 shows the structure of 
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cassettes 39-44. Cassettes 43 and 44 are hydrophobic in nature and were synthesized to 
encapsulate in silica or calcium phosphate nanoparticles (Chapter 4). Cassettes 39-43 
have Nile Red derivatives as their acceptor fragment and cassette 44 has cyanine dye 
Cy5 as the acceptor fragment. The donor fragment for all the cassettes are either 
fluorescein or BODIPY derivatives. Both of them absorb around 480-500 nm and emit 
in the 510-515 nm range. Cassettes 39-42 were designed to study the combination of 
donor and acceptor that would result in a TBET cassette with good energy transfer 
properties in aqueous media.  
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Figure 3.1. Structure of cassettes 39-44. 
  49 
3.1.1.1 Syntheses of Cassettes 
Figure 3.2 shows donor fragments used for cassettes 39-44. Dr. Yuichiro Ueno provided 
donor fragments 45 and 49. Mr. Juan Castro provided dichlorofluorescien derivative 46 
and Miss Lingling Li provided sulfonic acid BODIPY 47. Donor fragment 48 was 
synthesized using a procedure reported for synthesis of BODIPY 47.62 The nitro 
BODIPY 54 was refluxed in EtOH in presence of hydrazine for 30 minutes to form the 
amino derivative. The amino derivative being unstable was directly subjected to 
diazotization at 0 oC, followed by an azide transfer reaction with sodium azide to obtain 
donor fragment 47. (Scheme 3.1) 
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Figure 3.2. Structure of donors used for synthesis of cassettes 39-44. 
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Scheme 3.1. Synthesis of donor fragment 48. 
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Acceptor fragments 50 and 51 (Figure 3.3) were synthesized via triflation reaction.113 
Nile Red derivatives 55 and 56 were treated with N-phenyltriflamide in presence of 
triethylamine at 25 oC for 24 h in THF to obtain the corresponding triflates 50 and 51 in 
55 and 52 % yield respectively. Sonogashira coupling of 51 with trimethylsilylalkyne 
followed by deprotection at 25 oC for 30 minutes with TBAF afforded acceptor fragment 
52 in 58 % overall yield. (Scheme 3.2b) Condensation of indolium bromide 58 with 
N,N’-diphenylformamidine at 120 oC in acetic anhydride for 30 min followed by 
treatment with indolium iodide 59 at 25 oC afforded acceptor fragment 53 in 65 % yield 
(Scheme 3.2c). 
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Figure 3.3. Structure of acceptors used for synthesis of cassettes 39-44. 
 
Scheme 3.2. Synthesis of acceptor fragment (a) 50 (b) 51, 52 and (c) 53. 
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Cassette 39 (scheme 3.3) was prepared via Sonogashira coupling of Nile Red triflate 50 
with fluorescein alkyne 45. The coupling reaction proceeded only at high temperature 
(above 100 oC). An initial screening of reaction conditions showed that no coupling 
products were obtained even at high temperature when PdCl2(PPh3)2 was used as a 
catalyst. Use of Pd(PPh3)4 as catalyst and heating to 130 oC afforded product 39 in 49 % 
yield. At temperatures lower than 130 oC, the yield was very low, and in most cases, 
there was no reaction at all. 
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Scheme 3.3. Synthesis of cassette 39. 
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Cassettes 40 and 41 were also prepared via palladium catalyzed cross coupling reaction 
between the corresponding triflate and an alkyne. The reaction conditions were similar to 
the synthesis of cassette 39 and coupling was possible only at 130 oC. The dimethylester 
derivatives obtained were hydrolyzed to carboxylic acids using K2CO3 in MeOH/Water 
mixture and purified via acid base extraction and then by reverse phase HPLC to afford 
40 and 41 in 59 and 21 % yield. The dichlorofluorescien alkyne is not very stable at 130  
oC and therefore the yield of the coupling reaction is low in case of cassette 41. 
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Scheme 3.4. Synthesis of cassettes 40 and 41. 
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1,3 dipolar cycloadditions between an azide and an alkyne is a well established 
reaction.114-116 Cassettes 42 and 43 were synthesized using copper catalyzed 1,3 dipolar 
cycoladditons using tris(1 - benzyl - 1H - 1,2,3 - triazol - 4 - yl)methyl amine (TBTA) 
ligand as a copper stabilizer (Scheme 3.5). Reaction without the TBTA ligand resulted in 
poor yields of cycloaddition products. Reaction of water-soluble BODIPY 47 with Nile 
Red alkyne 52, followed by hydrolysis in aqueous methanol with K2CO3 afforded 
cassette 42. The product was purified on a reverse phase medium pressure liquid 
chromatography (MPLC) C-18 column using CH3CN/H2O (1/1) as eluent to afford 
cassette 42 as a dark purple colored material in 39 % yield. Cassette 43 was obtained in 
30 % yield under similar reaction conditions and purified on a reverse phase medium 
pressure liquid chromatography (MPLC) C-18 column using CH3CN/H2O (7/3) as 
eluent. The low yield of these two cassettes is due to the apparent instability of BODIPY 
in basic media. 
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Scheme 3.5. Synthesis of cassettes 42 and 43. 
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The final cassette 44 was synthesized via palladium catalyzed cross coupling reaction 
between BODIPY alkyne 48 and iodocyanine 53 (Scheme 3.6). Cyanine dyes are 
chemically unstable at temperatures above 40 oC and therefore the coupling reaction was 
carried out at 40 oC for 1 h. Attempted reactions at 25 and 30 oC resulted in either no 
reaction or very poor conversion, which was confirmed by TLC. Flash chromatography 
purification using 10 to 50 % MeOH/CH2Cl2 afforded cassette 44 as a dark purple solid 
in 26 % yield. 
 
Scheme 3.6. Synthesis of cassette 44. 
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3.1.1.2 Photophysical Properties of Cassettes 
The absorbtion and emission profiles of cassettes 39-44 in EtOH are shown in Figure 
3.4. As expected the absorbtion of cassettes shows the presence of two distinct 
absorbtion maxima corresponding to the donor and acceptor fragments of each cassette. 
The fluorescence of cassettes 39-44 in EtOH shows efficient energy transfer without 
significant leakage from the donor fragment. The prominent emissions from all the 
cassettes are seen from the acceptor fragment. The quantum efficiency of all cassettes in 
EtOH was in the range of 0.31 to 0.41 when excited at the donor. The energy transfer 
efficiency (ETE) calculated for cassettes 39-44 ranged from 77 to 97 %  (Table 3.1). 
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Figure 3.4. Normalized absorbance (a) and fluorescence (b) of cassettes 39-44 in EtOH. 
Concentration for absorbance measurement 10-6 M; concentration for fluorescence 
measurement 10-7 M. 
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Table 3.1. Photophysical properties of cassettes 39-44 in EtOH. 
dye λabs(nm) λem.(nm) ΦD ΦAc ETE % 
(ΦD/ΦA) 
      
39 498, 561 648 0.31+/-0.02a 0.40+/-0.03 77 
40 495, 546 644 0.34+/-0.01a 0.38+/-0.01 89 
41 515, 555 645 0.36+/-0.03b 0.43+/-0.02 83 
42 506, 553 632 0.41+/-0.02b 0.49+/-0.02 81 
43 501, 541 624 0.36+/-0.02b 0.37+/-0.01 97 
44 504, 662 687 0.35+/-0.01b 0.40+/-0.02d 90 
ΦD: quantum yield of cassette when excited at the donor. ΦA: quantum yield of cassette 
when excited at the acceptor. Standard used for quantum yield measurement: 
aFluorescien in 0.1 M NaOH (Φ: 0.92),  brhodamine 6G in EtOH (Φ: 0.94), crhodamine 
101 in EtOH (Φ: 1.0); dNile Blue (Φ: 0.27 in EtOH). Quantum yield measurements were 
repeated three times and averaged.  
 
The photophysical properties of the cassettes in pH 7.4 phosphate buffer were not that 
encouraging (Figure 3.5). Water-soluble cassettes 39-41 showed almost no energy 
transfer (Table 3.2). Cassette 42 showed 42 % energy transfer with a reduced quantum 
yield of 0.1 when excited at the donor. These results show that in cassettes 39-42 non-
radiative processes predominate in aqueous media, which result in poor energy transfer. 
Cassettes 39-41 all had fluorescein derivatives as the donor and in all cases almost no 
fluorescence output from the acceptor Nile Red was seen. The presence of water-soluble 
groups in these cassettes did not prevent it from aggregating in aqueous media, which 
contributes to their poor energy transfer efficiency. 
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Figure 3.5. Normalized absorbance (a) and fluorescence (b) of cassettes 39-42 in pH 7.4 
(0.1 M sodium phosphate buffer). Concentration for absorbance measurement 10-6 M; 
concentration for fluorescence measurement 10-7 M. 
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Table 3.2. Photophysical properties of cassettes 39-42 in pH 7.4 (0.1 M sodium 
phosphate buffer). 
 
dye λabs(nm) λem.(nm) ΦD ΦAc ETE % 
(ΦD/ΦA) 
      
39 493, 591 517 0.010a 0.14+/-0.02 7 
40 500, 577 520 0.008b 0.12+/-0.01 6 
41 506, 593 528, 662 0.016b 0.11+/-0.03 14 
42 497, 575 509, 637 0.10a 0.24+/-0.01 42 
ΦD: quantum yield of cassette when excited at the donor. ΦA: quantum yield of cassette 
when excited at the acceptor. Standard used for quantum yield measurement: 
aFluorescien in 0.1 M NaOH (Φ: 0.92),  brhodamine 6G in EtOH (Φ: 0.94), 
sulforhodamine in EtOH (Φ: 1.0); quantum were repeated three times and averaged.  
 
3.1.2 Conclusion 
Through-bond energy transfer cassettes based on Nile Red derivatives and cyanine dye 
Cy5 were synthesized to study their behavior in organic and aqueous media. TBET 
cassettes based on Nile Red derivatives showed good energy transfer in organic media 
but very poor energy transfer in aqueous media. TBET cassettes with a Nile Red 
derivative as the acceptor and fluorescein derivative as the donor showed almost no 
energy transfer in aqueous media. When the donor was changed to water-soluble 
BODIPY we observed 40 % energy transfer from the donor to the acceptor. These 
findings show that fluorescein is not a good donor for synthesis of water-soluble TBET 
cassettes. Another reason may be the low quantum yield and molar extinction coefficient 
of acceptor Nile Red derivatives compared to the fluorescein donor. Energy transfer is 
not properly mediated in such a system and non-radiative processes dominate in aqueous 
media. Substituting the alkyne linker with a triazole linker in these cassettes may help to 
some extent in improving energy transfer efficiency. 
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In conclusion we have prepared six cassettes based on Nile Red and cyanine acceptors 
and fluorescein or BODIPY fragments as donors.  These show efficient energy transfer 
in ethanol and fluoresce with a quantum yield of 0.31- 0.41. Their long wavelength 
emission and large Stokes’ shifts are useful for fluorescence studies in polar, hydrogen-
bonding, organic solvents.   Our current efforts are focused on making similar cassettes 
with improved photophysical properties for use in biological media. Cassettes 43 and 44 
were prepared for encapsulation in silica and calcium phosphate nanoparticles and will 
be discussed in Chapter IV. 
 
3.2 Chemiluminescent Energy Transfer Cassettes 
The two most common ways to induce chemiluminescence in purely organic, non-
biological, systems are to treat either oxalate esters or luminol derivatives with basic 
hydrogen peroxide.117,118 Both these types of mixtures give light of relatively short 
wavelengths that are not ideal for applications in biotechnology.  Luminol, for instance, 
emits in the range 420 - 450 nm, depending on the solvent media.119 Intimate mixtures of 
oxalate esters or luminol,120 an oxidant, and an acceptor dye give longer wavelength 
emissions via intermolecular energy transfer.  This results in the mesmerizing, long-lived 
emissions seen in “light stick toys”.  However, the options for forming discrete probes 
for biotechnology that emit at longer, and generally more useful, wavelengths are 
limited.121-124,125 All our published research to date features cassettes based on UV-
absorbing donors, like compound 3 (Figure 3.6).    We thought it would be intriguing to 
make cassettes where the donor might be activated chemically instead.  Oxalate esters 
are not useful donors for through-bond energy transfer cassettes because it is impossible 
to conjugate an acceptor to the oxalate fragment.  Consequently, luminol-based systems 
were selected.  Described here are the syntheses and spectroscopic properties of the 
fluorescein- and Nile Red-based, chemically activated, cassettes 60 and 61. 
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Figure 3.6.  Structure of (a) light activated and (b) chemically activated TBET cassettes. 
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3.2.1 Results and Discussions 
3.2.1.1 Synthesis of Chemiluminescent Cassettes 
Nearly all luminol derivatives are insoluble in most organic media, and this makes them 
extremely difficult to manipulate.  After considerable experimentation, one solution to 
this problem emerged: bis(N-protection) of compounds like 3 with 4-methoxybenzyl 
(PMB) groups.  This approach gave organic-soluble, easily chromatographed, 
intermediates, and the PMB group is removed in the closing stages of the synthesis via 
treatment with TFA.   Thus, Scheme 3.7 shows the syntheses that evolved for 
compounds 60 and 61.  In both routes, the cyclic hydrazide 63 was bis-N-protected, then 
elaborated via Sonogashira reactions.126  These featured derivatives of 5-
bromofluorescein127 and  2-hydroxy Nile Red.128  The route to the cassettes would have 
been more convergent if an alkyne derivative of luminol could have been coupled with 
halogenated/triflated acceptors, but that approach was ineffective. 
 
Scheme 3.7. Preparation of (a) fluorescein cassette 60 and (b) Nile Red cassette 61. 
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(i) 10 mol% Pd(PPh3)4
20 mol% CuI, Et3N, DMF 
63, 80 oC, 4 h
(ii) TFA, reflux, 1 h
61  57 %
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3.2.1.2 Photophysical Properties of Chemiluminescent Cassettes 
It is hard to describe the spectacular chemiluminescence of these compounds without 
showing pictures of the experiments to support the words (Figure 3.7).  For cassette 60, a 
100 µl aliquots of the compound (10-5 M, in pH = 10 aqueous Na2CO3/NaHCO3 buffer) 
was added to a sample cell containing CuSO4 (1.5 x 10-3 M) and H2O2 (2.0 x 10-3 M) 
with stirring.  Cassette 61 is not very soluble in aqueous media and, in any case, the 
quantum yield for Nile Red emission is less than 0.1 in water.  Consequently, for 61, 
potassium tert-butoxide in THF (10-2 M) was added to the compound dissolved in dry 
DMF (10-5 M).  This experiment is done open to the air and oxygen is presumed to be 
the oxidant.   Luminol under the conditions used for cassette 60 gives a bright blue 
emission. If efficient energy transfer occurred for compounds 60 and 61 then we were 
expecting them to emit yellow/green for fluorescein cassette 60 and red 
chemiluminescence for Nile Red cassette 61 instead, characteristic of fluorescein and 
Nile Red, respectively.  This is exactly what we saw.  Cassette 60 gave a bright 
yellow/green emission, while 61 glowed with a less intense red color.  No trace of blue 
in the emission was seen in either case. 
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Figure 3.7.  Pictures of a luminol, b cassette 60, and c cassette 61 when activated with 
an oxidant. 
 
Compounds 69 and 70 (Figure 3.8) were prepared as controls since it is thought that the 
excited species from luminol derivatives involves the corresponding phthalate dianions.  
Indeed, ESI-MS analysis of cassettes 60 and 61 after the oxidative activation revealed 
the presence of 69 and 70, respectively.  This was confirmed via HPLC analyses in the 
case of 60. 
 
O
N
Et2N O
CO2H
CO2H
70
CO2H
CO2H
OO OH
CO2H
69  
Figure 3.8. Control compounds 69 and 70. 
 
Figure 3.9a shows normalized UV absorption and fluorescence spectra for 69, and 70.  
The extent of overlap between the chemiluminescence output of the phthalate derived 
from luminol and the UV absorption of the acceptor part of cassettes 69 and 70 is shown 
in Figure 3.9b.  Normalized chemiluminescence emissions for 60 and 61 are shown in 
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Figure 3.9c.  The emissions of 60 and 61 are sharp and characteristic of the acceptors 
only; no chemiluminescence from the donor was detected. 
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Figure 3.9. Normalized UV and fluorescence spectra of cassettes. a UV/visible and 
fluorescence spectra of 69 in pH: 10 aqueous sodium carbonate/bicarbonate buffer 
solution, and of 70 in dry DMF; b chemiluminescence spectrum of luminol (blue), 
UV/vis absorption bands of compound 69 (green) and compound 70 (red); c 
chemiluminescence spectra of luminol (blue), cassette 60 (green), and cassette 61 (red). 
 
Sometimes, the eyes can play tricks on the brain, and that is partially true in this case.  
The chemiluminescence from cassette 61 appears to be weaker than that for 60, but the 
quantitative data collected in Table 3.3 indicates this is not the case.  Chemiluminescent 
quantum yields measured relative to luminol indicate 61 actually emits more strongly.  
Probably, chemiluminescence from 61 appears to be weaker than that from 71 because 
the human eye is about five times more sensitive to light near the emission maximum of 
fluorescein than it is to light emitted from the Nile Red acceptors.129 
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Table 3.3. Selected spectroscopic properties of luminol, 60, 69, 61, 70 and 71. 
compound UV fluorescence chemiluminesence 
 λabs max 
(nm) 
λfluor max 
(nm)b 
λchemi max 
(nm)b 
Relative Φchemi 
     
luminola - - 442 100a 
60a 494 518 524 61b 
69a 493 519 - - 
61b 558 628 634 >100b 
70b 558 628 - - 
71 - - 412 0.02d 
a In carbonate/bicarbonate buffer.  bIn dry DMF.  cFrom ref. 84. 
The relative quantum yields for chemiluminescence that are presented in Table 3.3 use 
luminol as a standard.  However, the donor fragments of cassettes 60 and 61 do not have 
the amino substituent of luminol.  Small changes to the luminol structure tend to reduce 
its chemiluminescence dramatically.119 If the emissions from cassettes 60 and 61 were 
compared with the hydrazide 71 (which has a much lower absolute quantum yield for 
chemiluminescence) then the data for cassettes 60 and 61 would appear to be even more 
impressive.   
 
NH
NH
O
O
71  
 
 
Experimentally, it is extremely challenging to determine the extent of energy transfer 
through bonds and through space in twisted but otherwise conjugated cassettes.  For the 
UV-activated system 3 we asserted that through-bond energy transfer must be fast and 
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efficient by considering rates of energy transfer.130  However, direct observation of rates 
is hard in chemically activated systems where excitation of the donor occurs 
continuously.  Further, we have so far been unable to prepare the logical control 
compounds for comparison: those in which the alkyne linker of cassettes 60 or 61 are 
replaced by an ethylene fragment.   In any case, through-space energy transfer for those 
controls might differ considerably from that occurring in 60 or 61 because the 
orientation of the donor and acceptor fragments would be dynamic in the reduced 
compounds.  However, the through-space energy transfer cassette 72, based on luminol, 
was prepared approximately four decades ago and does provide an interesting 
comparison.131-133  The reported relative chemiluminescence quantum yield for this 
compound (luminol standard) is significantly less than that measured here for cassettes 
60 and 61.  It may be that, just as in our UV-activated cassettes like 3, rapid and efficient 
energy transfer can occur for the systems that facilitate the possibility of through-bond 
energy transfer.   
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Calculations of Förster energy transfer for systems that have donor and acceptor 
fragments arranged within a few Ångstroms are not reliable because the theory implies a 
point dipole approximation which fails when the distance becomes less than the special 
size of the donor and acceptor charge distributions.  Nevertheless, these calculations 
were performed; the dipole-dipole energy transfer efficiency was smaller (39 and 42% 
for 60 and 61, respectively) than actually observed.  
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3.2.2 Conclusion 
Chemiluminescence provides detection methods that approach the sensitivity of ones 
based on radioactivity.134  In the context of intracellular imaging, it has the advantage 
that no excitation irradiation is required.  Simple in vitro experiments show that cassettes 
60 and 61 can be activated via treatment with peroxidase under physiological conditions, 
and they emit in longer wavelength regions that are more transparent to cellular tissues 
than the 420 - 450 nm range where luminol chemiluminesces.  Consequently, there is a 
possibility that probes based on chemically activated energy transfer can be applied in 
biotechnology. Dr. Junyan Han performed most work in synthesis of chemiluminescent 
energy transfer cassettes. 
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CHAPTER IV 
 
 
ENCAPSULATION OF ORGANIC FLUOROPHORES INTO WATER 
  
DISPERSIBLE NANOPARTICLES 
 
 
4.1 Organic Fluorophores Encapsulated in Silica Nanoparticles 
Recent work from several groups have shown that organic fluorophores can be 
encapsulated in silica nanoparticles thereby improving the photophysical properties of 
the fluorophores.135-137 These particles can be prepared with a uniform size, often smaller 
than 50 nm as shown by transmission electron microscopy (TEM) and scanning electron 
microscopy (SEM). They are well dispersed in water and remain without aggregations 
for several months. Under similar excitation conditions, a single silica nanoparticle can 
emit as many photons as the number of dye molecules in the nanoparticles as compared 
to a single photon from the corresponding unencapsulated fluorophore resulting in better 
resolution.138 The most promising characteristic of silica nanoparticles is that they are 
expected to be biologically inert and thus potentially non-cytotoxic for cellular imaging 
studies at concentrations below 0.1 mg/mL.139 
 
4.1.1 Synthesis of Silica Nanoparticles 
The synthesis of spherical silica nanoparticles can be broadly divided into two 
categories: (i) Reverse microemulsion and (ii) sol-gel synthesis. Reverse microemulsion 
relies on the controlled aqueous environment within surfactant-confined micelles in a 
nonpolar solvent such as cyclohexane to create monodisperse spherical colloids (Figure 
4.1).140 This method is used even today by various groups and has been shown to yield 
highly monodispersed particles suitable for incorporating nonpolar molecules into the 
silica matrix. The major drawback of this approach is the lack of non-covalent 
attachment of the fluorophore to the silica matrix, which results in leaching of the 
fluorophore out of the dye matrix over time, thereby reducing per particle brightness.138  
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This method of synthesis usually yields low amounts of silica nanoparticles and requires 
extensive washing procedures to remove surfactants.  
 
Si(OEt)4
NH4OH
dye
Si(OEt)4
dye doped silica 
nanoparticles
dye
in H2O
water-in-oil microemulsion
surfactant molecules
oil
 
Figure 4.1. Microemulsion method for synthesis of silica nanoparticles. 
 
In the late 1960s, Stoeber and coworkers developed a synthetic method for growing 
monodisperse 100 nm spherical silica nanoparticles  based on sol-gel chemistry of 
silicon alkoxides.141 This method involves hydrolysis and self-condensation of 
tetraethoxysilicate (TEOS) in EtOH in the presence of water and ammonia (used as a 
catalyst) to produce monodispersed 100 nm spherical silica nanoparticles. This method 
was improved upon by Van Blaaderen et al. to covalently incorporate organic 
fluorophores into the silica matrix by reacting them with organosilicates.142,143  However, 
the particle size of silica nanoparticles obtained by these methods were always in the 100 
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nm region, which is much larger than an organic fluorophore or fluorescent proteins and 
therefore, the nanoparticles have limited use in cellular imaging studies.144,145 In 2004, 
Weisner et al. reported the synthesis of fluorescent silica nanoparticles with 
hydrodynamic radii of 10-15 nm by modifying the procedure reported by Van Blaaderen 
et al. The procedure can be explained briefly as follows.42 
 
 An organic dye is conjugated via an isothiocyanate group or an activated carboxylic 
acid group to 3-aminopropyltriethoxysilane (APTS) at a molar ratio of 1:50 
(fluorophore:APTS) in degassed absolute EtOH (Figure 4.2). The resulting solution is 
then diluted to a concentration of 1.7 x 10-5 M in an ethanolic ammonia solution and 
deionized water. This forms the silica core that is made up of the organic fluorophores. 
To this, a pure silica precursor tetraethoxysilane  (TEOS) is added to grow the silica 
shell. The reaction is continued for 8 h and then further TEOS is added and allowed to 
react for a further 24 h period (total 32 h) followed by dialyzed to deionized water and 
stored. Particle size was determined by transmission electron micrography (TEM) and 
dynamic light scattering (DLS).  In this particular example, tetramethylrhodamine 
isothiocyanate (TRITC) was used as a fluorophore.  
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(EtO)3Si NH2
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HN Si(OEt)3
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(i) (0.2 M) NH3 in EtOH 
(ii) H2O (0.855 M)
EtOH, 25 oC, 8 h
O
HN Si(OH)3
3
(0.155 M) Si(OEt)4 
EtOH, 25 oC, 32 h
dye doped silica 
nanoparticles
silica core  
Figure 4.2. Covalent incorporation of dye molecule into silica matrix. 
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The versatility of this approach enables incorporation of various classes of organic 
fluorophores into the silica matrix. Figure 4.3 shows organic fluorophores encapsulated 
in silica nanoparticles using the above method. There are some report that suggest 
certain cyanine dyes that are particularly sensitive to reaction conditions used for silica 
nanoparticles synthesis cannot be incorporated due to their low synthetic stability.146 
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Figure 4.3. Structure of commonly used organic fluorophores for silica nanoparticle 
synthesis. 
 
4.1.2 Photophysical Properties of Silica Nanoparticles 
 
The photophysical properties of fluorescent silica nanoparticles were determined using  
multi-photon fluorescence correlation spectroscopy (FCS).41,147 This technique is similar 
to dynamic light scattering (DLS) except that the fluorescence is analyzed instead of 
scattered light. The particle size of the nanoparticles can be calculated using the Stokes-
Einstein equation, using the measured diffusion coefficients of the particles obtained by 
FCS. 
D = kBT/6πηr 
D is diffusion coefficient, kB is Boltzmann’s constant, T is temperature in Kelvin, η is 
viscosity of the medium and r is the spherical particle radius. 
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The per particle brightness of the silica core containing multiple fluorophores is less than 
both the free fluorophore as well as the fluorescent silica nanoparticles. This can be 
attributed to the quenching effect, which is dominant when dye molecules are very near 
each other. The enhancement in the brightness of the silica nanoparticle is due to an 
increase in the radiative and a decrease in non-radiative decay rates of the fluorophores 
inside the silica shell. Silica also protects the fluorophore from external environmental 
factors such as oxygen, water and other solvent molecules, which are known to induce 
non-radiative decays. Most fluorophores usually undergo a solvatochromic shift, a 
change in fluorescence emission with respect to solvent. This shift is owing to the 
changes in excited state energies in solvents with different polarities and is more 
prominent in polar solvents. Fluorophores encapsulated in silica nanoparticles are 
completely devoid of this shift; this proves that the fluorophores in silica nanoparticles 
are effectively removed form the external solvent environment and therefore produce a 
consistent fluorescence output in any solvent.  The silica shell is also beneficial in 
reducing photobleaching of the fluorophore; in most cases a two-fold enhancement in 
photostability is reported because of the protection given by the silica shell.148 
 
Comparison of brightness of fluorescent silica nanoparticles with quantum dots shows 
that their brightness is 2-3 times less than quantum dots. An organic fluorophore is 30 
times less bright than quantum dots and is also prone to photobleaching. This result 
shows that an organic fluorophore can be encapsulated in silica to enhance its brightness 
significantly and comparable to quantum dots. An advantage of silica nanoparticles over 
quantum dots is that quantum dot fluorescence occurs by single exciton transitions 
whereas in silica nanoparticles the multiple dye molecules within the particles each 
absorb and emit independently. This overcomes the issues of stochastic blinking suffered 
by quantum dots by providing multiple emitters within a single silica particle.138 
Furthermore, the silica matrix ensures that the dye molecules are separated from each 
other to avoid self-quenching. Each particle core is separated from its neighbors by twice 
the pure silica thickness creating high spatial emitter density without permitting energy 
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transfer between neighboring fluorophores.138  The dense packing of silica nanoparticles 
also helps in brightness enhancement, which is not possible with organic fluorophores. 
Most water-soluble organic fluorophores have a reduced fluorescence output in water 
when compared to their output in organic solvents; and this reduces their applicability in 
cellular imaging. This drawback coupled with synthetic difficulties in imparting water-
solubility makes them less attractive for single molecule detection studies. Fluorescence 
of silica nanoparticles is independent of the solvent media and can replace traditional 
organic fluorophores for such studies. 
 
4.1.3 Surface Modification of Silica Nanoparticles 
The surface of silica nanoparticles is amenable to chemical modification due to the 
presence of reactive hydroxyl groups. This is an advantage for performing fluorescent 
bioassays and bioimaging wherein these particles can be conjugated to different 
biomolecules such as proteins, antibodies and oligonucleotides via functional groups on 
their surface and specificity in targeting can be achieved.149 These functional groups also 
serve to improve the water disperability of particles and prevent aggregation. 
Introduction of polyethylene glycol (PEG) on the surface of silica nanoparticles is a 
common way to improve water solubility. PEG also serves to improve the colloidal 
stability of nanoparticles and therefore increases their bench life (Scheme 4.1a).150 
Sulfonic acid groups can also be introduced onto the silica surface by reaction with 
corresponding trimethoxysilyl aminopropyl thiol followed by oxidation with peroxide 
(Scheme 4.1b).151 
 
Carboxylic acid groups serve to improve water-solubility and are a suitable handle for 
conjugation to proteins and other biomolecules. The negative charge on a carboxylate 
group helps reduce aggregation and keeps the particle in a monodispersed state. Reaction 
with carboxyethylsilane triol in pH 7.4 sodium phosphate buffer affords carboxyl 
modified particles in quantitative yields (Scheme 4.1c).35  
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Scheme 4.1. Surface modification of silica nanoparticles with (a) PEG and (b) sulfonic 
acid and (c) carboxyl groups. 
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The introduction of amino groups on the surface of silica nanoparticles is 
straightforward.152 Reaction of 3-aminopropyltriethoxysilane (APTS) with silica 
nanoparticles in toluene at 95 oC for 3 h yields amine functionalized nanoparticles in 
quantitative yield (Scheme 4.2). Amino group is particularly attractive because it can be 
readily coupled with carboxylic acids on proteins and antibodies. A similar approach 
also yields alkyne and azide terminated linkers on the surface which can be used for 
performing 1,3-cycloaddition reactions with modified proteins or biotin substrates. It is 
also possible to quantify the amine moiety on a silica surface by performing the Fmoc 
test. Briefly the amine-functionalized nanoparticles in anhydrous DMF is added to a 
solution of FmocCl DMF. The mixture is stirred overnight under nitrogen for the 
reaction to go to completion and washed thoroughly with MeOH and dried. The dried 
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nanoparticles are weighed and redispersed in DMF by sonication. To this solution 
piperidine is added and reaction continued for 20 min. Amine quantification is 
performed using standard Fmoc protocol by detecting the UV absorbtion of the 
supernatant solution at λ = 300 nm after centrifugation at 13000 rpm for 20 min. The 
extinction coefficient at this wavelength is 7800 M-1cm-1.153 
 
Scheme 4.2. Surface modification of silica nanoparticle with amino, azido and alkyne 
groups. 
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Folic acid, also known as vitamin B9, is a vital vitamin for survival and proliferation of 
animal cells. Animal cells cannot produce folic acid and therefore express folate 
receptors, which can capture exogenous folates. Cancerous cells overexpress these 
receptors because of rapid cell division. Any biomarker used for tracking such cancerous 
cells will be easily taken up if its surface is conjugated to folic acid. Amine 
functionalized fluorescent silica nanoparticles can be conjugated to folic acid using 
carbodiimide chemistry and used for detection of cancer cells (Scheme 4.3).154  
 
Scheme 4.3. Folic acid conjugation to silica nanoparticles. 
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Folic acid is insoluble in water so it is important not to overload silica nanoparticles with 
folic acid to prevent aggregation. Presence of one or two folic acid molecules on a single 
nanoparticle is enough for cancer cells to uptake these particles. 
 
Surface characterization of silica nanoparticles is done by solid-state 29Si NMR, IR 
spectroscopy and X-ray diffraction (XRD). Silicon-29 NMR is used to probe detailed 
solid-state chemistry of silica materials. The chemical shift of various silica groups spans 
120 ppm, which allows all types of chemical functionalities to be readily observed. 
Presence of different functional groups on the surface changes the chemical environment 
of silica that can be detected by 29Si NMR.  IR spectroscopy is used to determine the 
presence of different functional groups on the surface. XRD is a non-destructive 
technique, which reveals information about chemical composition and physical 
properties of materials. The diffraction pattern formed when X-rays are focused on a 
material is interpreted to give information about the surface morphology and chemical 
composition. 
 
4.1.3 Toxicology Studies on Fluorescent Silica Nanoparticles 
Toxicity is a major roadblock in implementing any imaging agents for clinical use. This 
is evident from the fact that even though quantum dots are the brightest imaging agents 
available, they are not widely used due to the toxicity of heavy metals associated with 
such particles. The cytotoxicity and genotoxicity studies of fluorescent silica 
nanoparticles on A549 cancer cell lines suggests that they are safe to use at the 
molecular and cellular levels below 0.1 mg/mL and cells live at least 24 h after exposure 
to silica nanoparticles.139 Labeling of the A549 cancer cell line with 50 nm silica 
nanoparticles results in an induction of DNA repair protein which prevents DNA injury, 
and therefore, less genotoxicity. Cell death observed when working with concentration 
of nanoparticles above 0.1 mg/mL were mainly due to cellular organelle destruction 
rather than genome damage. However, accumulated silica can cause chronic or acute 
toxicity in animal models if exposed for a longer period of time (weeks), which is of less 
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concern because imaging experiments are usually done for not more than 3 days. 
Cytotoxicity is more prevalent with aggregated particles than with monodispersed ones. 
The surface charge of silica nanoparticles, which is negative at physiological pH, helps 
to prevent aggregation due to repulsion between like charges. Several studies also 
indicate that fibroblast cells with long doubling time (average time between two cell 
divisions) are more prone to injury induced by silica nanoparticles than tumor cells with 
short doubling time,139 which suggests that the cytotoxicity of silica nanoparticles also 
varies depending on the cell lines used. Experiments on cultured human bronchoalveolar 
carcinoma-derived cells with 15 nm and 46 nm silica nanoparticles reveal that dosage 
levels between 10-100 µg/mL for a period of 48 h decreased cell viability in a dose 
dependent manner. Cell deaths were observed even at the lower limit 10 µg/mL.45  
 
Nanoparticles with sizes ranging from 10-50 nm have large specific surface area and are 
not affected by gravitational force. This may raise a potential problem for in vitro 
imaging studies in which the cell adhering to the bottom of the culture vessel is not 
exposed to the majority of nanoparticles in suspension. Thus, we may assume the 
effective dose (the number or mass of particles that actually affect the cells) is different 
from the administered dose. A detailed experimental study on three different cell lines 
(A549 epithelial cells, EAHY926 endothelial cells, and J774 monocyte-macrophage) 
with silica nanoparticles proved otherwise.155 This is because the majority of particles 
reach the cell and induce cytotoxicity due to the convection force usually present in 
solution. Although a minor finding, this shows that the toxicity observed is mainly due 
to the entire administered dose of nanoparticles. 
 
Available reports on toxicological effects show that colloidal silica is less toxic than 
crystalline forms in animal models. There are studies suggesting that colloidal silica with 
particle size less than 100 nm induces greater lung inflammation and lung damage than 
larger particles in mice. These studies were carried out by intratracheally administering 
silica nanoparticles of different sizes to mice models. Fluorescent silica nanoparticles 
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with average particle size of 30 nm showed no apparent toxicity in mice when 
administered through tail vein injection. The discrepancy with previous studies is likely 
due to the different administration route. Intraperitonial administration of silica 
nanoparticles (particle size 50 nm) into mice and examination after four weeks revealed 
their presence in brain indicating that such particles can cross blood-brain barrier 
without disturbing its function. The particles were present in various organs without 
producing any toxicity.153  
 
4.1.4 Biological Applications of Fluorescent Silica Nanoparticles 
One important method for determining spread of cancer is sentinel lymph node mapping 
which helps in performing more accurate biopsies and gaining information that reduces 
the amount of surgery needed. It is usually done by injecting an imaging agent or a 
radioactive tracer into the tumor site and visualizing the tracer as it drains into the 
lymphatic basin. The sentinel lymph node collects the imaging agent and can be 
removed for biopsy. Further analysis of the node may reveal whether or not the lymph 
nodes contain any cancer cells and provides an efficient means to monitor the spread of 
cancer through the body. Mapping experiments with fluorescent silica nanoparticles 
were able to detect sentinel lymph nodes with much greater accuracy and can be 
substituted for radioactive tracers, which is associated with long term side effects.44 
 
The surface of fluorescent silica nanoparticles can be easily modified to attach different 
functional groups and molecules. This is an advantage for applications such as imaging 
cancer cell lines to determine their response to various therapeutic drugs. Fluorescent 
silica nanoparticles that were surface functionalized with cell penetrating peptides were 
used to label the cells and track metastatic prostate carcinoma cells through the body.44 
The interaction between cancer cells and bone marrow cells is a field of intense research 
due to the findings that such interaction induces osteoclastogenesis, a type of bone 
metastase in the bone microenvironment. These interactions were tested by labeling 
prostate cancer cells and bone marrow cells in vivo using TAT-conjugated fluorescent 
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silica nanoparticles loaded with fluorophores emitting at different wavelength. The 
localization of the silica nanoparticles were detected by multiphoton microscopy and 
showed that the cancer cells and bone marrow cells are co-localized which results in 
metastasis of bone.   
 
Silica nanoparticles are also used for photodynamic therapy (PDT) of certain types of 
cancer.156 Photodynamic therapy is a targeted treatment and involves administering 
photosensitizers, a molecule which can be activated by an appropriate wavelength of 
light from the UV-Vis region, to the malignant tissue. The irradiation of light results in 
formation of reactive oxygen species (ROS), which are toxic to cells and tissues. PDT is 
very selective in its mode of action because the cancerous cells take up more of the 
photosensitizer and retain them for a longer duration of time than normal cells. 
Commonly used photosensitizers such as 5-aminolevulinic acid and methyl 
aminolevulinate are hydrophobic in nature and no one has yet developed a formulation 
that can be easily injected in vivo. Silica nanoparticles with covalently attached 
photosensitizer molecules were prepared and in vitro treatment with RIF-1 cancer cells, 
a human colon cancer cell line, shows ready uptake of these particles which then show 
phototoxicity upon irradiation with light, thus demonstrating the potential use of these 
nanoparticles for PDT.157  
 
Targeted delivery of therapeutic drugs and imaging agents, which involves delivering 
medication in a manner that increases the concentration of the medication at the required 
site relative to others, has become a very important part of cancer diagnosis and 
treatment. This not only improves efficacy of the drug, but also reduces side effects 
associated with treatment. Silica nanoparticles stand out as an ideal platform for 
preparing such targeted delivery systems because their surface can be synthetically 
modified to accommodate many functional groups that can be attached to targeting 
ligands. Any desired drug, polar or nonpolar, and imaging agent can be covalently 
incorporated into silica nanoparticles, and after modifying the nanoparticle surface with 
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appropriate ligands, they can be used for treatment and diagnosis. In one such example, 
20 nm fluorescent silica nanoparticles were conjugated to biotargeting molecules such as 
Transferrin158, anti-claudin 4 and antimesothelin via a carboxyl functional group on their 
surface. Confocal microscopy studies were performed to monitor the uptake of these 
particles in pancreatic cancer cell lines in vitro. It was shown that the uptake is greatly 
enhanced with bioconjugated silica nanoparticles as compared to the non-bioconjugated 
ones. The enhanced efficiency is due to the receptor-mediated uptake of these 
bioconjugated nanoparticles with their corresponding receptors, which are known to be 
overexpressed on the surface of the cell line used.   
 
Surface modified silica nanoparticles are used in protein purification studies. 
Tetramethylrhodamine doped silica nanoparticles (particle size 23 nm) were surface 
modified with nitrilotriaceticacid (NTA) and exposed to NiCl2 to generate fully 
functionalized (Ni-NTA) nanoparticles.  Ni-NTA is known to have great affinity for 
histidine-tagged proteins, and if exposed to a cell lysate containing many different 
proteins, will selectively react with only histidine-tagged proteins. Thus, fluorescent 
silica nanoparticles with Ni-NTA surface functionality, when exposed to a cell lysate 
containing histidine-tagged protein (in this case Estrogen receptor, ERα) as a minor 
component, showed very high binding specificity enabling protein purification in a 
single step. Such studies cannot be performed using organic fluorophores because their 
fluorescence is often quenched in presence of metals like Nickel.159 
 
Use of silica as a host material for encapsulating fluorophores looks promising due to the 
number of biological applications reported based on them. Improving the performance of 
organic fluorophores by encapsulating them in water-dispersible silica nanoparticles will 
significantly reduce the cost of synthesis of water-soluble fluorophores because any 
nonpolar organic fluorophore can be encapsulated in silica. By combining functionalities 
such as targeting, imaging and treatment, silica nanoparticles can be envisioned as a 
“guided missile” for selectively attacking cancerous cells without affecting normal cells. 
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These particles would give feedback on the activity of the therapeutic agents rather than 
simply identifying the cancerous cells. 
 
4.1.5 Results and Discussions 
Some of the TBET cassettes prepared in our laboratory showed poor energy transfer 
efficiency and low fluorescence quantum yields in aqueous media in spite of having 
water-soluble groups, presumably due to aggregation induced fluorescence quenching. 
We hypothesized that encapsulating such cassettes in silica nanoparticles will minimize 
their interaction with external solvents and will enable them to fluoresce with improved 
energy transfer efficiency. Described here is research undertaken to compare the 
properties of the energy transfer cassettes 43, 44, 73, and 74 encapsulated in silica with 
the free fluorophores in solution (Figure 4.4). The acceptor fragments of these cassettes 
were also encapsulated in silica nanoparticles to study the improvement in photophysical 
properties in aqueous media (Figure 4.5). Silica nanoparticle are easily dispersible in 
water and therefore provide an alternate pathway for solubilizing any organic 
fluorophore in aqueous media. 
 
This project is part of a broader effort to produce fluors that can absorb UV strongly at a 
convenient wavelength (eg 488 nm), and emit it efficiently at much higher wavelengths. 
Our experience has been that it is relatively easy to prepare cassettes that do this in 
organic media, much harder to make them water soluble, and extremely difficult to 
design water-soluble cassettes that have good quantum yields in aqueous media.  This 
goal was reached for some cassette designs, but 43, 44, 73, and 74 are illustrative of ones 
that failed to reach it, primarily for solubility reasons (Figure 4.4).  Cassette 73 in pH 7.4 
phosphate buffer has poor solubility, even for fluorescence experiments, and it dissolves 
extremely slowly.  The other cassettes are even less soluble in aqueous media.  Thus, we 
sought to understand how encapsulation of these cassettes in silica nanoparticles would 
impact their compatibility with aqueous media.  Further, the influence of nanoparticle 
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formation on the photophysical properties of these “through-bond energy transfer 
cassettes” was an unknown that was to be probed in this study. 
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Figure 4.4. Structure of cassettes encapsulated in silica. 
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Figure 4.5. Structure of acceptors of cassettes encapsulated in silica. 
 
4.1.5.1 Synthesis 
The encapsulation of cassettes and corresponding acceptors were achieved by following 
a reported procedure by Wiesner et al (Scheme 4.4).41,42 The organic dye is conjugated 
via activated carboxylic acid group to 3-aminopropyltriethoxysilane (APTS) at a molar 
ratio of 1:50 (fluorophore:APTS) in degassed absolute EtOH under nitrogen. The above 
dye solution (0.14 mL, 1.7 x 10-5 M) was added to EtOH along with water (1.52 mL, 
1.71 M) and NH3 in EtOH (5.0 mL, 0.2 M) at 25 oC to make up a final volume of 50 mL 
and stirred for 12 h at 25 oC. TEOS (1.63 mL, 0.155 M) was then added in aliquots of 
0.4 mL every fifteen minutes and stirring continued for another 12 h at 25 oC. The 
resulting silica nanoparticles were dialyzed into EtOH to remove unreacted starting 
materials. Further dialysis was performed to transfer the formed silica nanoparticles 
from EtOH to deionized water and finally to pH 7.4 (0.1 M sodium phosphate buffer). 
Consequently, it was possible to study the encapsulated cassettes in aqueous media 
whereas the parent systems are insufficiently soluble to do this. 
 
Scheme 4.4. Syntheses of dye doped silica nanoparticles. 
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Transmission electron microscopy (TEM) images were obtained for the synthesized 
nanoparticles (Figure 4.6). Particles were spherical, well dispersed, and homogeneous in 
size with an average diameter of 20-24 nm. The silica nanoparticles did not undergo any 
degradation in spite of continuous exposure to the electron beam from the TEM 
instrument thereby proving to be a robust encapsulation material. The TEM 
measurements were performed by Dr. Hansoo Kim from the micropscopy and imaging 
center at Texas A&M University. 
 
a 
 
 
 
Figure 4.6. Transmission electron microscopy (TEM) images of (a) acceptors and (b) 
cassettes. Particle size: 20-24 nm. 
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Figure 4.6. Continued. 
 
4.1.5.2 Photophysical Properties 
The absorbance and emission maxima of the acceptors 26, 44a, 73a, and 74a 
encapsulated in silica nanoparticles and dispersed in pH 7.4 phosphate buffer are shown 
in Figure 4.7a and 4.7b. Figure 4.8a shows the normalized absorbance of the particles 
from cassettes 43, 44, 73, and 74 under the same conditions.  The cassettes each have 
two distinct absorbance maxima corresponding to their donor and acceptor fragments.  
Direct comparison of the free and encapsulated cassettes in phosphate buffer is not 
possible because the unencapsulated systems are insufficiently soluble.  For this reason, 
the following discussion compares the free cassettes in EtOH with the corresponding 
nanoparticles in phosphate buffer. Encapsulation in silica did not change the relative 
intensities of the donor and acceptor absorption peaks relative to the free cassettes (in 
EtOH, please see Appendix C). We have defined the ratio of the fluorescence quantum 
yields of cassettes when excited at the donor to that when excited at the acceptor as the 
energy transfer efficiency (ETE). This parameter for the encapsulated cassettes is very 
high: 74 – 93 %.  However, the overall quantum yield decreases in the order 73 > 43 > 
74 > 44.  In other words, the overall quantum yields for the cassettes excited at the 
donors are a function of the ETE, and the quantum yields of the acceptor fragments. 
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Figure 4.7. Normalized absorbance (a) and fluorescence (b) of acceptors encapsulated 
in silica in pH 7.4. 
 
 
Figure 4.8. Normalized absorbance (a) and fluorescence (b) of cassettes encapsulated in 
silica in pH 7.4. 
 
The quantum yields of these acceptors in silica nanoparticles, except Nile Red acceptor 
26 showed marked improvement in aqueous media (Table 4.1). Particularly acceptor 74a 
showed a ten fold improvement in quantum yield as compared to the bare dye in aqueous 
media, which is reported to have a quantum yield of 0.037.160,161 The Nile Red acceptor 
26 is water-soluble and the fluorescence quantum yield does not improve upon 
encapsulation in silica nanoparticles. The acceptors 73a and 44a are by themselves 
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insoluble in water and therefore nonfluorescent. Encapsulating these acceptors in silica 
nanoparticles not only made them water-soluble but also fluorescent. 
 
Table 4.1. Photophysical properties of acceptors encapsulated silica in pH 7.4. 
 
dye λabs(nm) λem.(nm) fwhm (nm) Φ 
     
73a 548 601 49 0.32+/-0.01a 
26 532 637 57 0.27+/-0.01a 
74a 550 566 37 0.30+/-0.02a 
44a 646 666 39 0.09+/-0.02b 
Standards used for quantum yield measurement:  arhodamine 6G (Φ 0.92 in EtOH); bNile 
Blue (Φ 0.27 in EtOH).  Quantum yields were measured three times and averaged. 
 
 
Encapsulating these cassettes in silica nanoparticles made them easily dispersed in 
water.  Cassettes 43 and 44 have quantum yields of 0.31 and 0.18 when excited at the 
donor in pH 7.4 buffer (Table 4.2).  However, the quantum yields of cassettes 73 and 74 
when excited at the donor were very low, even after encapsulation.  Both these cassettes 
showed good energy transfer in pH 7.4 phosphate buffer, so energy loss can be attributed 
to the acceptor fragments. 
 
Table 4.2. Energy transfer efficiency of cassette encapsulated silica in pH 7.4. 
 
dye λabs(nm) λem.(nm) ΦDa ΦA ETE % 
(ΦD/ΦA) 
      
73 499, 544 597 0.31+/-0.02 0.33+/-0.01a 93 
43 502, 539 512, 627 0.18+/-0.03 0.24+/-0.02a 74 
74 504, 568 592 0.04 0.05b 78 
44 504, 659 687 0.02 0.03c 81 
ΦD: quantum yield of cassette when excited at the donor absorbtion maxima. ΦA: 
quantum yield of cassette when excited at the acceptor absorbtion maxima. Standards 
used for quantum yield measurement:  arhodamine 6G (Φ 0.92 in EtOH); brhodamine 
101 (Φ 1.0 in EtOH); cNile Blue (Φ 0.27 in EtOH). Quantum yields were measured three 
times and averaged. 
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Photostabilities of dyes used for intracellular imaging is a significant issue; probes that 
readily photobleach tend to be less useful. The photostability of the encapsulated 
cassettes 73, 74 and acceptor 74a were studied and compared to the corresponding bare 
cassettes and acceptor. In all cases the encapsulated fluorophores were found to be more 
photostable than the unencapsulated ones. Photobleaching, which is usually a result of 
interaction between the fluorophore and dissolved oxygen in the solvent, is less severe in 
the encapsulated silica nanoparticle. The silica matrix protects the encapsulated 
fluorophore from dissolved oxygen, which often leads to photobleaching (Figure 4.9). 
An argon ion laser (Spectra-Physics) fitted with notch filter to remove 514 nm 
wavelength light was used to perform the photostability studies and samples were 
irradiated with 488 nm wavelength light with power density of 1.2W/cm2 for 73 and 
12W/cm2  for sample 74a and 74. 
 
 
 
Figure 4.9. Photostability studies of silica nanoparticles. (a) Half life for cassette 73 and 
cassette 73 doped silica nanoparticles and (b) half life comparison for acceptor 74a and 
cassette 74. 
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4.1.5.2 Cellular Imaging Studies 
Cassettes 73 and 74 encapsulated in silica nanoparticles were used for in vitro cellular 
imaging studies with COS7 cells.  Incubation with 0.02 mg/mL (73) and 0.01 mg/mL 
(74) of the silica nanoparticles in pH 7.4 phosphate buffer at 37 oC for 2 h resulted in 
efficient uptake of these particles.  Upon excitation at 488 nm, no significant output was 
observed in the green channel (503 – 553 nm; Figure 4.10a) but strong fluorescence was 
observed in the red one (575 – 625 nm; Figure 4.10b) for cassette 73.  This demonstrates 
that the encapsulated cassette 73 gave good energy transfer inside cells.  The ETE for the 
encapsulated cassette 74 was less than for 73 (78% relative to 93%, see Table 4.2) so for 
this probe emission from the green and red channels was expected, and it was observed 
(Figure 4.10c and 4.10d).  No significant cytotoxicity was observed after uptake of either 
of these nanoparticles types, however some vacuoles could be observed (yellow arrows 
in Figure 4.10b) indicative of some adverse effects on the cells at this particle 
concentration. 
a     b 
Exc 488 nm; Emis 503-553 nm   Exc 488 nm; Emis 575-625 nm 
 
 
c       d 
Exc 488 nm; Emis 500-530 nm    Exc 488 nm; Emis 565-615 nm 
 
 
 
Figure 4.10. Cellular uptake of cassette (a) 73 and (b) 74 doped silica nanoparticles. 
Intracellular fluorescence of SiO2-nanoparticles from cassette 73 excited at 488 nm and 
observed at: a 503 – 553 nm; and, b 575 – 625 nm.  Images c and d are the 
corresponding ones for SiO2-nanoparticles from cassette 74.  
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4.1.5 Conclusion 
In conclusion, we have shown that cassettes that have very poor water solubility can be 
encapsulated in silica nanoparticles, and they can be easily dispersed in water.  SiO2-
encapsulation of the cassettes 73 and 74 improved their photostability with respect to 
photobleaching.   The silica nanoparticles could be imported into cells without use of 
reagents to induce this, and without noticeable levels of cytotoxicity.   Leaching of the 
dyes out of the silica nanoparticles would be highly unlikely since they are covalently 
attached to the silica when the nanoparticles are formed. Methods to provide surface 
modifications of silica nanoparticles are known.162,163   Consequently, this work may lay 
foundations for applications of encapsulated energy transfer cassettes in intracellular 
imaging. 
 
4.2 Encapsulation of Organic Fluorophores in Calcium Phosphate Nanoparticles 
 
Many advances have been achieved in diagnosis as well as treatment of diseases each 
with its own level of sensitivity and efficacy. Early detection and treatment is the best 
way to confront any type of disorder and developments of tools to accomplish this 
simultaneously are always in the forefront of research. Recent advances in our 
knowledge of nanoparticles such as gold, iron oxide, polymer, silica have paved the way 
for many new technologies to be utilized in biological assays in basic research setup. 
They have the potential to radically change cancer therapy by allowing for effective and 
targeted drug delivery by overcoming the many biological, biophysical and biomedical 
barriers an animal model presents against conventional drugs and imaging agents. These 
particles help us to detect cells and biomolecules that cannot be detected by conventional 
imaging agents. The ability to clearly observe changes in a cancer cell is critical to the 
success of any treatment.  To realize their full potential, as a potent tool for widespread 
application in clinical trials and eventually on humans requires a deeper understanding 
of their mode of action and the toxicity associated with such nanoparticles. Ensuring that 
nanoparticles are safe for use in humans will be a key factor in determining their impact 
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on imaging and treatment. Concerns are growing as to whether they have unintended 
consequences when exposed to humans or the environment. 
 
4.2.1 Calcium Phosphate Nanoparticles Synthesis 
4.2 Encapsulation of Organic Fluorophores in Calcium Phosphate Nanoparticles 
 
Calcium phosphate is a biomineral present in the body mainly in bone and tooth enamel. 
It is distributed in intra and extracellular spaces and also in blood streams in millimolar 
concentrations.164 It plays important roles in blood clotting, nerve impulse transmission, 
muscle contraction and enzyme regulation165,166 mediates constriction and relaxation of 
blood vessels167 and the secretion of hormones.168 Their presence in the human body and 
their biodegradability makes them safe in handling and administering. Moreover they 
can be easily cleared from human body once imaging is done unlike other agents. 
Calcium phosphate is stable at physiological pH and becomes completely soluble at pH 
levels below 5.5,47 which makes it an efficient transporter of bioactive agents.  
 
4.2.1 Calcium Phosphate Nanoparticles 
Nanoparticles have the potential to change cancer diagnosis by allowing detection of 
cells and biomolecules that cannot be traced by conventional imaging agents. 
Development of such nanoparticles with low cytotoxicity is the focus of this section. 
Some early literature reports describes syntheses of plasmid DNA loaded calcium 
phosphate nanoparticles.169 Water in oil microemulsion method is used to synthesize 
these nanoparticles. They range in size from 30-40 nm. Recently Adair et al reported a 
similar method to encapsulate hydrophobic and hydrophilic organic fluorophores in 
calcium phosphate nanoparticles with an average particle size of 16-20 nm.46,170 The 
calcium phosphate shell apparently improves the colloidal stability and the 
photophysical properties of the encapsulated fluorophore.171 Figure 4.12 shows 
fluorophores encapsulated in calcium phosphate nanoparticles.170  
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Figure 4.11. Structures of organic fluorophores doped in calcium phosphate 
nanoparticles. 
 
The brightness of the fluorophore doped calcium phosphate nanoparticles is reported to 
be enhanced significantly compared to the parent fluorophore. In one such example one 
indocyanine green-doped calcium phosphate nanoparticle is 1000 times better than one 
indocyanine green molecule.46 The improved brightness results from a decrease in non-
radiative process inside the calcium phosphate matrix and the protection it gives the 
fluorophore from out side quenching agents like solvents and dissolved gases. The 
improvement in brightness also signifies that the fluorophore is not self-aggregating 
inside the matrix, which would result in quenching. The fluorescence quantum yield, is 
twice for the fluorophore encapsulated in calcium phosphate nanoparticles compared to 
the bare fluorophore in some cases which proves that radiative processes dominate non-
radiative ones inside the matrix.171 Most organic fluorophores show solvent-dependent 
fluorescence characteristics due to hydrogen bonding with solvents and also due to 
intermolecular charge transfer. In contrast the fluorescence spectra of encapsulated dyes 
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are stable regardless of solvents used proving minimum interaction between the solvent 
and the encapsulated fluorophore.170 The encapsulated fluorophore has higher 
photostability than the bare fluorophore because it is protected from environmental 
oxygen by the calcium phosphate matrix.  
 
4.2.2 Surface Modification of Calcium Phosphate Nanoparticles 
Particle surfaces are modified to improve their water-solubility, colloidal stability, and 
for bioconjugation to biomolecules. Most nanoparticles possess a surface charge known 
as zeta potential, the overall charge the particle acquires in a particular medium. The 
magnitude of this charge is a measure of the repulsive forces present and can give an 
idea about the long-term stability of the particle solution. If all the particles in the 
solution have a large negative or positive zeta potential, then they will repel each other 
and no aggregates will be formed. Lower zeta potential values often result in lower 
colloidal stability due to particles coming together and forming clumps. The pH of the 
medium, concentration of the additives and the polarity of the solvent used affect zeta 
potential. 
 
Negatively charged carboxylate functional groups on the surface of calcium phosphate 
nanoparticles provide them with colloidal stability. Such carboxylate groups are formed 
by adsorption to the surface of calcium phosphate during nanoparticle synthesis. Apart 
from carboxylate functionality, there are few reported surface modifications of calcium 
phosphate nanoparticles. One such modification involved attachment of polyethylene 
glycol (PEG) amine to carboxylic acid functionalized particles (Scheme 4.5). A 
carbodiimide activation of the carboxylate on the surface of the nanoparticle followed by 
reaction with the amine resulted in PEG functionalized nanoparticles.172 In in vivo 
imaging experiments with animal models, PEGylation is known to provide physiological 
dispersion and inhibits protein absorption providing maximum retention in circulatory 
systems. 
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Scheme 4.5. Surface modification of calcium phosphate nanoparticles with PEG. 
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4.2.3 Biological Applications of Calcium Phosphate Nanoparticles 
In vivo imaging helps in understanding a living organism with respect to its metabolic 
processes and cancer related changes in the body. PEGylated calcium phosphate 
nanoparticles doped with indocyanine green fluorophore accumulated in solid, 5 mm 
diameter xenograft breast adenocarcinoma tumors within 24 h after tail vein injection in 
nude mouse model.46 The fluorescence of these nanoparticles were significantly 
prolonged compared to the bare fluorophore. Most near IR organic fluorophores suffer 
from quenching in physiological environment. The fluorescence signal from the 
nanoparticles was visible even after 4 days of administering them albeit with reduced 
intensity proving their robustness in a physiological environment. Dissection of the 
specimen after 10 min of administering shows only minor renal imaging, suggesting 
very low potential for renal toxicity. The PEGylated calcium phosphate nanoparticles, 
unlike organic fluorophores have a longer circulatory time in animal models, which 
helps in their collection in tumors. The fluorophore encapsulated calcium phosphate 
nanoparticles were also used to image the rat sympathetic stellate ganglion neurons.173  
 
Biological tissues are highly scattering media and therefore imaging them at a significant 
tissue depth is always very difficult and conventional fluorophores cannot be used to 
perform such studies due to their low penetration. The dense muscle tissue has a total 
optical attenuation coefficient µτ = 541 cm
-1 at 515 nm wavelength and it is very difficult 
for light to penetrate. Detectable penetration and emission depths were seen with 
  98 
calcium phosphate nanoparticles up to 3 cm tissue depth in muscle tissues of nude mice 
compared to only weakly fluorescent bare fluorophore indocyanine green at only 2 cm.46 
 
4.2.4 Encapsulation of Cassettes in Calcium Phosphate Nanoparticles 
Incorporating water-soluble groups in TBET cassettes is difficult and time consuming. 
Purification of such water-soluble systems is often achieved via reverse phase HPLC or 
medium pressure liquid chromatography, which reduces the yield of product, and scale 
up is often not possible. Calcium phosphate serves as an excellent matrix, for imparting 
water-solubility to hydrophobic TBET cassettes and to improve their photophysical 
properties in water. We modified the literature methods to encapsulate TBET cassettes in 
calcium phosphate nanoparticles. The major difference in our method and Adair’s 
method46 is the reaction time (24 h compared to 5 min). An increase in reaction time was 
found to improve the photophysical properties of encapsulated dyes in some cases but 
not all. We performed dialysis to exchange the nanoparticles from organic media to 
aqueous media which is not attempted by Adair et al. The important parameters in our 
method and the published methods are shown in Table 4.3. The fluorophores are not 
covalently attached to the encapsulating material, which may result in their leaching out. 
The particles are stable without aggregation for at least a month. Figure 4.12 shows 
structures of cassettes and the corresponding acceptors encapsulated in calcium 
phosphate. 
 
Table 4.3. Important parameters in different methods used for synthesis of calcium 
phosphate nanoparticles. 
 
early methods Adair's method our method
particle size 30-40 nm 16-20 nm 14-29 nm
reaction time 12 h 5 min 24 h
purification
centrifugation
followed by EtOH wash
HPLC with
20 µm silica embedded
column
column chromatography
with 15 µm silica
followed by dialysis
type of 
synthesis
oil in water
microemulsion
oil in water
microemulsion
oil in water
microemulsion
encapsulated
material
plasmid DNA organic fluorophores TBET cassettes
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Figure 4.12. Structures of cassettes (a) and corresponding acceptors (b). 
 
4.2.4.1 Synthesis of TBET Cassette Encapsulated Calcium Phosphate Nanoparticles 
Synthesis of calcium phosphate nanoparticles is shown in Figure 4.13. Two water in oil 
reverse microemulsions are formed one with aqueous CaCl2 and the second one with 
aqueous disodium phosphate in Igepal CO-520 in cyclohexane. Both microemulsions are 
stirred for 1 h and then mixed with each other for 24 h to form calcium phosphate 
nanoparticles. The reaction is quenched by addition of sodium citrate and the 
nanoparticles formed are purified by column chromatography. Details of synthesis are 
outlined in the appendix. 
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Figure 4.13. Synthesis of cassette doped calcium phosphate nanoparticles. 
 
 
4.2.4.2 Photophysical Properties of Acceptors and TBET Cassettes Encapsulated 
Calcium Phosphate Nanoparticles 
The absorbance and emission of the acceptor fragments encapsulated in calcium 
phosphate nanoparticles were measured in pH 7.4 buffer (Figure 4.14). A direct 
comparison between the encapsulated acceptors and the nonencapsulated acceptors in 
aqueous media was not possible due to the insolubility of the acceptors used. The 
fluorescence quantum yields of all acceptors in pH 7.4 buffer were in the acceptable 
range and did not change much with changes in reaction time (Table 4.4).  
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Figure 4.14. Normalized absorption and fluorescence of acceptors doped calcium  
phosphate particles in pH 7.4. 
 
 
Table 4.4. Photophysical properties of acceptor encapsulated calcium phosphate 
nanoparticles in pH 7.4. 
 
acceptors  
(reaction time) 
λmax abs 
(nm) 
λmax emiss 
(nm) 
Φ 
 
74a (5 min) 543 564 0.07a 
74a (24 h) 543 564 0.08 
    
44a (5 min) 643 663 0.21+/-0.01b 
44a (24 h) 643 665 0.20+/-0.02 
    
75a (5 min) 748 774 0.14+/-0.01c 
75a (24 h) 748 774 0.16+/-0.01 
    
73a (24 h) 548 602 0.35+/-0.02d 
76a (24 h) 654 672 0.34+/-0.01b 
Standards used for quantum yield measurements: arhodamine 101 (Φ 1.0 in EtOH); bNile 
Blue (Φ 0.27 in EtOH); cCardiogreen (Φ 0.04 in MeOH); drhodamine 6G (Φ 0.92 in 
EtOH); Quantum yields were measured three times and averaged. 
 
 
The absorbance of the cassettes encapsulated in calcium phosphate nanoparticles shows 
two distinct peaks corresponding to donor and acceptor fragments respectively. In all 
cases except cassette 76 we observed almost complete energy transfer in pH 7.4 buffer 
(Figure 4.15). Cassette 76 is an exception because the donor and acceptor absorbance are 
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separated by a distance of 260 nm and therefore suffers from loss of energy via non-
radiative processes. The energy transfer efficiency for cassettes 44, 73, 74 and 76 were 
in the range of 86-90 %. Energy transfer calculation for cassette 75 was not possible due 
to non-availability of a suitable standard. Cassettes 73 and 74 have quantum yields of 
0.38 and 0.26 in pH 7.4 buffer whereas cassettes 44 and 76 had lower quantum yields of 
0.063 and 0.14 in pH 7.4 buffer (Table 4.5). 
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Figure 4.15.  Normalized absorption and fluorescence of cassettes doped calcium 
phosphate nanoparticles in pH 7.4. 
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Table 4.5. Photophysical properties of cassette doped calcium phosphate nanoparticles  
in pH 7.4 (0.1 M sodium phosphate buffer). 
 
cassettes  
(reaction time) 
λmax abs 
(nm) 
λmax emiss 
(nm) 
Φda 
 
Φab 
 
ETE (%) 
= Φd/Φa x 100 
74 (5 min) 504, 569 590 0.037 0.041b 90 
74 (24 h) 504, 568 592 0.26+/-0.01 0.29+/-0.02 b 88 
      
44 (5 min) 504, 659 687 0.051 0.057c 90 
44 (24 h) 504, 659 687 0.063 0.071c 89 
      
75 (5 min) 504, 764 793 0.039 - 40 
75 (24 h) 504, 764 793 0.053 - 41 
      
73 (24 h) 499, 543 606 0.38+/-0.01 0.44+/-0.03a 86 
      
76 (24 h) 506, 657 674 0.14+/-0.01 0.16+/-0.02c 88 
Φd: excited at donor; Φa: excited at acceptor. Standards used for quantum yield 
measurements:  arhodamine 6G (Φ 0.92 in EtOH); brhodamine 101 (Φ 1.0 in EtOH); 
cNile Blue (Φ 0.27 in EtOH). Quantum yields were measured three times and averaged. 
 
A comparison of absorbance of cassette 76 and 76 encapsulated in calcium phosphate in 
pH 7.4 buffer shows that the absorbtion of the acceptor fragment of cassette 
encapsulated in calcium phosphate is greater than that of the donor fragment, whereas in 
the unencapsulated cassette the absorbtion of donor fragment is greater than the acceptor 
fragment (Figure 4.16). This difference in absorbance is due to the relative insolubility 
of the acceptor in the free cassette in aqueous media, which leads to reduced 
fluorescence output. Once encapsulated inside calcium phosphate, the cassette becomes 
water-soluble and therefore does not suffer from any aggregation related quenching. The 
fluorescence output of the encapsulated cassette 76 is 3.7 fold higher than the cassette 
itself when excited at the donor absorbance maxima. The quantum yield of the 
encapsulated cassette 76 is 0.14 whereas the free cassette 76 has a quantum yield of 
0.032 (Table 4.6). The enhancement in quantum yield further proves that calcium 
phosphate shields the cassette from solvents and prevents quenching.  
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Figure 4.16. (a) Absorbtion and (b) relative fluorescence of cassette 76 and 76 doped 
calcium phosphate nanoparticles (CPNP) in pH 7.4. Concentration for absorbance: 10-6 
M; concentration for fluorescence: 10-7 M. 
 
Table 4.6. Comparison of photophysical properties of encapsulated and un encapsulated 
cassette 76 in pH 7.4 (0.1 M sodium phosphate buffer). 
 
cassettes  λmax abs 
(nm) 
λmax emiss 
(nm) 
Φda 
 
Φab 
 
ETE (%) 
= Φd/Φa x 100 
76 500, 655 674 0.032 0.037 86 
      
76 in CPNP 506,657 674 0.14+/-0.01 0.16+/-0.02 88 
      
CPNP: calcium phosphate nanoparticles;; aΦd excited at donor relative to rhodamine 6G 
(Φ 0.92 in EtOH);  bΦa excited at acceptor relative to Nile Blue (Φ 0.27 in EtOH). 
Quantum yields were measured three times and averaged. 
 
The reaction time for nanoparticle formation did not seem to improve the photophysical 
properties of the encapsulated fluorophores significantly except in case of cassette 74 
where the quantum yield of calcium phosphate nanoparticles formed after 24 h reaction 
was 7 fold higher than the ones obtained after 5 min reaction (Figure 4.17 and 4.18). In 
most cases the reaction between calcium chloride and sodium phosphate to form calcium 
phosphate is very rapid and is completed in a short period of time. A graph of integrated 
fluorescence intensity against absorbtion for acceptors and cassettes for different 
  105 
reaction times did not show any significant difference except for cassette 74 (Figure 
4.18). 
 
Figure 4.17. Effect of reaction time on fluorescence output of encapsulated 
fluorophores. Integrated fluorescence intensity of: (a) cyanine acceptor doped calcium 
phosphate nanoparticles and (b) cassette doped calcium phosphate nanoparticles in pH 
7.4 (0.1 M sodium phosphate buffer) for reaction time 5 min (blue) and 24 h (red). All 
acceptors excited at their corresponding λmax and all cassettes excited at their 
corresponding donor λmax. All measurements done for similar absorbance range for each 
sample. 
 
 
Figure 4.18. Effect of reaction time on fluorescence output of encapsulated 
fluorophores. Comparison of integrated fluorescence intensity of cyanine acceptor doped 
calcium phosphate particles a, b, c and cassette doped calcium phosphate particles d, e, f 
in pH 7.4 (0.1 M sodium phosphate buffer) for reaction time 5 min (blue) and 24 h (red). 
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Figure 4.18. Continued 
 
Particle size of the calcium phosphate nanoparticles formed was measured using atomic 
force microscopy (AFM). A freshly cut mica surface was pressed with adhesive tape and 
peeled off to clean the mica surface.  A drop of nanoparticle dispersion in water was 
placed on the mica surface and dried with compressed nitrogen for 5 min.  The surface 
was scanned with Digital Instruments Nanoscope AFM in tapping mode. An SPM 
ULTRASHARP silicon cantilever of the NSC15 series with a resonance frequency of 
325 KHz was used for scanning. The typical tip curvature radius of the uncoated probe 
was < 10.0 nm. Particle size of the calcium nanoparticles was in the range of 14-29 nm 
and they were spherical in shape and well dispersed (Figure 4.19 and 4.20). 
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Figure 4.19. AFM images for cyanine cassettes encapsulated in calcium phosphate 
nanoparticles. Particle size: 14- 29 nm. 
 
 
 
 
Figure 4.20. AFM images for cyanine cassette acceptors encapsulated in calcium 
phosphate nanoparticles. Particle size: 16- 28 nm.  
 
4.2.5 Conclusion 
 
TBET cassettes were successfully encapsulated in silica and calcium phosphate 
nanoparticles. These fluorescent nanoparticles are completely water dispersible and can 
encapsulate either hydrophilic or lipophilic fluorophores. This serves as a novel method 
to make any organic fluorophore water-soluble. The advantage of these nanoparticles is 
the improvement in the photophysical properties of the encapsulated fluorophores. In 
most cases we observed an improvement in quantum yield and energy transfer efficiency 
in cassettes encapsulated. 
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Silica nanoparticles involve covalent attachment of the fluorophore within the silica 
matrix. This prevents leaking of the fluorophore from the nanoparticle for a prolonged 
period of time (for at least a month). Surface modifications of these particles are 
reported152,174,175 and can be attempted to attach these particles to protein and other 
biomolecules. Selected silica nanoparticles were used for cellular imaging studies and 
stained COS7 cells. 
 
Calcium phosphate nanoparticles are easy to synthesize and also biocompatible. Their 
unique property of being stable at physiological pH and increased solubility in acidic pH 
makes them an imaging agent as well as a delivery vehicle for carrying therapeutic 
drugs. Their nontoxic nature and ease of preparation makes them a superior choice over 
silica nanoparticles for future biological applications. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  109 
 
CHAPTER V 
 
 
OUTLOOK AND CONCLUSIONS  
 
 
5.1 Outlook 
The demand for understanding cells on a microscopic level continues to fuel 
development of new imaging agents. Organic fluorophores emitting in the near IR region 
are most preferred but their robustness in the cellular environment is usually a concern. 
The ones that are available suffer from low photostability, aggregation and quenching 
issues which hampers their widespread use in imaging studies. Nevertheless there are 
literature reports, which try to over come these issues by synthetic manipulation of 
fluorophores mainly by introduction of water-soluble groups4,33,176,177 and structural 
designs3,12,178 that make them more photostable. Molecular probes® is one of the leading 
providers of novel fluorophores for biomedical applications and have a wide range of 
products for imaging different regions of the cell.179 The advantage of organic 
fluorophores over other imaging agents such as nanoparticles is their size which is 
usually 2-3 nm, almost 10 times smaller than fluorescent quantum dots and similar 
nanoparticles. The cytotoxicity associated with such nanoparticles is also a cause of 
concern for their widespread use in imaging studies. 
 
The current state of the art involves encapsulating organic fluorophores in a relatively 
nontoxic matrix like calcium phosphate and formation of nanoparticles, which can then 
be used for cellular imaging studies. This approach is advantageous because the 
photophysical property of the fluorophore is enhanced inside the calcium phosphate 
matrix. There is, however, a limit to the extent to which the properties of a fluorophore 
can be enhanced. For example, brightness of a fluorophore depends on the number of 
photons it absorbs and the quantum efficiency, the fraction of photons absorbed that are 
emitted as light. These two parameters are inherent properties of the fluorophore and 
calcium phosphate does not increase or decrease the number of photons absorbed by the 
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fluorophore. Thus focus should be on synthesizing fluorophores with high molar 
extinction coefficients. Among organic fluorophores cyanines have high molar 
extinction coefficient5 but suffer from low quantum efficiency and chemical instability. 
 
5.1.1 Conjugated Organic Polymers  
Conjugated organic polymers are mainly organic compounds with an extended π orbital 
system through which an electron can move from one end of the polymer to the other. 
Their extended π conjugation renders it with a molar extinction coefficient much higher 
than traditional organic fluorophores. Most conjugated organic polymers reported in 
literature are used in applications such as electrochemical sensors,180 polymer based 
solar cells,181 optical amplifiers,182 and flat panel displays using OLEDS.36,54 One of the 
main drawbacks of conjugated organic polymers is their insolubility in aqueous media, 
which makes them less useful for biological applications such as cell imaging. This 
problem can be overcome by developing polymers with saccharide groups attached to 
conjugated polymers. These saccharides not only impart water-solubility but also 
interact specifically with cell surface receptor proteins. Such polymers are known as 
glycopolymers and they are useful candidates for imaging and targeted drug delivery. 
Currently such glycopolymers are widely used for imaging lectins and bacteria.183 Two 
such glycopolymers are shown in Figure 5.1.  They are fluorine-based polymers with a 
polyethylene glycol chain and a glucose residue to impart water-solubility. The use of 
long flexible polyethylene glycol as tethered spacers helps reduce steric hindrance for 
cellular recognition and prevents non-specific interactions. The strong interactions 
between the carbohydrates on the polymer with bacteria such as E. coli results in 
significant red shifts in UV/Vis absorbtion and fluorescence spectra. 
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Figure 5.1. Structures of water-soluble conjugated polymers. 
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Figure 5.1. Continued. 
 
Synthesis of such polymers (Scheme 5.1) involves Suzuki cross coupling of 
phenyldiboronic acid and a bromide bearing monomer, E to form polymer F bearing 
polyethylene glycol tethers. The bromide bearing monomer E was prepared by reacting 
compound C with polyethylene glycol mono laurate in the presence of sodium hydride 
in THF at 25 oC, followed by hydrolysis under basic conditions to afford intermediate D. 
Bromination of D with bromine and triphenylphosphine in acetonitrile yielded E which 
was used for the polymerization reaction. Post polymerization reaction of polymer F 
with 1-thiol-β-D-glucose tetraacetate and 1-thioethyl-α-D-mannose tetraacetate under 
basic conditions afforded polymers G and H. These polymers were subjected to de-
acetylaion under Zemplen conditions in methanol with sodium methoxide to yield 
polymer A and B. 
 
Scheme 5.1. Synthesis of water-soluble polymers A and B 
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Polymers A and B are highly water-soluble and fluoresce with a quantum yield of about 
44 % in pH 7.4 phosphate buffer. They exhibit absorbtion maximum peak at 380 nm and 
emission maximum peak at 426 nm. Polymer B was used for imaging studies of 
ORN178 strain of E.coli that expresses wild type 1 pili, which specifically binds to 
mannose. Pili is a hair like appendage found on the surface of many bacteria. Pili 
connect a bacterium to another of its species and build a bridge between the cytoplasm 
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of the cells and allows for exchange of plasmids between the bacteria. Incubation of 
polymer B with the ORN178 strain resulted in the formation of fluorescently stained 
bacterial clusters from which the polymer was not removed by rinsing and 
centrifugation. There was a significant red shift in UV/Vis absorbtion and fluorescence 
spectra of polymer B in the presence of bacteria indicating enhanced π conjugation of 
the polymer with bacterial pili through multivalent interactions. The polymer absorbtion 
maximum was shifted to 400 nm and emission maximum to 460 nm in the presence of 
bacteria. These glycopolymers look promising for biosensing applications for cells and 
viruses. 
 
5.1.2 Conjugated Polymer Nanoparticles 
A simpler approach towards integrating conjugated polymers for biological applications 
was put forth by McNeill et al whose work involves formation of nanoparticles from 
conjugated polymers, which are dispersible in aqueous media.184 The polymers used for 
synthesis of nanoparticles need not be water-soluble to begin with thereby saving 
considerable synthetic effort and time. Conjugated polymer nanoparticles possess 
several advantageous properties for fluorescence labeling applications such as short 
excited state life time, high quantum yields and large absorbtion cross section per 
particle which makes them extremely bright. 
 
The preparation of these nanoparticles is simple and straightforward and does not 
involve emulsion polymerization or surfactants. This method can be applied to a wide 
range of conjugated polymers that are soluble in organic solvents. The method is based 
on addition of a solution of conjugated polymer dissolved in an organic water miscible 
solvent to water, followed by rapid mixing. The particle size of these nanoparticles 
ranges between 5-10 nm and they are stable in aqueous suspensions. 
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Figure 5.2. Structure of commercially available conjugated polymers used for 
nanoparticle synthesis. Photophysical properties measured in THF. MW denotes 
molecular weight. 
 
Figure 5.2 shows commonly used conjugated polymers for nanoparticle synthesis and 
they are sold by ADS Dyes, Inc®. The procedure for preparing these nanoparticles can 
be described as follows (Scheme 5.2). The polymer was dissolved overnight by stirring 
in THF under an inert atmosphere. The solution was filtered and diluted to a 
concentration of 20 ppm. A part of this solution is added to deionized water with 
sonication. The resulting solution was again filtered to remove any aggregates and any 
starting material remaining. The THF was removed by partial evaporation under vacuum 
and the resulting solution was further filtered to obtain a clear solution with well-
dispersed nanoparticles. The particle size was determined by atomic force microscopy 
(AFM) and transmission electron microscopy (TEM). The suspension is reported to be 
stable for weeks without any aggregation.185 
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Scheme 5.2. Synthesis of nanoparticles from conjugated polymer PFO. 
conjugated 
polymer PFO
C8H17C8H17
n
(i) THF, 25 oC, 12 h
(ii) filter (1.6 µm filter) and 
dilute to 20 ppm
2 mL of this solution in 8 mL
deionized water
may contain some 
aggregates
 
filter (0.2 µm filter) and remove
THF by partial evaporation and again
filter (0.2 µm filter) overall yield 80 %
particle size: 10 nm  
 
The nanoparticle dispersion in water displays blue shifted, broadened absorbtion spectra 
and a red-shifted emission spectra as compared to their parent polymer in THF (Figure 
5.3). The blue shifted absorbtion spectra can be attributed to bending or kinking of the 
polymer backbone.185 This is also in agreement with simple geometric consideration ie 
the diameter of a nanoparticle is roughly 50 % of the effective conjugation length of the 
unconstrained polymer. The presence of some aggregates due to interactions between 
segments of polymer chain is evident from the red tail in the absorbtion spectra. The red 
shift in the fluorescence spectra of these nanoparticles can be ascribed to the increasing 
interaction between segments of the polymer chain in a compact nanoparticle which 
leads to energy transfer to low energy chromophores and weakly fluorescent interchain 
aggregates. The fluorescence quantum yields of these nanoparticles in water were in the 
range of 0.1 with a molar extinction coefficient of approximately 5 x 107 M-1cm-1. It 
should be mentioned that the quantum yields of these nanoparticles are 4-fold less for 
PFO, 7-fold less for PFPV and 25 –fold less for MEH-PPV as compared to their parent 
polymer in THF. Nevertheless the comparison of quantum yield and molar extinction 
coefficient of one such nanoparticle dispersion in water prepared from PFPV with that of 
fluorescent dye rodhamine 6G, a widely used biological stain indicates that the PFPV 
nanoparticles are 50 times brighter than rodhamine 6G. 
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Figure 5.3. Normalized absorbtion (a) and fluorescence spectra (b) of the conjugated 
polymer nanoparticle dispersions (solid lines). Their comparison to corresponding 
polymers in THF solution (dashed lines). 
 
As mentioned before conjugated organic polymers have high fluorescence quantum 
yields and broad emission spectra with full width at half maxima (fwhm) of around 50-
100 nm, meeting the requirement for an efficient donor in FRET based systems. They 
also have high molar extinction coefficients and can harvest light very efficiently. These 
characteristics make them suitable for FRET based systems in which these polymers can 
act as donors to fluorescent dyes which absorb and emit at a longer wavelength 
compared to the polymer.186 Scheme 5.3 shows preparation of dye doped fluorescent 
nanoparticles with an average particle size of 30 nm. The procure is similar to preparing 
undoped polymer nanoparticles, except that a given 100 ppm solution of fluorescent dye   
in THF is added in varying amounts of 0-10 % to the polymer solution. In order to make 
sure that the dye is primarily located inside the nanoparticles and not as free dye 
molecules in solution, the dye doped polymer nanoparticle solution was concentrated by 
a factor of 6 using centrifugal concentrators with a molecular weight cut off of 30,000. A 
very weak absorbtion and fluorescence from the dopant dye was observed in the filtrate 
proving that most of the dye was encapsulated in the polymer nanoparticle. The 
repetition of the above procedure after two weeks also did not result in any absorbance 
or fluorescence of the dopant dye in the filtrate indicating minimal dye leakage.  
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Scheme 5.3. Synthesis of dye doped polymer nanoparticles. 
conjugated 
polymer PDHF
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of fluorescent dye in THF
(iv) add varying amount of above dye solution
to polymer solution to obtain a dye/polymer fraction
ranging from 0-10 wt %
 
filter (0.2 µm filter) and remove
THF by partial evaporation and again
filter (0.2 µm filter) overall yield 80 %
particle size: 30 nm  
 
 
Polymer PDHF was used as a host polymer in preparing these dye doped polymer 
nanoparticles because of its high molar absorptivity and broad emission spectrum, which 
provides favorable spectral overlap with dopant dyes. Structure and photophysical 
properties of dopant dyes are shown in Figure 5.4. Figure 5.5a represents normalized 
fluorescence emission spectrum of the PDHF nanoparticles in water and absorbtion 
spectra of perylene, coumarin 6, Nile Red and TPP in THF solution. The fluorescence of 
the polymer PDHF in the 400-550 nm region possess good overlap with the absorbtion 
spectra of all the dyes, a key requirement for energy transfer via Forster mechanism. 
Figure 5.5b shows the normalized absorbtion (dashed line), fluorescence excitation and 
emission spectra (solid line) of the undoped PDHF and the four dye doped nanoparticles 
in water. The dominant absorbtion peak around 375 nm of the dye-doped nanoparticles 
is due to PDHF and the weak absorbtion is from the dopant dye. When excited at 375 
nm, the fluorescence emission from PDHF is almost completely quenched and the 
nanoparticle exhibits fluorescence characteristic of the dopant fluorescent dye. This 
proves efficient energy transfer between the host polymer PDHF and the dopant dye 
within the nanoparticles. 
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Figure 5.4. Dopant dyes used for nanoparticle synthesis. Photophysical properties 
measured in THF. 
 
The fluorescence energy transfer increases with increasing concentration of the dopant 
dye and reaches a maximum at 1.0 wt % of the dopant dye. Further increase in the 
concentration of the dopant dye caused a significant reduction in the fluorescence energy 
transfer. The reduction in fluorescence energy transfer is caused by formation of dye 
aggregates at higher concentrations. The dye doped polymer nanoparticles are many 
times brighter than inorganic quantum dots and dye loaded silica nanoparticles of similar 
dimensions.186 The quantum yields of nanoparticles were approximately 0.4 with a molar 
extinction coefficient of 1.5 x 109 M-1 cm-1. The photostability of the dye doped polymer 
nanoparticles was analyzed using a 1.0 mW, 380 nm UV light source. The dye doped 
polymer nanoparticles showed a 4 fold improvement in photostability compared to the 
undoped nanoparticles. The efficient energy transfer between the host polymer and the 
dopant dye gives an alternate path for energy dissipation thereby improving 
photostability of the nanoparticle as a whole. 
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Figure 5.5. (a) Normalized fluorescence spectrum of PDHF nanoparticles in water and 
absorbtion spectra of dopant dyes in THF. (b) Normalized absorbtion (dashed), 
fluorescence excitation and emission spectra (solid) of pure and dye doped PDHF 
nanoparticles in water. 
 
The nondoped polymer nanoparticles were used for bioimaging studies in cells.187 
J774.A1 macrophage cells were used for this particular study based on the ability of the 
macrophage cell line to efficiently ingest cellular debris and small particles such as 
nanoparticles. Figure 5.6 shows differential interference contrast (DIC) and fluorescence 
images of the cells incubated with PPE, PFPV, PFBT and MEH-PPV nanoparticles. The 
images indicate internalization of the nanoparticles by cells. The nanoparticle appears to 
be stable in the cell culture medium and most nanoparticle fluorescence is seen from the 
cytoplasm indicating that most of them crossed the cell membrane. 
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Figure 5.6. Differential interference contract (DIC) images (top) and fluorescence 
images (bottom) of macrophage cells labeled with PPE, PFPV, PFBT, and MEHPPV 
polymer nanoparticles. Scale bar: 10 µm. 
 
5.1.3 Encapsulation of Conjugated Polymers in Calcium Phosphate Nanoparticles 
5.1.3.1 Preliminary Data 
Conjugated organic polymer nanoparticles show promise as an imaging agent for 
biological studies because of their extreme brightness and ease of preparation. 
Photostability of these nanoparticles are reported to be similar to fluorescent organic 
dyes and further investigation is required to ascertain their long-term stability in order 
for them to be useful for in vivo animal imaging. Macrophages are a type of white blood 
cell involved in cleaning up any foreign debris and as such can uptake any material, 
therefore cellular imaging studies with other more widely used cell lines such as HeLa 
cells should be carried out to study the broad applicability of these nanoparticles. The 
cytotoxicity of these nanoparticles should also be evaluated on different cell lines with 
respect to particle size and polymer used in their preparation. 
 
The widespread use of these polymer nanoparticles in biological studies can be 
envisioned only if they are modified so as to make them (i) more photostable (ii) have 
emission characteristics shifted closer to the near infrared region (iii) minimally 
cytotoxic and (iv) biocompatible. In order to achieve these objectives a rational design 
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comprising conjugated organic polymers, near infrared fluorophore and calcium 
phosphate nanoparticle can be put forward. The idea is to covalently attach fluorophores 
to the polymer backbone in such a way to facilitate through-bond energy transfer from 
the polymer to the fluorophore and then encapsulate these modified polymers in 
biocompatible and non-cytotoxic calcium phosphate nanoparticles to improve their 
photostability. As mentioned earlier there need not be any overlap of the emission of the 
polymer with the absorbance of the fluorophore for energy transfer to occur.  
 
We modified the published procedure for calcium phosphate nanoparticle synthesis so 
that polymer nanoparticles from PFO could be used as the organic cargo, and cast 
calcium phosphate around the organic nanoparticle.  Since polymer nanoparticles are 
unstable in organic media no surfactant was used in their encapsulation in calcium 
phosphate. Briefly 1.0 mL of the polymeric nanoparticles 20 nm in diameter and 40 ppm 
in concentration were stirred along with sodium phosphate 0.1 mL (6 x 10-3 M) and 
sodium silicate 0.05 mL (8 x 10-4 M) for 5 min and calcium chloride 0.1 mL (10-2 M) 
was added. The solution was stirred for 10 or 20 minutes for calcium phosphate 
nanoparticle formation and then quenched with 0.1 mL sodium citrate (10-3 M). Overall 
these particles were 90- 110 nm in diameter (atomic force microscopy, AFM, Figure 
5.7).  
 
 
Figure 5.7. AFM images of polymer nanoparticles encapsulated in calcium phosphate at 
different reaction times. 
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The large size of these particles makes them less useful for imaging studies because 
large particles have a tendency to aggregate and they are less cell permeable. An 
optimum size for nanoparticles for cellular imaging studies is 20-30 nm as is the case 
with silica and calcium phosphate nanoparticles.170,174 We reasoned that instead of 
encapsulating polymer nanoparticles in calcium phosphate, the polymer could be directly 
encapsulated in calcium phosphate to obtain nanoparticles in the size range of 20-30 nm.  
The synthetic procedure for polymer encapsulated calcium phosphate nanoparticles is 
shown in Figure 5.8. The procedure is similar to the published procedure,170 except the 
reaction time, which is 6 h instead of the usual 5 min. We believe the increase in reaction 
time will help achieve complete encapsulation of the polymer and help in formation of a 
compact shell. The concentration of the polymer cargo used was 10-5 M and 1.0 mL of 
polymer solution in THF was used for nanoparticle synthesis. The polymer was not very 
soluble in THF or any other solvents and therefore the encapsulation process was not 
very efficient. 
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Na2SiO3
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Na2HPO4
CaCl2
microemulsion A
microemulsion B
calcium phosphate
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carboxyl group on surface
purified by MPLC
Sodium silicate Na2SiO3 is for nucleation of nanoparticles.
O
OH
5
C9H19
Igepal CO-520 
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+Na–O2C CO2
–Na+
OH
CO2H
sodium citrate
 
Figure 5.8. Synthesis of polymer doped calcium phosphate nanoparticles. 
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Figure 5.9 shows the normalized absorbance and emission spectra of PFPV encapsulated 
calcium phosphate nanoparticles. The absorbtion and emission properties of these 
particles are similar to the parent polymer, indicating that unlike polymer nanoparticles, 
polymer inside calcium phosphate matrix exists as dispersed single molecules, thereby 
reducing intermolecular quenching. 
 
a 
 
b 
 
Figure 5.9. (a) Normalized absorbtion and emission of polymer doped calcium 
phosphate nanoparticles and (b) comparison of photostability of PFPV polymer 
nanoparticles and PFPF encapsulated calcium phosphate nanoparticles in pH 7.4 
phosphate buffer. 
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The photostability of polymer encapsulated calcium phosphate nanoparticles is greater 
than the corresponding polymer nanoparticles by a factor of 10 % (Figure 5.9b). These 
measurements were done by exposing the nanoparticle samples to ambient light for two 
days. The sharp decrease in fluorescence intensity from day one to day two for both sets 
of nanoparticles is due to the extreme instability of PFPV towards light. Calcium 
phosphate does seem to provide some protection to the encapsulated polymer as evident 
from the fluorescence output of the samples on day two. The photostability studies were 
repeated two times and averaged. PFPV being the least light stable among all the 
available polymers, we expect the photostability of calcium phosphate nanoparticles 
prepared from other conjugated polymers to be better. 
 
 
Figure 5.10. AFM images of PFPV and PFO encapsulated calcium phosphate 
nanoparticles.  
 
Atomic microscopy images (AFM) show well dispersed particles with particle size 
ranging from 12 -31 nm (Figure 5.10). These smaller particles are better suited for 
imaging purposes than the larger ones previously prepared. With this preliminary data in 
hand we will try to encapsulate polymers covalently linked to near infrared fluorophores 
into calcium phosphate nanoparticles. 
 
5.1.3.2 Future Goals 
The most important step in our approach is the synthesis of polymer with a fluorophore 
covalently attached to it. This is somewhat similar to the synthesis of through-bond 
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energy transfer cassettes, the major difference being the ratio of donor and acceptor 
used. From reported literature,186 it is known that for FRET based systems efficient 
energy transfer form the polymer to the dopant dye is possible at a dopant concentration 
of 1.0 wt %. A further increase in dopant concentration results in decreased energy 
transfer due to intermolecular quenching of the dopant dye molecules. Therefore our 
synthesis will be modified to include relatively small amounts of acceptor fragments that 
fluoresce at long wavelengths relative to the polymer donor, and that become 
electronically conjugated to the polymer.  Thus acceptor-containing monomers will be 
added to the polymer syntheses at relatively low levels (around one acceptor molecule 
per 100 donor monomers used in the polymerization would be a good starting point).  
For instance, the PF polymer derivatives will be made using Suzuki coupling procedures 
that have been used extensively for these polymer types.  In the proposed work relatively 
low concentrations of acceptor fragments will also be added to the syntheses. The part of 
the acceptor that becomes integrated into the main polymer chain may modulate the 
spectroscopic properties of the polymer and is therefore called “modulator”. These 
modulators might be significantly more or less electron donating than the core of 
polymer, thus improving its “push-pull” characteristics, increasing its one- and two-
photon cross sections (Figure 5.11b). 
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Figure 5.11. (a) Proposed backbone modified conjugated organic polymer with an 
acceptor fluorophore. (b) Modulator fragments for efficient energy transfer. (c) 
Fluorophores for polymer synthesis. 
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Figure 5.11. Continued. 
 
Polymer encapsulated calcium phosphate nanoparticles holds promise because of their 
high per particle brightness and nontoxic nature. Through-bond energy transfer systems 
where conjugated polymers act as donors and near infrared emitting fluorophores act as 
acceptors is a novel approach towards channeling the vast photon energy absorbed by 
the polymer to the fluorophore thereby shifting the emission of the system to a longer 
wavelength. Non-radiative processes can be minimized by encapsulating them in 
calcium phosphate, which gives sufficient shielding from quenchers such as oxygen and 
solvents. A further advantage of such nanoparticles is their biocompatibility because 
calcium and phosphate ions are ubiquitously present in human beings and possess no 
toxic side effects at millimolar concentrations.  
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5.1.4 Sensing and Detecting Explosives Using Organic Fluorophores 
Detection of explosives in aqueous media as well as in gaseous environment is gaining 
widespread research interest for security reasons.188-190 Detection techniques need to be 
sensitive with low detection limit, accurate and less time consuming to ensure the safety 
of everyone and reduce damages in the event of an explosion. The most widely studied 
explosives are nitro compounds such as TNT, RDX and PETN (Figure 5.12). Most of 
these chemical compounds have low vapor pressures and are therefore difficult to detect. 
Most explosives are fluorescence quenchers and therefore the decrease in fluorescence 
of a fluorophore can be monitored for the detection of such compounds. Fluorescence 
based methods for detection requires only an excitation source and a detector, which can 
be easily incorporated into a hand held device for field detection of explosives. 
Explosives are inherently non-fluorescent and therefore background interference in such 
measurements is minimal.  
 
NO2O2N
NO2
trinitrotolene (TNT)
N
N
N
NO2
NO2O2N
cyclotrimethylene
trinitramine
(RDX)
ONO2
ONO2
O2NO
O2NO
pentaerythritol
tetranitrate (PETN)  
Figure 5.12. Structure of common nitro explosives. 
 
Figure 5.13 shows some commonly used organic fluorophores for detection of nitro 
explosives.190,191 These fluorophores are able to detect nitro explosives in picomolar and 
even ppb levels, which can be quantified by the reduction in their fluorescence upon 
interaction with the explosives. Detection of explosives via fluorescence can be 
classified into the following three categories: (i) indirect fluorescence methods (ii) 
indirect laser induced fluorescence (iii) fluorescence immunoassays. All three methods 
detect the decrease in fluorescence of the fluorophore upon interaction with an 
explosive. Detection is either done in solution phase or in solid state. For field detection 
of explosives it is beneficial for the fluorophore to be solid state, due to ease of handling. 
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Most often fluorophores are incorporated into a poly(vinylchloride) membrane or into a 
silica monolith. Polymers and silica beads have also been used as a solid support for 
organic fluorophores. The fluorophore doped particles are fixed on to a glass slide or 
onto the end of an optical fiber and then exposed to the explosive vapor. The rate of 
reduction in fluorescence of the fluorophore is related to the diffusion of the vapor into 
the particles which allows the identity of the explosive to be determined. 
 
Indirect laser induced fluorescence approaches involve displacement of the fluorophore 
by the explosive based on either charge or space considerations, leading to a local 
decrease in fluorescence. The fluorophore is usually contained in a micelle such as 
sodium dodecyl sulfate that favors radiative processes and therefore the fluorophore is 
highly fluorescent. The presence of an explosive will disturb the equilibrium between the 
fluorophore and the micelle there by reducing the fluorescence intensity. In this method 
a laser is used to excite the fluorophore and reduction in fluorescence is correlated to the 
concentration of fluorophore.  
 
Fluorescence immunoassays are widely used for detecting nitrated explosives. An 
explosive specific antibody is saturated with a fluorescently labeled analog of the 
explosive molecule. When this antibody is exposed to an explosive, the explosive 
displaces the fluorescent label. This causes a change in the fluorescence properties of the 
fluorescent label and enables detection. These immunoassays have been incorporated 
into a number of field devices and tested on real samples. 
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Figure 5.13. Structure of commonly used organic fluorophores for detection of nitrated 
explosives. Photophysical properties measured in THF. 
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Figure 5.13. Continued. 
 
From the above fluorescence based detection methods used, it is clear that the solubility 
of the fluorophore in aqueous media is very important for their success in field 
measurements because most often explosives are found in a hydrophilic environment. 
Water-soluble analogues of above mentioned fluorophores and ones that emit to the far 
red could be easily synthesized, thereby improving detection limits and sensitivity. Some 
examples of such fluorophores are shown in figure 5.14. Since most of these 
fluorophores are used in field detection studies, their photostability to ambient light is 
very important. Their photostability can be improved by encapsulating them in 
mesoporous silica nanoparticles. In this particular type of application control of particle 
size need not be very stringent and can be in the range of 100-200 nm.  
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Figure 5.14. Water-soluble organic fluorophores for detection and sensing of nitrated 
explosives. Absorbance and emissions measured in pH 7.4 (0.1 M phosphate buffer). 
 
Conjugated organic polymers are the most widely used materials for the detection of 
nitrated explosives and the process was first developed by Swager et al.192 These 
polymers are characterized by a “molecular wire” effect, in which the conjugated 
backbone of the polymer helps in efficient delocalization of electron density due to the 
absorbtion of light and they emit in the visible region of the spectrum.193 Perturbation in 
electron delocalization by any external factor, in this case by the interaction of explosive 
with the polymer chain results in a significant reduction in the fluorescence output. The 
sensitivity of such conjugated polymers towards nitrated explosives are 50 fold higher 
than organic fluorophores. The quenching occurs via an electron transfer mechanism and 
is dominated by a static interaction between the explosive and the polymer. This 
nonbonding electrostatic interaction between the electron rich polymer and the electron 
deficient nitrated explosives is critical in the detection process. The response of the 
polymer was initially verified using paraquat, a well known electron transfer quenching 
agent (Figure 5.15). 
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Most of the conjugated polymers used are iptycene based and their response to 
explosives is dependent on the vapor pressure of the explosives and the charge 
distribution of the polymer and the explosives (Figure 5.15).194 Presence of the iptycene 
moiety in the polymer backbone prevents π stacking or excimer formation and thus 
prevents self quenching of the polymers. The rigid iptycene moiety also provides 
cavities for the explosives to bind to the polymer, an important reason behind their high 
sensitivity.195   The response time of such polymers is usually measured in seconds. 
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Figure 5.15. Structure of iptycene based polymers and paraquat. Photophysical 
properties measured in dichloromethane. 
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Synthesis of such polymers (Scheme 5.4) involves palladium catalyzed cross coupling 
reaction of corresponding disubstituted diiodobenzenes with iptycene diacetylenes.194 
The iptycene diacetylenes are obtained from the corresponding iptycene quinones, which 
in turn are obtained from reaction of benzoquinone and anthracene or pentacene. As 
evident from the reaction scheme the synthesis of iptycene precursors is low yielding 
and accompanied by isomers that makes purification difficult. This step is a bottleneck 
in the synthesis of iptycene based polymers.  
 
Scheme 5.4. Synthesis of polymer 1 and iptycene precursor. 
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The absorbance and emission of iptycene based polymers are in the 400-500 nm region. 
There are hardly any literature reports on fluorene based polymers for explosive sensing 
and detection. We believe that electron rich fluorene based polymers will be a useful 
addition to the growing number of polymers used for such applications. It would be 
interesting to synthesize a copolymer from iptycene and fluorene and study its 
photophysical properties (Figure 5.16). Most polyfluorenes have a red shifted emission 
compared to the iptycene polymers and by following the strategy described in the 
previous section (covalent attachment of an organic fluorophore to the polyfluorene back 
bone to form through-bond energy transfer system) the emission wavelength can be 
shifted to any desired wavelength. One important draw back of polymers in field 
detection of explosives is their photo instability in ambient light. This can be overcome 
by either encapsulating these polymers in calcium phosphate or silica to form 
nanoparticles with improved photostability and dispersibility in aqueous media. 
 
C8H17O
OC8H17
 
Figure 5.16. Proposed copolymer from iptycene and fluorene. 
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5.1.5 Solid Emissive Organic Fluorophores 
 
Solid emissive organic fluorophores is the focus of intense research because of their 
possible application in optoelectronics such as organic light emitting diodes 
(OLED).54,196 OLED is any light emitting diode whose emissive electroluminescent layer 
is composed of a film of organic dye deposited by a polymer coat. OLED finds 
widespread application in television screens, computer displays, cell phones and can be 
used as a general light source. A significant benefit of OLED is that they do not require 
any backlight to function and therefore draw far less power than liquid crystal displays 
(LCD).  
 
In OLED applications efficient green and blue emitting materials have been developed197 
and commercialized whereas red emitting material is still proving to be a stumbling 
block. Organic fluorophores with emissions in the 600-800 nm region in solution and 
solid phase are very rare. This is because their dense packing in amorphous or crystalline 
state leads to quenching of the fluorescence. Most organic fluorophores have high 
planarity in molecular structures and result in well-ordered π stacking leading to 
aggregation in solid states. Aggregation in solid state can be prevented by introducing 
bulky substituents thereby disrupting the ordered π stacking and minimizing quenching 
effects.  
 
BODIPY dyes with their fine tunable emission and ease in synthetic manipulation 
appear to be a suitable candidate for investigation in solid-state emissive materials. 
Akkaya et al198 reported the synthesis of solid emissive BODIPY dyes with bulky 
substituents to prevent π stacking and quenching. They introduced tert-butyl and 3,5-di-
tert-butyl phenyl substituents and found that these groups are very effective in keeping 
the π system apart. Scheme 5.5 shows the synthesis of BODIPY dyes 1 and 2. The 
reaction of appropriate aldehyde with corresponding pyrrole following standard 
BODIPY synthesis conditions afforded 1 and 2 in 45 and 26 % yield respectively. 
Crystal structures obtained for dyes 1 and 2 showed that the distance between the closest 
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overlapping near-parallel π-surfaces in compound 1 and 2 are considerably larger than 
BODIPY dyes with no substituents. This indicates that tert-butyl group acts as a 
molecular separator in these dyes and reduces quenching in the solid state. Both dyes 
showed a red shifted emission in solid state (BODIPY 1: 590 nm and 2: 610 nm) as 
compared to their emission in solution (BODIPY 1: 500 nm and dye 2: 520 nm). The 
absorbtion of both dyes in solid phase were 1: 490 nm and 2: 510 nm respectively and 
absorbtion in solution phase were not reported. 
 
Scheme 5.5. Synthesis of BODIPY with bulky tert-butyl substituents to prevent 
π stacking. 
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Qian et al199 reported a similar modification of BODIPY dyes with bulky trityl groups 
and found that the introduction of the trityl group caused a significant red shifted 
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emission compared to parent BODIPY dye in solid state possibly due the extended 
conjugation afforded by the trityl groups. Thus the trityl groups serve the dual purpose of 
disrupting π stacking and extending conjugation. Scheme 5.6 illustrates the synthesis of 
BODIPY3. Trityl chloride is converted to the corresponding tritylalkyne in four steps via 
palladium catalyzed cross coupling. The tritylalkyne is coupled to diiodo BODIPY to 
afford BODIPY3 in 71 % yield. 
 
Scheme 5.6. (a) Synthesis of  (a) Trityl alkyne A and (b) BODIPY decorated with trityl 
groups. 
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The photophysical properties of BODIPY3 in dichloromethane were measured and 
found to have a quantum yield of 0.79 with an absorbtion at 575 nm and emission at 610 
nm. The dye exhibited similar photophysical properties in solid state. The enhanced 
fluorescence emission in solid state can be attributed to the steric bulk of the trityl group, 
which prevents π stacking of the molecules, weakens intermolecular interactions and 
inhibits self-quenching. 
 
Another bulky group used for improving the photophysical properties of a dye in solid 
state is the perfluoropropylene trimer (Figure 5.17) derived substituents. 
Benzophenoxazine dye Nile Red with trimer A at the 2 position showed exceptional 
fluorescence emission in solid state; where as Nile Red with no substitution is 
completely non fluorescent.200  
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Figure 5.17. Perfluoropropylene trimers. 
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Scheme 5.7. Synthesis of solid emissive Nile Red dye. 
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The emission profile of fluorinated Nile Red is vastly different in solid phase and 
solution phase. The fluorescence emission in solid state has maxima at 717 nm where as 
in solution phase the fluorescence maxima is at 632 nm. The authors attribute this 
bathochromic shift to an increased intermolecular interaction between dye molecules in 
solid phase compared to solution phase. The quantum yield of the fluorinated Nile Red 
in dichloromethane is 0.69 and in solid state it is 0.024 which shows that inspite of the 
presence of trimer A in the dye structure there is significant quenching of the dye in 
solid state and a more bulky group is required to prevent π stacking.  
 
A more direct way of overcoming quenching interactions in fluorescent dyes in solid 
state is to encapsulate them in a matrix such as silica or calcium phosphate. Results 
obtained from our laboratory have shown that Nile Red dye upon encapsulation in silica 
nanoparticles (20 nm dimension) is bright red fluorescent in solid state (Figure 5.18). We 
do not find any bathocromic shift in fluorescence emission probably due to less 
intermolecular interaction between dye molecules inside the silica matrix. Since any 
organic fluorophore except few cyanine dyes (Cy7 and similar ones) can be encapsulated 
in silica using simple synthetic procedures, fluorescent silica nanoparticles can be used 
as a possible substitute for organic dyes in preparation of organic light emitting diodes 
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(OLED). The most important draw back of organic dyes is their photo instability, which 
greatly effects the lifetime of OLED. The lifetime of OLED is nearly half of the 
traditional liquid crystal display (LCD).201 Encapsulation of organic dyes in silica 
nanoparticles is known to improve their photostability and therefore will improve the 
lifetime of OLED and make it cost efficient. 
 
 
Figure 5.18. (a) Absorbance of 13 encapsulated in silica nanoparticles in solid state 
and (b) comparison of solid-state emission of 13 and 13 encapsulated in silica 
nanoparticles. 
 
5.2 Conclusions 
Nine water-soluble benzophenoxazine dyes were prepared and their photophysical 
properties in aqueous media evaluated (Figure 5.19). It was found that carboxylic acid 
and hexaethylene glycol chains have a greater impact on fluorescence output in aqueous 
media compared to sulfonic acid groups. This is probably because these groups are 
better suited to disrupt π stacking of dyes than sulfonic acids, thereby preventing self 
quenching of the dye molecules. The quantum yields of these dyes were in the range of 
0.1-0.33 in pH 7.4 phosphate buffer. Selected dyes 25 and 27 specifically stained the 
mitochondria and the golgi apparatus respectively proving their applicability for 
bioimaging studies. Dye 13 was used for preparation of so called “SNAP-tag” by 
attaching it to benzylguanine derivatives. Transfection of CHO cell lines CHO-K1 and 
CHO-NLS with AGT26-his fusion protein and treatment with 13a, 13b, and 13c gave 
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distinct fluorescence, indicating that the compound is entering the cell but was trapped in 
either vesicles and in some cases mitochondria. Further investigation is required for 
constructing a SNAP-tag that can track specific organelles.  Dye 33a was used for 
conjugate addition to ovalbumin with a labeling efficiency of 22 %. The fluorescence 
intensity of the dye-ovalbumin conjugate was much less than the dye itself. This dye was 
also used to measure ovalbumin concentrations in dilute samples. It was found that with 
increasing addition of small amounts of ovalbumin there was a corresponding increase in 
fluorescence output of the dye. The water-solubility of the dye circumvents the need for 
any detergent additives for such studies. 
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Figure 5.19. Structure of synthesized water-soluble benzophenoxazine dyes. 
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Figure 5.19. Continued. 
 
We synthesized six through-bond energy transfer cassettes that showed good energy 
transfer in organic media but poor energy transfer in aqueous media. Presence of water-
soluble groups did not improve energy transfer in these cassettes. Therefore some of 
these cassettes were encapsulated in a silica or calcium phosphate matrix to form 20-30 
nm nanoparticles. These nanoparticles were easily dispersible in pH 7.4 phosphate buffer 
after dialysis and improved energy transfer efficiency of the encapsulated cassettes. The 
cassettes encapsulated in silica nanoparticles were used for cellular imaging studies and 
showed good uptake in COS7 cell lines. Silica and calcium phosphate nanoparticles 
serve as a useful matrix to encapsulate both water-soluble and insoluble fluorophores. 
The encapsulation indirectly makes these fluorophores water-soluble and also improves 
their photophysical properties. 
 
For almost 80 years fluorescence has been used as a sensitive technique for biological 
studies and most recently in detection of explosives and for preparation of 
optoelectronics such as OLED. Organic fluorophores due to their low toxicity and 
tunable fluorescence properties continue to hold a prominent place in all the above 
applications. Their drawbacks such as low photostability, poor water-solubility and 
aggregation can be over come by either synthetic manipulation or more conveniently by 
their encapsulation in matrixes such as silica and calcium phosphate to form 
nanoparticles. 
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APPENDIX A 
 
 
EXPERIMENTAL DATA FOR CHAPTER II 
 
 
General Experimental Methods 
All reactions were carried out under an atmosphere of dry nitrogen.  Glassware were 
oven-dried prior to use.  Unless otherwise indicated, common reagents or materials were 
obtained from commercial source and used without further purification.  All solvents 
were dried prior to use with appropriate drying agents.  Dry distilled DMF was obtained 
from Acros and used as such.  Flash column chromatography was performed using silica 
gel 60 (230-400 mesh).  Analytical thin layer chromatography (TLC) was carried out on 
Merck silica gel plates with QF-254 indicator and visualized by UV.  Fluorescence 
spectra were obtained on a Varian Cary Eclipse fluorescence spectrophotometer at room 
temperature.  Absorbance spectra were obtained on a Varian 100 Bio UV-Vis 
spectrophotometer at room temperature.  IR spectra were recorded on a Bruker Tensor 
27 spectrometer. Preparative HPLC data were obtained on a Beckmann Coulter 
preparative HPLC instrument with a C18 reverse phase column. Solvent system used 
(20-95% CH3CN/1%TFA in H2O. Analytical HPLC data were obtained on a Beckmann 
Coulter Analytical HPLC instrument with a C18 reverse phase column. Solvent system 
used 10-90% CH3CN/0.1% TFA in H2O. 
 
1H and 13C spectra were recorded on a Varian 300 (300 MHz 1H; 75 MHz 13C) or Varian 
500 (500 MHz 1H; 125 MHz 13C) spectrometer at room temperature.  Chemical shifts 
were reported in ppm relative to the residual CDCl3 (δ 7.26 ppm 1H; δ 77.16 ppm 13C), 
CD3OD (δ 3.31 ppm 1H; δ 49.0 ppm 13C), DMSO-d6 (δ 2.54 ppm 1H; δ 39.52 ppm 13C) 
or acetone-d6 (δ 2.05 ppm 1H; δ 29.84 and 206.26 ppm 13C). Trichloro-fluoro-methane 
(CFCl3, δ 0.00 ppm 19F) was used a standard for fluorine NMR. Coupling constants (J) 
were reported in Hertz. 
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Photophysical Properties and Determination of Quantum Yields 
Steady-state fluorescence spectroscopic studies were performed on a Cary Eclipse 
fluorometer.  The slit width was 5 nm for both excitation and emission.  The relative 
quantum yields of the samples were obtained by comparing the area under the corrected 
emission spectrum of the test sample with that of a solution of Nile Blue in ethanol, 
which has a quantum yield of 0.27 according to literature reports.202 The quantum 
efficiencies of fluorescence were obtained from three measurements with the following 
equation: 
Φx = Φst (Ix/Ist) (Ast/Ax) (ηx2/ηst2)   
 
Where Φst is the reported quantum yield of the standard, I is the area under the emission 
spectra, A is the absorbance at the excitation wavelength and η  is the refractive index of 
the solvent used, measured on a pocket refractometer from ATAGO.  X subscript 
denotes unknown, and st denotes standard.203  A dye concentration of 10-6 M was used 
for the measurement of quantum yield. 
Molar extinction coefficients were obtained from the slope of a graph of absorbance vs 
concentration for each dye with five different concentrations  (10-6 M).  0.25, 0.5, 1.0, 
1.5, and 3.0 x 10-6 M were the concentration used. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  157 
Experimental Section 
 
N OH
CO2Et
10
EtO2C
 
A solution of dicarboxylic acid 9 (2.0 g, 7.9 mmol) in ethanol (100 mL) along with HCl 
(10 M, 0.2 mL) was refluxed for 12 h. The reaction mixture was cooled and ethanol 
evaporated under reduced pressure. The residue obtained was dissolved in 
dichloromethane (20 mL) and organic layer washed with water (5 mL x 5). The organic 
layer was dried under Na2SO4 and solvent evaporated to obtain a residue which was 
purified by passing through a short flash chromatography normal phase silica column 
eluting with 1/1 EtOAc/hexanes to yield 10 as an yellow oil (1.64 g, 67 %). Rf = 0.8 (1/1 
EtOAc/hexanes). 1H NMR (500 MHz, CDCl3) δ 7.05 (t, 1H, J = 5.0 Hz), 6.99 (s, 1H), 
6.24 (br, 2H), 4.13 (q, 4H, J = 7.1 Hz), 3.61 (t, 4H, J = 7.0 Hz), 2.58 (t, 4H, J = 7.0 Hz), 
1.24 (t, 6H, J = 7.1 Hz); 13C NMR (125 MHz, CDCl3) δ 172.9, 157.7, 148.4, 130.6, 
105.0, 104.6, 99.9, 61.1, 47.1, 32.8, 14.4. MS (ESI) m/z (M+H)+ 310.32; IR (neat) 
3387, 2962, 1732 cm -1. 
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1H NMR (CDCl3) 
13C NMR (CDCl3) 
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OHN
CO2Et
EtO2C NO
.HCl
11  
Sodium nitrite (0.24 g, 3.5 mmol) in water (3 mL) was added, over a period of 15 min, 
via a syringe pump at the rate of 0.2 mL/min, to a solution of 10 (1.0 g, 3.2 mmol) in 
HCl (3 mL, 10 M) and water (1.5 mL) at 0 oC. The mixture was stirred for 3 h at 0 oC 
and filtered to remove residual impurities. The filtrate was evaporated under reduced 
pressure to yield 11 as a yellow solid (0.92g, 77 %). The crude product was very 
moisture sensitive and therefore directly used without further purification for the next 
step. 
O
N
OH
N O
CO2Et
EtO2C
12  
1,6-Dihydroxynaphthol (0.34 g, 2.1 mmol) with HCl (0.1 mL, 10 M) was added to a 
solution of 11 (0.8 g, 2.1 mmol) in EtOH (30 mL) all in one portion. The reaction 
mixture was refluxed for 5 h. The solvent was evaporated and residue purified by flash 
chromatography eluting with 1/1 EtOAc/hexanes and 10 % MeOH/EtOAc to afford 12 
as a red solid (372 mg, 37 %). Rf = 0.8 (10 % MeOH/EtOAc). 1H NMR (300 MHz, 
acetone-d6) δ 8.07 (d, 1H, J = 8.5 Hz), 8.0 (s, 1H), 7.62 (d, 1H, J = 8.5 Hz), 7.19 (dd, 
1H, d, J = 9.1, 2.6 Hz), 6.89 (dd, 1H, d, J = 9.1, 2.6 Hz), 6.72 (s, 1H), 6.14 (s, 1H), 4.13 
(q, 4H, J = 7.0 Hz), 3.89 (t, 4H, J = 7.0 Hz), 2.74 (t, 4H, J = 7.0 Hz), 1.22 (t, 6H, J = 7.0 
Hz); 13C NMR (125 MHz, CD3OD) δ 183.8, 172.1, 161.2, 153.5, 152.8, 146.8, 139.9, 
134.3, 131.5, 127.6, 125.8, 125.5, 110.8, 106.9, 104.3, 97.1, 95.0, 60.8, 32.2, 29.6, 13.3. 
MS (ESI) m/z  (M)+ 478.33. IR (neat) 3427, 2944, 1736 cm–1. 
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O
N
O
N O
CO2Et
CO2t-Bu
EtO2C
12a  
Compound 12 (0.42 g, 0.9 mmol) and Cs2CO3 (1.43 g, 4.4 mmol) was dissolved in 
CH3CN (5 mL). Tertiary butyl bromoacetate (0.86 g, 4.4 mmol) was added after 5 min. 
and the reaction mixture heated to 60 oC for 6 h. The solvent was evaporated under 
reduced pressure and the residue purified by flash chromatography eluting with 1/1  
EtOAc/hexanes to afford 12a as a red solid (360 mg, 69 %). Rf = 0.6 (1/1 
EtOAc/hexanes). 1H NMR (500 MHz, CDCl3) δ 8.12 (d, 1H, J = 9.3 Hz), 7.94 (s, 1H), 
1H NMR (acetone-d6) 
13C NMR (CD3OD) 
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7.53 (d, 1H, J = 9.3 Hz), 7.17 (dd, 1H, J = 8.7, 4.2 Hz), 6.60 (dd, 1H, J = 8.7, 4.2 Hz), 
6.43 (s, 1H), 6.22 (s, 1H), 4.86 (s, 2H), 4.11 (q, 4H, J = 4.8 Hz), 3.72 (br, 4H), 2.64 (br, 
4H), 1.41 (s, 9H), 1.18 (t, 6H, J = 4.8 Hz); 13C NMR (125 MHz, CDCl3) δ 183.0, 172.1, 
168.9, 161.3, 152. 2, 150.0, 146.8, 141.9, 133.8, 131.4, 128.8, 127.0, 125.7, 118.9, 
110.3, 107.1, 106.4, 97.9, 83.3, 66.2, 61.4, 47.3, 33.1, 28.2, 14.3. MS (ESI) m/z (M)+ 
592.21. IR (neat) 3423, 2941, 1747 cm–1. 
 
 
 
 
13C NMR (CDCl3) 
1H NMR (CDCl3) 
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O
N
O
N O
CO2Et
CO2H
EtO2C
13  
A solution of 12a (100 mg, 0.17 mmol) in trifluoroacetic acid (3 mL) and 
dichloromethane (3 mL) was stirred for 4 h. The excess trifluoroacetic acid was 
neutralized by adding sodium hydroxide solution (2 mL, 2 M). The solvent was 
evaporated and residue purified by flash chromatography eluting with 20 % 
MeOH/EtOAc to afford 13 as a purple solid (60 mg, 66 %). Rf = 0.6 (EtOAc). 1H NMR 
(500 MHz, DMSO-d6) δ 8.03 (d, 1H, J = 10.0 Hz), 7.88 (s, 1H), 7.61 (d, 1H, J = 10.0 
Hz), 7.27 (dd, 1H, J = 10.0, 5.0 Hz), 6.82 (dd, 1H, J = 10.0, 5.0 Hz), 6.73 (s, 1H), 6.19 
(s, 1H), 4.88 (s, 2H), 4.08 (q, 4H, J = 5.0 Hz), 3.73 (t, 4H, J = 5.0 Hz), 2.63 (t, 4H, J = 
5.0 Hz), 1.19 (t, 6H, J = 5.0 Hz); 13C NMR (125 MHz, DMSO-d6) δ 182.2, 172.3, 170.6, 
161.3, 152.4, 151.3, 146.9, 140.1, 134.1, 131.7, 128.1, 126.0, 124.9, 118.7, 111.1, 107.3, 
105.1, 97.8, 65.6, 60.9, 47.1, 32.4, 14.9. MS (ESI) m/z (M+H)+ 537.18. IR (neat) 3389, 
2954, 1721 cm–1. 
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N
H
OH
15  
 
A solution of 3-aminophenol 14 (4.0 g, 37.0 mmol) and K2CO3 (5.0 g, 37.0 mmol) in 
DMF (20 mL) was stirred at 25 ºC for 15 min.  Iodoethane (5.6 g, 37.0 mmol) was then 
added and heated at 100 ºC for 2 h.  The reaction mixture was cooled to 25 ºC and 
filtered to remove solid impurities.  Water (20 mL) was added to the filtrate and 
extracted with EtOAc (20 mL × 2), then the combined organic layer was concentrated 
under reduced pressure and the residue was purified by flash chromatography eluting 
with 20–50 % EtOAc/hexanes to afford 15 as a brown oil (3.5 g, 70 %).  Rf 0.5 (50 % 
EtOAc/hexanes).  1H NMR (300 MHz, CDCl3) d 7.07 (t, 1H, J = 8.0 Hz), 6.32–6.28 (m, 
2H), 6.16 (s, 1H), 3.09–3.05 (m, 2H), 1.21 (t, 3H, J = 7.5 Hz); 13C NMR (125 MHz, 
CDCl3) d 157.2, 149.9, 130.6, 106.9, 106.0, 101.5, 39.3, 14.8; MS (ESI) m/z 137.08 
(M+H)+. 
 
 
 
 
 
 
 
 
1H NMR (CDCl3) 
13C NMR (CDCl3) 
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N OH
HO3S
16
 
 
Compound 15 (3.5 g, 25.5 mmol) and 1,3-propanesultone (3.36 g, 27.5 mmol) were 
dissolved in iPrOH (20 mL) and refluxed for 3 h.  The reaction mixture was cooled to 
room temperature and the precipitate was filtered and washed with cold distilled water to 
remove any unreacted propanesultone to afford product 1666 as a colorless powder (2.6 
g, 60 %).  Rf 0.3 (10 % MeOH/EtOAc).  1H NMR (300 MHz, DMSO-d6) δ 11.22 (br, 
1H), 10.21 (br, 1H), 7.36 (t, 1H, J = 4.8 Hz), 7.04 (m, 2H), 6.91 (s, 1H), 3.63–3.53 (br, 
4H), 2.60–2.58 (m, 2H), 1.81–1.74 (br, 2H), 1.00–0.95 (m, 3H); 13C NMR (75 MHz, 
DMSO-d6) δ 159.7, 140.1, 131.8, 117.3, 113.9, 110.4, 57.9, 53.4, 49.4, 22.1, 11.2; MS 
(ESI) m/z 258.02 (M–H)–. 
 
 
1H NMR (DMSO-d6) 
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N OH
HO3S
NO
•HCl
17
 
 
Compound 16 (1.0 g, 3.9 mmol) in HCl (10 mL, 10 M) and distilled water (5 mL) was 
cooled to 0 ºC.  Sodium nitrite (0.13 g, 1.8 mmol) in distilled water (2 mL) was added 
over a period of 10 min using a syringe pump at the rate of 0.2 mL/min.  The mixture 
was stirred at 0 ºC for 3 h and filtered to remove residual impurities.  The filtrate was 
evaporated under reduced pressure to yield product 17 (1.05 g, 80 %) as a yellow solid.66 
The crude product was very moisture sensitive and therefore directly used without 
further purification for the next step. 
13C NMR 
(DMSO-d6) 
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O
N
N O
OH
HO3S 20  
The nitroso compound 17 (1.0g, 3.1 mmol) and 1,7-dihydroxynaphthol 19 (0.5 g, 3.1 
mmol) was dissolved in dry DMF (20 mL) and heated to 140 oC for 4 h. The reaction 
mixture was cooled to 25 oC and DMF removed under reduced pressure. The residual 
material was purified by column chromatography eluting with 1/1 MeOH/EtOAc to 
afford 20 as a blue solid (0.94 g, 71 %). Rf = 0.3 (10 % MeOH/EtOAc). 1H NMR (500 
MHz, CD3OD) δ 8.55 (d, 1H, J = 8.8 Hz), 7.65 (d, 1H, J = 8.7 Hz), 7.56 (s, 1H), 7.23 
(dd, 1H, J = 8.7, 2.7 Hz), 6.95 (dd, 1H, J = 8.7, 2.7 Hz), 6.74 (s, 1H), 6.35 (s, 1H), 3.66 
(t, 2H, J = 8.3 Hz), 3.59 (q, 2H, J = 6.8 Hz), 2.92 (t, 2H, J = 8.3 Hz), 2.15 (br, 2H), 1.26 
(t, 3H, 6.8 Hz); 13C NMR (125 MHz, CD3OD) δ 184.3, 172.0, 159.9, 152.7, 151.3, 
146.6, 138.9, 133.2, 130.7, 126.0, 125.9, 120.1, 110.9, 109.9, 104.3, 96.5, 49.4, 48.3, 
45.2, 23.0, 11.5. MS (ESI) m/z (M-H)- 427.02. IR (neat) 3397, 2931, 1689 cm–1. 
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2-Hydroxy Diethyl Nile Red 24 (50.0 mg, 0.15 mmol) and K2CO3 (103.0 mg, 0.75 
mmol) were dissolved in CH3CN (5 mL). 23 (162.0 mg, 0.18 mmol) in CH3CN (2 mL) 
was added drop wise in 5 min. to above solution at 25 oC. The reaction mixture was 
heated to 50 oC for 4 h. After completion of reaction the solvent was evaporated and 
residue was subjected to flash chromatography eluting with 30-40 % acetone/EtOAc and 
then with 10 % MeOH/CH2Cl2 to afford 150.0 mg of red colored material. Flash 
chromatography was performed to remove excess 23. 
Above red material (60.0 mg, 0.06 mmol) was dissolved in TFA/CH2Cl2 (1/1, 3 mL) and 
stirred at 25 oC for 1 h. Solvent was removed under reduced pressure and the residual 
material was dissolved in 5 mL of water.  This solution was filtered to remove solid 
impurities and the filtrate was purified by reverse phase medium pressure liquid 
chromatography (MPLC) eluting with 30 % CH3CN/H2O to afford 25 as a dark red solid 
(35.0 mg, 58%). 1H NMR (500 MHz, CD3OD) δ 8.06 (d, 1H, J = 8.9 Hz), 8.01 (s, 1H), 
7.97 (d, 1H, J = 3.0 Hz), 7.54 (d, 1H, J = 8.9 Hz), 7.17 (dd, 1H, J = 9.2, 3.0 Hz), 6.79 
(dd, 1H, J = 9.2, 3.0 Hz), 6.54 (d, 1H, J = 3.0 Hz), 6.17 (s, 1H), 4.61 (s, 2H), 4.55 (t, 2H, 
J = 5.0 Hz), 4.32-4.29 (br, 2H), 3.93 (br, 2H), 3.89 (t, 2H, J = 5.0 Hz), 3.77-3.74 (br, 
2H), 3.70-3.68 (br, 2H), 3.66-3.52 (m, 40H), 1.27 (t, 6H, J = 7.0 Hz); 13C NMR (75 
 
13C NMR (CD3OD) 
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MHz, CD3OD) δ 183.7, 161.9, 152.8, 151.8, 147.1, 144.6, 143.8, 138.1, 134.3, 131.3, 
127.3, 125.1, 124.7, 118.1, 110.7, 106.4, 103.7, 96.0, 72.5, 70.7, 70.5, 70.4, 70.3, 70.2, 
70.1, 69.6, 69.2, 67.9, 63.8, 61.0, 50.2, 44.9, 11.8; MS (ESI) 944.49 (M+H)+  966.45 
(M+Na)+ ; IR (neat) 3435, 2925, 1641 cm–1.  
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Compound 26 (25 mg, 0.06 mmol) and activating agent EDCI (28 mg, 0.24 mmol) was 
dissolved in pyridine (2 mL). Tris(hydroxymethyl)aminomethane 21  (43 mg, 0.36 
mmol) was added and reaction continued at 25 oC for 24 h. The solvent was evaporated 
and residue purified by reverse phase medium pressure liquid chromatography (MPLC) 
eluting with 3/2 CH3CN/H2O to afford 27 as a dark red solid (22 mg, 59 %). 1H NMR 
(500 MHz, DMSO-d6) δ 7.96 (d, 1H, J = 10.0 Hz), 7.87 (s, 1H), 7.61 (d, 1H, J = 10.0 
Hz), 7.39 (s, 2H), 7.08 (dd, 1H, J = 10.0, 5.0 Hz), 6.84 (dd, 1H, J = 10.0, 5.0 Hz), 6.68 
(s, 1H), 6.19 (s, 1H), 4.73 (br, 6H), 3.65 (br, 4H), 3.53 (s, 12H), 2.51 (br, 4H); 13C NMR 
(125 MHz, DMSO-d6) δ 182.4, 172.1, 152.2, 152.2, 151.3, 146.9, 140.1, 134.4, 131.4, 
128.2, 124.8, 119.2, 110.8, 110.2, 109.2, 105.2, 97.4, 63.2, 61.2, 48.1, 34.6. MS (ESI) 
m/z (M+H)+ 629.23. IR (neat) 3412, 3316, 1693 cm–1. 
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Tris(hydroxymethyl)aminomethane 21 (2g, 16.5 mmol) was dissolved in THF (10 mL) 
and aqueous 40 % KOH (1mL). Acrylonitrile (5.4 mL, 82.5 mmol) was added to the 
above solution and stirred at 25 oC for 24 h. The solvent was evaporated and water (10 
mL) added. The aqueous layer was extracted with dichloromethane (5 x 5 mL) and dried 
over Na2SO4. The residue obtained was purified by flash chromatography eluting with 
10% MeOH/EtOAc to obtain cyano derivative as a yellow oil (2.8 g, 61%).  
1H NMR (500 MHz, CD3OD) δ 3.70 (t, 6H, J = 8.8 Hz), 3.48 (s, 6H), 2.74 (t, 6H, 8.8 
Hz); 13C NMR (125 MHz, CD3OD) δ 118.8, 71.8, 66.1, 56.1, 18.1. IR (neat) 3378, 
2290, 1732, 1616 cm -1. Above cyano derivative  (1 g, 3.6 mmol) was dissolved in 
concentrated HCl (3 mL) and refluxed at 100 oC for 4 h. The reaction mixture was 
cooled to 25 oC and diluted with water (20 mL). The solvent was evaporated and residue 
purified by reverse phase medium pressure liquid chromatography (MPLC) eluting with 
1/4 CH3CN/H2O to afford 22 as a colorless viscous solid (0.91 g, 75 %). 1H NMR (500 
MHz, D2O) δ 3.56 (t, 6H, J = 6.1 Hz), 3.43 (s, 6H), 2.41 (t, 6H, J = 6.1 Hz); 13C NMR 
(125 MHz, D2O) δ 177.6, 68.1, 67.4, 59.7, 35.3. MS (ESI) m/z (M)+ 337.18. IR (neat) 
2927, 1732, 1615 cm–1. 
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Compound 26 (60 mg, 0.14 mmol), N-hydroxysuccinimide (81 mg, 0.7 mmol) and N,N’-
diisopropylcarbodiimide (88 mg, 0.7 mmol) were dissolved in dry DMF (2 mL) and 
stirred at 25 oC for 24 h. Solvent was evaporated under reduced pressure and residue 
dissolved in EtOAc (5 mL) and washed with water (5 mL x3). The organic layer was 
dried over MgSO4 and solvent evaporated to obtain a red colored material.  
The above red colored material was dissolved in DMF (2 mL) along with tricarboxylic 
acid 22 (479 mg, 1.4 mmol), DMAP (1 mg, 0.01 mmol) and triethylamine (0.2 mL, 1.4 
mmol). The reaction mixture was stirred at 25 oC for 48 h. After removal of DMF under 
reduced pressure the residue was dissolved in water (2 mL) and washed with EtOAc (2 
mL x 3). The aqueous layer containing crude product was loaded on to a reverse phase 
MPLC column and purified using 3/2 CH3CN/H2O solvent mixture. The solvent was 
evaporated to afford 28 as a dark purple solid (43 mg, 28 %). 1H NMR (500 MHz, 
CD3OD) δ 8.04 (br, 1H), 7.94 (br, 1H), 7.56 (br, 1H), 7.08 (br, 1H), 6.91 (s, 1H), 6.74 (s, 
1H), 6.20 (s, 1H), 3.76 (br, 4H), 3.67 (br, 24H), 2.75 (br, 4H), 2.47 (s, 12H); 13C NMR 
(125 MHz, CD3OD) δ 183.9, 175.6, 172.4, 161.0, 152.5, 151.3, 146.5, 139.1, 134.3, 
130.8, 127.3, 125.1, 123.9, 118.0, 110.8, 108.4, 103.6, 96.9, 68.5 (2C), 67.2, 60.9, 35.4, 
34.2; MS (MALDI) m/z 1063.35 (M+3H)+. IR (neat) 2942, 1722, 1621 cm–1. 
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Compound 986 (2.0 g, 7.9 mmol) in HCl (20 mL, 10 M) and distilled water (10 mL), 
was cooled to 0 ºC.  Sodium nitrite (0.59 g, 8.5 mmol) dissolved in distilled water (5 
mL) was added over a period of 50 min using a syringe pump at the rate of 0.2 mL/min.  
The mixture was stirred at 0 ºC for 3 h and filtered to remove residual impurities.  The 
filtrate was evaporated under reduced pressure to yield product 34 (1.93 g, 77 %).  The 
crude product was very moisture sensitive and therefore directly used without further 
purification for the next step. 
General Procedure for The Synthesis of Nile Blue Derivatives (32a-b and 33a-b) 
Nitroso compound 17 or 34 (0.3 mmol) was dissolved in 5 mL of dry distilled DMF and 
5-amino-2-naphthol 36a or 36b (0.3 mmol) was added while stirring.  The reaction 
mixture was heated to 90 oC for 5 h and cooled to room temperature.  DMF was removed 
under reduced pressure and the residual material was dissolved in 10 mL of water.  This 
solution was filtered to remove solid impurities and the filtrate was purified by reverse 
phase medium pressure liquid chromatography (MPLC) eluting with 1/1 CH3CN/H2O to 
afford the corresponding Nile Blue derivatives as a dark blue solid. 
Nile Blue Derivative 32a 
 
N O
N
N
H
OH
HO3S
SO3H
Cl–
32a
 
Dark blue solid (120 mg, 68 %).  1H NMR (500 MHz, CD3OD) δ 7.87 (d, 1H, J = 9.0 
Hz), 7.83 (m, 1H), 7.53 (d, 1H, J = 9.0 Hz), 7.15 (d, 1H, J = 9.0 Hz), 7.00 (dd, 1H, J = 
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9.0, 2.0 Hz), 6.71 (s, 1H), 6.69 (s, 1H), 3.81 (t, 2H, J = 7.0 Hz), 3.77 (t, 2H, J = 6.5 Hz), 
3.68-3.65 (m, 2H), 3.07 (t, 2H, J = 6.5 Hz), 2.98 (t, 2H, J = 7.5 Hz), 2.34-2.31 (m, 2H), 
2.21-2.19 (m, 2H), 1.33 (t, 3H, J = 7.0 Hz); 13C NMR (75 MHz, CD3OD) δ 161.2, 158.4, 
154.8, 152.0, 148.1, 134.0, 133.8, 132.9, 129.1, 125.3, 118.9, 115.8, 114.9, 108.7, 96.4, 
92.3, 49.8, 45.9 (2C), 43.5, 43.4, 24.1, 23.6, 11.9; MS (ESI) m/z 548.03 (M–2H)– ; HR-
MS (ESI) m/z calculated for (M–2H)–  548.1167 found 548.1170; IR (neat) 3361, 3059, 
1627 cm–1. 
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Dark blue solid (82 mg, 46 %).  1H NMR (500 MHz, CD3OD) δ 8.08-8.01 (m, 1H), 7.96 
(d, 1H, J = 3.0 Hz), 7.61-7.57 (m, 1H), 7.24-7.21 (m, 1H), 7.17 (dd, 1H, J = 2.5, 10.0 
Hz), 6.83 (s, 1H), 6.51 (d, 1H, J = 10.0 Hz), 4.32 (t, 2H, J = 4.0 Hz), 3.98-3.96 (m, 2H), 
3.83-3.67 (m, 10H), 3.61-3.60 (m, 2H), 2.96 (t, 2H, J = 7.0 Hz), 2.21-2.19 (m, 2H), 1.33 
(t, 3H, J = 7.0 Hz); 13C NMR (75 MHz, CD3OD) δ 169.2, 163.6, 161.9, 160.6, 154.2, 
150.8, 147.4, 133.7, 132.4, 128.7, 125.7, 118.6, 115.9, 114.7, 105.8, 96.0, 72.5, 70.6, 
70.3, 69.4, 68.0, 61.0, 49.9, 46.4, 35.8, 23.7, 11.0; MS (ESI) m/z 558.12 (M–2H)–;  
HR-MS (ESI) m/z calculated for (M–2H)–  558.1916 found 558.1915; IR (neat) 3348, 
3049, 2938, 1587 cm–1. 
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Dark blue solid (115 mg, 66 %).  1H NMR (500 MHz, CD3OD) δ 7.99 (d, 1H, J = 8.5 
Hz), 7.94 (m, 1H), 7.62 (d, 1H, J = 9.0 Hz), 7.22 (m, 1H), 7.10 (m, 1H), 6.77 (s, 2H), 
3.94 (t, 2H, J = 8.0 Hz), 3.85 (t, 2H, J = 7.0 Hz), 3.07 (t, 2H, J = 7.0 Hz), 2.63 (t, 2H, J = 
8.0 Hz), 2.34 (m, 2H); 13C NMR (125 MHz, CD3OD) δ 177.08, 161.7, 158.5, 154.2, 
152.2, 147.8, 134.4, 133.5, 132.3, 129.3, 125.1, 118.9, 115.8, 114.9, 108.7, 96.4, 92.4, 
48.6, 44.7, 43.5, 34.8, 24.4; MS (ESI) m/z 542.05 (M–2H)– ; HR-MS (ESI) m/z 
calculated for (M–2H)–  542.1239 found 542.1237; IR (neat) 3358, 3187, 2924, 
1584 cm–1. 
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Nile Blue Derivative 33b 
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Dark blue solid (78 mg, 44 %).  1H NMR (500 MHz, CD3OD) δ 8.24-8.21 (m, 1H), 8.19 
(d, 1H, J = 9.0 Hz), 7.83-7.80 (m, 1H), 7.38 (dd, 1H, J = 2.5, 9.0 Hz), 7.2 (dd, 1H, J = 
2.5, 10.0 Hz), 6.92 (s, 1H), 6.71 (s, 1H), 4.4 (t, 2H, J = 4.5 Hz), 3.97 (t, 4H, J = 6.5 Hz), 
3.82-3.78 (m, 4H), 3.72 (t, 2H, J = 2.5 Hz), 3.67 (t, 2H, J = 5.0 Hz), 3.59 (t, 2H, J = 5.0 
Hz), 2.76 (t, 4 H, J = 7.5 Hz); 13C NMR (75 MHz, CD3OD) δ 172.0, 161.4, 160.7, 152.3, 
150.7, 146.3, 134.1, 133.0, 131.0, 127.3, 124.5, 117.6, 115.1, 112.8, 105.5, 95.2, 94.7, 
71.0, 69.1, 68.7, 67.8, 66.7, 59.4, 45.8, 30.2; MS (ESI) m/z 554.20 (M)+; HR-MS (ESI) 
m/z calculated for (M)+  554.2133 found 554.2136; IR (neat) 3227, 2984, 1604 cm–1. 
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EXPERIMENTAL DATA FOR CHAPTER III 
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Phenyl triflamide (0.21 g, 0.60 mmol) was added gradually over a period of 10 minutes 
to a solution of 55 (0.10 g, 0.24 mmol) and triethylamine (0.13 mL, 0.96 mmol) in 5 mL 
dry distilled THF.  The mixture was stirred at 25 oC for 24 h. Reaction mixture was 
diluted with EtOAc and was washed with 0.1 M HCl (2 x 10 mL). Organic layer was 
evaporated under reduced pressure and purified by flash chromatography eluting with 
1/1 EtOAc /hexanes to afford 50 as a red solid (0.07 g, 55 %). Rf = 0.2 (1/1 
EtOAc/hexanes). 1H NMR (300 MHz, CD3OD) δ 8.49 (s, 1H), 8.24 (d, 1H, J = 6.3 Hz), 
7.69-7.61 (br, 2H), 6.94 (dd, 1H, J = 6.3 Hz, J = 3.2 Hz), 6.70 (s, 1H), 6.23 (s, 1H), 3.71-
3.54 (m, 4H), 3.21(br, 6H), 2.96 (t, 2H, J = 7.2 Hz), 2.19-2.10 (br, 2H), 1.32-1.29 (br, 
12H); 13C NMR (75 MHz, CD3OD) δ 182.0, 153.6, 152.2, 151.9, 146.7, 136.3, 134.1, 
132.0, 131.2, 128.9, 125.7, 122.5, 118.2, 115.3, 111.6, 103.9, 96.8, 49.3, 49.1, 45.3(2C), 
22.3, 10.9, 10.1. 19F NMR (282 MHz, CD3OD) δ  104.1. IR (neat, cm-1) 3402, 2917, 
1644; MS (ESI) m/z 558.95 (M)- 
19F NMR (CD3OD) 
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Phenyl triflamide (1.9 g, 5.5 mmol) was added gradually over a period of 10 minutes to a 
solution of 56 (1.0g, 2.2 mmol) and triethylamine (1.2 mL, 8.8 mmol) in 20 mL dry 
distilled THF.  The mixture was stirred at 25 oC for 24 h. Reaction mixture was diluted 
with EtOAc and washed with 0.1 M HCl (2 x 10 mL). Organic layer was evaporated 
under reduced pressure and purified by flash chromatography eluting with 1/1 
EtOAc/hexanes to afford 51 as a red solid (0.67g, 52 %). Rf = 0.4 (1/1 EtOAc/hexanes) 
1H NMR (300 MHz, acetone-d6) δ 8.57 (s, 1H), 8.38 (d, 1H, J = 8.4 Hz), 7.79 (d, 1H, J 
= 8.4 Hz), 7.70 (d, 1H, J = 9.3 Hz), 6.98 (d, 1H, J = 9.3 Hz), 6.79 (s, 1H), 6.30 (s, 1H), 
3.93 (t, 4H, 7.2 Hz), 3.67 (s, 6H), 2.78 (t, 4H, J = 7.5 Hz) 13C NMR (75 MHz, acetone-
d6) δ 181.9, 173.1, 153.3, 152.0, 151.8, 146.3, 139.8, 135.7(2C), 133.7, 129.1, 124.3, 
123.4, 118.1(2C), 111.1, 106.8, 98.2, 60.36, 49.3, 33.4. 19F NMR (282 MHz, acetone-d6) 
δ 104.4. IR (neat, cm-1) 3421, 2938, 1638; MS (ESI) m/z 582.09 (M+). 
19F NMR (acetone-d6) 
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Pd(PPh3)4 ( 50.0 mg, 0.04mmol), CuI (8.2 mg, 0.04 mmol) was added to a solution of  
51 (200mg, 0.4 mmol) in 5 mL of dry DMF.  To the above mixture was added an excess 
of TMS alkyne (0.6 mL, 4.30 mmol) and triethyl amine (0.6 mL, 4.3 mmol). Reaction 
mixture was freeze-pump-thawed three times with nitrogen after cooling to -78 oC in an 
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acetone/dry ice bath. The acetone/dry ice bath was removed and the temperature was 
allowed to rise to 25 oC and then heated to 80 oC for 24 h.  Filtered through a sintered 
glass funnel and organic layer evaporated under reduced pressure.  Purified by flash 
chromatography using 30% EtOAc/hexanes to obtain 57 (125 mg, 73%) as a red solid.  
Rf = 0.6 (30 % EtOAc/hexanes) 1H NMR (300 MHz, acetone-d6) δ 8.62 (s, 1H), 8.14 (d, 
1H, J = 8.1 Hz), 7.72 (d, 1H, 6.3 Hz), 7.66 (d, 1H, J = 8.1 Hz), 6.90 (d, 1H, J = 6.3 Hz), 
6.70 (s, 1H), 6.22 (s, 1H), 3.89 (t, 4 H, J = 7.5 Hz), 3.62 (s, 6H), 2.77 (t, 4H, J = 6.9 Hz), 
0.31 (s, 9H).  13C NMR (75 MHz, acetone –d6) δ 181.7, 171.9, 152.4, 151.2, 146.9, 
139.7, 132.9, 131.4, 127.1, 126.2, 125.9, 125.3, 110.7, 105.6, 104.3, 100.1, 97.39, 51.3, 
47.0, 31.8, 0.7. (2C missing). MS (ESI) m/z 530.14 (M+). 
1H NMR (acetone-d6) 
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TBAF (1.0 M solution in THF, 0.6 mL, 0.6 mmol) was added to a solution of 57 (100 
mg, 0.17 mmol) in 10 mL of dry distilled THF at -78 oC. The reaction mixture was 
allowed to warm to 25 oC for 30 min. The reaction mixture was diluted with EtOAc and 
excess TBAF was removed by washing with water (2 x 10.0 mL) and organic layer 
evaporated under reduced pressure. The residue was purified by flash chromatography 
using 1/1 EtOAc/hexanes to yield 52 (63 mg, 80%) as a red solid.  Rf = 0.4 (1/1 
EtOAc/hexanes) 1H NMR (300 MHz, CD3OD/CDCl3) δ 8.80 (s, 1H), 8.22 (d, 1H, 8.0 
Hz), 7.72 (d, 1H, J = 8.0 Hz), 7.68 (br, 1H), 6.83 (d, 1H, J = 6.5 Hz), 6.60 (s, 1H), 6.49 
(s, 1H), 3.71 (s, 6H), 3.60 (t, 4H, J = 6.5 Hz), 3.53 (s, 1H), 2.72 (t, 4H, J = 6.5 Hz). 13C 
NMR (75 MHz, DMSO–d6) δ 181.8, 172.4, 153.8, 152.8, 147.5, 137.85, 133.2, 132.4, 
131.8, 131.4, 127.2, 126.3(2C), 125.6, 125.4(2C), 105.4, 84.2, 83.4, 52.2, 39.1, 34.8; MS 
(ESI) m/z 459.15 (M+H)+. 
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Nitro BODIPY 54 (provided by Mrs. Lingling Li,100.0 mg, 0.27 mmol) and hydrazine 
(0.2 mL) along with 10 % Pd/C (38.0 mg, 0.36 mmol) were dissolved in EtOH (4 mL) 
and refluxed for 30 min. The reaction mixture was cooled to 25 oC and filtered through 
celite to remove Pd/C and any solid impuritues.  The filtrate obtained was then 
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evaporated under reduced pressure and purified by flash column chromatography using 
1/1 EtOAc/hexanes as eluent. The yellowish orange solid (54.0 mg) obtained was 
dissolved in 1/1 HCl (1.0 M)/MeOH (3 mL) and cooled to 0 oC for 10 min. Sodium 
nitrite (31.0 mg, 0.44 mmol) in H2O (0.5 mL) was added drop wise in 5 min and stirred 
at 0 oC for 1 h. Sodium azide (57.0 mg, 0.88 mmol) in water (1 mL) was added and the 
reaction mixture stirred for further 1 h at 25 oC. The solvent was evaporated and crude 
product purified using flash chromatography eluting with 30 % EtOAc/hexanes to yield 
48 as an yellowish orange solid (47.0 mg, 38 %) Rf = 0.6 (30 % EtOAc/hexanes). 1H 
NMR (500 MHz, CDCl3) δ 7.25 (br, 2H), 7.15 (br, 2H), 5.98 (s, 2H), 2.56 (s, 6H), 1.41 
(s, 6H); 13C NMR (125 MHz, CDCl3) δ 155.7, 142.9, 141.0, 140.6, 131.5, 129.6, 121.4, 
119.7, 119.6, 14.6; MS (ESI) m/z 372.18 (M+ Li)+. 
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Compound 50 (40.0 mg, 0.08 mmol), 45 (38.0 mg, 0.12 mmol), Pd(PPh3)4 (8.0 mg, 
0.008 mmol), copper(I)iodide (1.4 mg, 0.08 mmol) and triethylamine (0.10 mL, 0.8 
mmol) were dissolved in 4 mL dry distilled DMF. The solution was freeze-pump-thawed 
three times with nitrogen after cooling to -78 oC in an acetone/dry ice bath. The 
acetone/dry ice bath was removed and the temperature was allowed to rise to 25 oC and 
then heated to 130 oC for 12 h. The solution was concentrated in vacuo and purified by 
flash chromatography eluting with 30% MeOH/EtOAc to afford 39 (27.0 mg, 49%) as a 
red solid. Rf = 0.2 (1/1 EtOAc/hexanes). 1H NMR (500 MHz, CD3OD) δ 8.91 (s, 1H), 
8.53 (d, 1H, J = 3.1 Hz), 8.22 (br, 2H), 7.89(s, 1H), 7.79-7.71 (br, 2H), 7.32 (t, 3H, J = 
6.1 Hz), 7.09-7.01 (br, 2H), 6.71 (s, 1H), 6.63 (br, 3H, 6.4), 3.77-3.63 (br, 4H), 2.92 (q, 
2H, J = 6.7 Hz), 2.19-2.096 (br, 2H), 1.32-1.29 (br, 3H); 13C NMR (125 MHz, CD3OD) 
δ 179.8, 168.3, 161.7, 153.5, 153.3, 152.4, 152.2, 147.1, 137.8, 134.2, 133.9, 131.8, 
131.7, 128.9, 128.1, 125.6, 125.5, 123.7, 122.6, 118.6, 118.4, 113.1, 111.8, 109.6, 108.4, 
102.9, 98.7, 96.5, 96.4, 82.1, 80.2, 75.3, 49.4, 49.3, 45.4, 23.7, 10.8. IR (neat, cm-
1) 3451, 2887, 2911, 1657; MS (ESI) m/z 764.99 (M-H)- 
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Compound 50 (110.0 mg, 0.2 mmol), 45 (101.0 mg, 0.3 mmol), Pd(PPh3)4 (22.0 mg, 
0.02 mmol), copper(I)iodide (3.6 mg, 0.02 mmol) and triethylamine (265.0 mg, 1.9 
mmol) were dissolved in 10 mL dry distilled DMF. The solution was freeze-pump-
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thawed three times with nitrogen after cooling to -78 oC in an acetone/dry ice bath. The 
acetone/dry ice bath was removed and the temperature was allowed to rise to 25 oC and 
then heated to 130 oC for 12 h. The solution was concentrated in vacuo and purified by 
flash chromatography eluting with 30% MeOH/EtOAc to afford 111.0 mg of red solid. 
Rf = 0.3 (1/1 EtOAc/hexanes). 
Above Red solid (30 mg, 0.04 mmol) and potassium carbonate (66.7 mg, 0.48 mmol) 
was dissolved in MeOH/water (5 mL, 1/1) and heated to 40 oC for 12 h. The solution 
was filtered to remove solid impurities and concentrated in vacuo. The crude residue was 
dissolved in 5 mL water and washed with ethyl acetate (5 mL x 3) to remove any organic 
impurities. The pH of the aqueous layer was adjusted to 6 by careful drop wise addition 
of HCl (5 to 6 drops, 1.0 M). The aqueous layer was then extracted with 2/1 CHCl3/iso-
propanol (5 mL x 3).  The organic extract was dried with magnesium sulfate and solvent 
evaporated. The residue obtained was further purified by reverse phase preparative 
HPLC (20-95 % CH3CN/1 % TFA in H2O) to afford the desired product 40 as dark blue 
solid (22.0 mg, 59 %). 1H NMR (500 MHz, DMSO-d6) δ 8.72(s, 1H), 8.24(s, 1H), 
8.17(d, IH, J = 7.8 Hz), 8.01(d, 1H, J = 7.8 Hz), 7.90 (d, 1H, J = 8.9 Hz), 7.68(d, 1H, J = 
8.9 Hz), 7.35 (d, 1H, J = 8.7 Hz), 6.88 (d, 1H, J = 8.8 Hz), 6.75 (s, 1H), 6.68 (m, 2H), 
6.63 (m, 2H), 6.56 (m, 2H), 6.33 (s, 1H), 3.73 (m, 4H), 2.65 (t, 4H, J = 7.3 Hz). 13C 
NMR (125 MHz, DMSO-d6) δ 182.0, 172.4, 168.6, 160.3, 153.3, 152.8, 152.5, 151.4, 
147.0,139.1, 133.3, 132.8, 132.4, 132.1, 131.7, 131.4, 129.9,129.4, 128.4, 127.6, 127.3, 
126.5, 125.6, 125.4, 124.9, 124.4, 113.6, 111.5, 109.9, 105.7, 103.0, 97.9, 90.7, 47.0, 
32.1. IR (neat, cm-1) 3424, 3061, 2931, 1641, 2887; MS (ESI) m/z 379.02 (M-2H)2- MS 
(MALDI) m/z 763.21 (M+3H)+ 
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13C NMR (DMSO-d6) 
 
O
N
ON
CO2H
O OHO
CO2H
ClCl
HO2C
41  
Compound 51 (50.0 mg, 0.09 mmol), 46 (50.0mg, 0.11 mmol), Pd(PPh3)4 (10.0 mg, 
0.009 mmol), copper(I)iodide (2.0 mg, 0.009mmol) and triethylamine (0.12 mL, 1.9 
mmol) were dissolved in 5 mL dry distilled DMF. The solution was freeze-pump-thawed 
three times with nitrogen after cooling to -78 oC in an acetone/dry ice bath. The 
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acetone/dry ice bath was removed and the temperature was allowed to rise to 25 oC and 
then heated to 130 oC for 12 h.  The solution was concentrated in vacuo and purified by 
flash chromatography eluting with 30% MeOH/EtOAc to afford 21.0 mg of red solid. Rf 
= 0.3 (1/1 EtOAc/hexanes). 
Above red solid (20.0 mg, 0.02 mmol) and potassium carbonate (19.0 mg, 0.14 mmol) 
was dissolved in MeOH/water (5 mL, 1/1) and heated to 40 oC for 12 h. The solution 
was filtered to remove solid impurities and concentrated in vacuo. The crude residue was 
dissolved in 5 mL water and washed with EtOAc (5 mL x 3) to remove any organic 
impurities. The pH of the aqueous layer was adjusted to 6 by careful drop wise addition 
of HCl (5 to 6 drops, 1.0 M). The aqueous layer was then extracted with 2/1 CHCl3/iso-
propanol (5 mL x 3).  The organic extract was dried with magnesium sulfate and solvent 
evaporated. The residue obtained was further purified by reverse phase preparative 
HPLC (20-95% CH3CN/1 % TFA in H2O) to afford 41 (9.0 mg, 12 %) as a dark blue 
solid. 1H NMR (500 MHz, DMSO-d6) δ 11.17 (br, 2H), 8.74 (s, 1H), 8.24 (s, 1H), 8.18 
(d,1H, J = 8.6 Hz), 8.05 (d, 1H, J = 8.1 Hz), 7.91 (d,1H, J = 8.1 Hz), 7.70 (br, 1H), 7.43 
(br, 2H), 6.91 (br, 2H), 6.81 (br, 2H), 6.75 (s, 1H), 6.35 (s, 1H), 3.73 (br, 4H), 2.57 (t, 
4H, J = 7.1 Hz). 13C NMR (125 MHz, DMSO-d6) δ 181.7, 173.3, 167.9, 155.7, 152.6, 
152.0, 151.3, 150.5, 146.8, 139.1, 138.7, 132.9, 132.3, 132.1, 131.6, 131.5,  131.2, 
128.9, 127.3, 127.0, 126.2, 125.2, 125.1, 124.5, 116.8, 111.3, 110.4, 105.9, 104.1, 97.3, 
90.9, 90.8, 82.3, 47.1, 32.3; IR (neat, cm-1) 3416, 3023, 2897, 1703; MS (ESI) m/z 
415.06 (M+2H)2+ MS (MALDI) m/z 830.18 (M+2H)+ 
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  196 
N
O ON
CO2H
N
NN
NF2B
N
SO3
-Na+
+Na-O3S
HO2C
42  
 
Compound 47 (42.0 mg, 0.07 mmol) and alkyne 52 (68.0 mg, 0.14 mmol) along with 
copper metal (5.0 mg, 0.07 mmol), CuSO4 (0.1 mL, 0.1 M) and tris (1 - benzyl - 1H - 
1,2,3 - triazol - 4 - yl) methyl amine (TBTA) (1.0 mg, 0.02 mmol) were taken in 
THF/H2O mixture (5 mL, 4/1) and stirred at 25 oC for 24 h. The reaction mixture was 
filtered through celite to remove metallic copper. The filtrate obtained was evaporated 
under reduced pressure and columned on flash chromatography using CH2Cl2/MeOH as 
eluent. The red colored material obtained (60.0 mg) was dissolved in MeOH/H2O (4 mL, 
1/1) along with K2CO3 (33.0 mg, 0.24 mmol) and heated at 40 oC for 12 h. The solvent 
was evaporated and residue dissolved in water (2 mL) and washed with EtOAc (1 mL) 
three times to remove any organic impurities. The aqueous layer was purified on a 
reverse phase medium pressure liquid chromatography (MPLC) C-18 column using 
CH3CN/H2O (1/1) as eluent. The solvent was evaporated and dried under vacuum 
overnight to obtain product 42 as a dark purple colored material (27 mg, 39 %); 1H 
NMR (500 MHz, DMSO-d6) δ 9.83 (s, 1H), 9.18 (s, 1H), 8.26 (br, 4H), 7.75 (d, 1H, J = 
8.2 Hz), 7.68 (d, 2H, J = 9.7 Hz), 6.91 (d, 1H, J = 7.3 Hz), 6.78 (br, 1H), 6.34 (s, 1H), 
3.74 (br, 4H), 2.65 (s, 6H), 2.53 (br, 4H), 1.61 (s, 6H); 13C NMR (125 MHz, DMSO-d6) 
δ 182.8, 172.4, 166.9, 155.1, 152.5, 151.0, 147.1, 146.7, 142.6, 140.0, 138.3, 137.5, 
135.2, 133.6, 132.7, 131. 4, 131.1, 130.3, 130.0, 126.6, 125.2, 121.7, 121.2, 120.4, 
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111.1, 105.4, 97.4, 47.2, 31.9, 14.2, 13.2 (1 carbon missing); MS (ESI) m/z 475.24 (M-
2H)2-. 
1H NMR (DMSO-d6)   
 
 
 
 
 
13C NMR (DMSO-d6) 
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BODIPY azide 48 (35.0 mg, 0.1 mmol) and alkyne 52 (65.0 mg, 0.14 mmol) along with 
copper metal (6.0 mg, 0.1 mmol), CuSO4 (0.1 mL, 0.1 M) and tris (1 - benzyl - 1H - 
1,2,3 - triazol - 4 - yl) methyl amine (TBTA) (1.0 mg, 0.02 mmol) were taken in 
THF/H2O mixture (5 mL, 4/1) and stirred at 25 oC for 24 h. The reaction mixture was 
filtered through celite to remove metallic copper. The filtrate obtained was evaporated 
under reduced pressure and residue obtained dissolved in CH2Cl2 (5 mL) and washed 
with water (2 mL) three times and organic layer dried over sodium sulfate. The solvent 
was evaporated and flash chromatography performed on silica gel with EtOAc/hexanes 
(1/1) to obtain a red colored material after solvent evaporation under reduced pressure 
and drying. The red material (42.0 mg), and K2CO3 (28.0 mg, 0.2 mmol) were dissolved 
in MeOH/H2O (4 mL, 1/1) and heated at 40 oC for 12 h. The blue solution obtained was 
evaporated under reduced pressure and residue purified by flash chromatography eluting 
with EtOAc/hexanes (1/1) and then with EtOAc/MeOH (4/1) to obtain a dark purple 
colored material which was further purified on a reverse phase medium pressure liquid 
chromatography (MPLC) C-18 column using CH3CN/H2O (7/3) as eluant. The solvent 
was evaporated and dried under vacuum overnight to obtain product 43 as a dark purple 
colored material (23 mg, 30 %) 1H NMR (500 MHz, CDCl3) δ 9.15 (s, 1H), 8.59 (br, 
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1H), 8.38 (br, 1H), 8.25 (s, 1H), 8.08 (br, 2H), 7.69 (br, 1H), 7.56 (br, 2H), 6.72 (s, 1H), 
6.51 (d, 1H, J = 4.7 Hz), 6.42 (d, 1H, J  = 4.7 Hz), 6.02 (s, 2H), 3.81 (t, 4 H, J  = 8.8 
Hz), 2.71 (t, 4 H, J = 8.8 Hz), 2.58 (s, 6H), 1.48 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 
183.1, 171.8, 156.2, 152.0, 150.0, 147.9, 146.6, 142.8, 141.0, 139.5, 137.4, 135.8, 133.0, 
132.5, 131.5, 131.3, 131.2, 130.0, 127.5, 126.7, 125.6, 124.8, 121.6, 121.0, 118.7, 110.1, 
106.3, 97.3, 47.1, 32.1, 14.8;   MS (ESI) m/z (M-H)- 794.21.  
 
1H NMR (CDCl3) 
 
 
 
 
13C NMR (CDCl3) 
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This compound was synthesized following a previously published procedure.204  
para-iodo-phenylhydrazine (2.0 g, 8.46 mmol) and iso-propylmethyl ketone (0.92 mL, 
8.46 mmol) was dissolved in acetic acid (5 mL) and heated to 105 oC for 3 h. The 
reaction mixture was cooled to 25 oC and diluted with water (10 mL) and pH adjusted to 
7 by adding solid NaHCO3. The indole formed was then extracted with diethyl ether (10 
mL) three times and organic layer dried with sodium sulfate followed by solvent 
evaporation to obtain a brown oil (2.37 g, 8.30 mmol). This oil was dissolved in 
methanol (10 mL) along with iodomethane (1.12 mL, 17.95 mmol) and heated at 110 oC 
in a sealed tube for 6 h. The reaction mixture was cooled to 25 oC and filtered and 
washed with methanol and dried to obtain the product 59 as a brown colored solid (1.37 
g, 38 %).  
1H NMR (500 MHz, DMSO-d6) δ 8.27 (s, 1H), 7.98 (d, 1H, J = 5.0 Hz), 7.70 (d, 1H, J = 
5.0 Hz), 3.92 (s, 3H), 2.72 (s, 3H), 1.50 (s, 6H); 13CNMR (125MHz, DMSO-d6) δ 196.8, 
144.9, 142.6, 138.7, 132.9, 117.8, 96.8, 55.0, 35.5, 22.5, 15.3. 
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This compound was synthesized following a previously published procedure.205 A 
solution of indolinium bromide 58 (100 mg, 0.28 mmol) and N,N’-diphenylformamidine 
(88 mg, 0.34 mmol) in Ac2O (1 mL) was heated at 120 ºC for 30 min.  The reaction 
mixture was cooled to room temperature and a solution of indolinium iodide (119 mg, 
0.34 mmol) in pyridine (1.5 mL) was added.  The reaction mixture was stirred at 25 ºC 
for 30 min.  Ether (100 mL) was added and dark red oil was obtained after the remove of 
ether.  The residue was purified by flash chromatography eluting with 100 % EtOAc and 
10 % to 15 % MeOH/CH2Cl2 to afford product Cy5 as a dark purple solid (128 mg, 74 
%).  Rf 0.3 (10 % MeOH/CH2Cl2). 1H NMR (500 MHz, CDCl3) δ 8.05 (t, 2H, J = 10.0 
Hz) 7.39-7.34 (br, 4H), 7.24-7.21 (br, 2H), 7.15-7.12 (br, 2H), 6.94 (t, 1H, J = 10.0 Hz), 
6.43 (d, 1H, J = 5.0 Hz), 6.36 (d, 1H, J = 5.0 Hz), 4.08 (m, 2H), 3.71 (s, 3H), 2.44 (t, 4H, 
J = 7.0 Hz), 1.84 (m, 2H), 1.74 (s, 6H), 1.72 (s, 6H), 1.57 (m, 2H); 13CNMR (125 MHz, 
CDCl3) δ 173.8, 172.9, 172.2, 153.6, 153.5, 143.2, 142.2, 141.5 (2C), 141.2, 129.0, 
126.9, 125.4, 122.5, 122.4, 110.7, 110.6, 104.6, 104.0, 49.5, 49.4, 44.5, 34.3, 32.7, 28.4, 
28.3, 27.2, 26.5, 24.6. (1 carbon overlapping) 
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A solution of indolinium bromide 58 (150 mg, 0.43 mmol) and N,N’-
diphenylformamidine (132 mg, 0.51 mmol) in Ac2O (1.2 mL) was heated at 120 ºC for 
30 min.  The reaction mixture was cooled to 25 oC and a solution of indolium iodide 59 
(254 mg, 0.59 mmol) in pyridine (1.2 mL) was added.  The reaction mixture was stirred 
at 25 ºC for 30 min.  Ether (25 mL) was added and the reaction mixture was filtered off 
to afford 53 as dark blue solid.  The residue was purified by flash chromatography 
eluting with 100 % EtOAc and 5 % to 15 % MeOH/CH2Cl2 to afford product as a dark 
purple solid (203 mg, 65 %).  Rf  = 0.4 (10 % MeOH/CH2Cl2). 1H NMR (500 MHz, 
CDCl3) δ 8.09 (t, 1H, J = 10.0 Hz), 8.02 (t, 1H, J = 10.0 Hz), 7.63 (dd, 1H, J = 5.0 Hz, J 
= 1.0 Hz), 7.57 (d, 1H, J = 1.0 Hz), 7.40-7.35 (m, 2H), 7.24-7.19 (m, 2H), 6.95 (t, 1H, J 
= 5.0 Hz), 6.88 (d, 1H, J = 5.0 Hz), 6.48 (d, 1H, J = 7.5 Hz), 6.29 (d, 1H, J = 7.5 Hz), 
4.14 (m, 2H), 3.62 (s, 3H), 2.40 (m, 2H), 1.79-1.74 (m, 4H), 1.74 (s, 6H), 1.72 (s, 6H), 
1.57 (m, 2H); 13CNMR (125MHz,CDCl3) δ 174.2, 171.4, 154.5, 153.0, 152.9, 143.2, 
143.0, 142.0, 141.7, 137.9, 131.4, 129.1, 127.3, 125.7, 122.6, 112.4, 111.6, 105.3, 103.8, 
87.9, 50.0, 49.1, 45.0, 34.8 (2C), 30.1, 28.3, 27.5, 26.7, 24.8. MS (ESI) m/z 609.15 (M)+. 
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A solution of 5-iodo-Cy5 53 (62 mg, 0.084 mmol), 4-ethynyl BODIPY 49 (54 mg, 0.14 
mmol), Pd(PPh3)4 (20 mg, 0.020 mmol), CuI (3.0 mg, 0.020 mmol) in DMF (2 mL) was 
freeze-pump-thawed at –78 ºC (3 times).  Et3N (58 µL, 0.42 mmol) was added to a 
solution and the reaction mixture was stirred at 40 ºC for 1 h under nitrogen.  Ether (60 
mL) was added to a reaction mixture and reaction mixture was filtered off to afford 
product 44 as a dark purple solid.  The residue was purified by flash chromatography 
eluting with 100 % EtOAc and 10 to 50 % MeOH/CH2Cl2 to afford product as a dark 
purple solid (21 mg, 26 %).  Rf = 0.5 (10 % MeOH/CH2Cl2).  1H NMR (500 MHz, 
CD3OD) δ 8.35-8.21 (m, 2H), 7.67 (s, 1H), 7.60 (d, 1H, J = 10.0 Hz), 7.55 (d, 1H, J = 
5.0 Hz), 7.45 (t, 1H, J = 10.0 Hz), 7.39 (d, 1H, 5.0 Hz), 7.35-7.31 (m, 3H), 7.28 (d, 1H, J 
= 10.0 Hz), 7.20 (d, 1H, J = 5.0 Hz), 6.68 (t, 1H, J = 10.0 Hz), 6.42 (d, 1H, J = 15.0 Hz), 
6.24 (d, 1H, J = 15.0 Hz), 6.07 (s, 2H), 4.22-4.17 (m, 2H), 3.87 (s, 3H), 3.60 (s, 3H), 
2.49 (s, 6H), 2.37-2.33 (m, 2H), 1.88-1.83 (m, 2H), 1.75 (s, 6H), 1.73 (s, 6H), 1.66-1.63 
(m, 2H), 1.54 (s, 6H), 1.39-1.34 (br, 2H); 13CNMR (125 MHz, CD3OD) δ 176.1, 173.8, 
172.3, 157.1, 156.2 (2C), 153.9, 142.3, 142.1, 138.9, 133.1, 133.0, 131.7, 131.5, 130.2, 
128.9, 126.1, 125.8, 124.9, 124.7, 124.3, 124.1 (2C), 123.0, 121.9, 119.3, 114.2, 111.9, 
110.8, 105.6, 104.3, 80.2, 79.7, 68.2, 65.7, 55.8, 49.7, 44.1, 39.2, 26.6, 26.4, 25.1, 24.9, 
14.1; (1 carbon missing). MS (MALDI) m/z 859.29 (M)+. 
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APPENDIX C   
 
EXPERIMENTAL DATA FOR CHAPTER IV 
 
a 
 
b 
 
Figure C.1. Normalized absorbance (a) and fluorescence (b) spectra of cassettes in 
EtOH (at 10-6 and 10-7 M for absorbance and fluorescence measurements, respectively). 
All cassettes were excited at their corresponding donor absorption maxima. 
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Table C.1. Energy transfer efficiency of bare cassettes in EtOH. 
 
dye λabs(nm) λem.(nm) ΦDa ΦA ETE % 
(ΦD/ΦA) 
      
73 498, 543 600 0.46+/-0.02 0.48+/-0.01a 96 
43 502, 533 624 0.36+/-0.02 0.37+/-0.01a 97 
74 504, 569 590 0.20+/-0.01 0.22+/-0.02b 90 
44 504, 662 687 0.35+/-0.02 0.40+/-0.03c 87 
ΦD: quantum yield of cassette when excited at the donor absorption maxima. ΦA: 
quantum yield of cassette when excited at the acceptor absorption maxima. Standards 
used for quantum yield measurement:  arhodamine 6G (Φ 0.92 in EtOH); brhodamine 
101 (Φ 1.0 in EtOH); cNile Blue (Φ 0.27 in EtOH). Quantum yields were measured three 
times and averaged. 
 
 
Table C.2. Energy transfer efficiency of cassettes encapsulated in silica in EtOH. 
 
dye λabs(nm) λem.(nm) ΦDa ΦA ETE % 
(ΦD/ΦA) 
      
73 492,542 600 0.36+/-0.03 0.37+/-0.02a 97 
43 501, 539 624 0.22+/-0.01 0.29+/-0.01a 76 
74 504, 568 592 0.23+/-0.01 0.25+/-0.02b 92 
44 504, 659 687 0.34+/-0.01 0.37+/-0.02c 92 
ΦD: quantum yield of cassette when excited at the donor absorption maxima. ΦA: 
quantum yield of cassette when excited at the acceptor absorption maxima.Standards 
used for quantum yield measurement:  arhodamine 6G (Φ 0.92 in EtOH); brhodamine 
101 (Φ 1.0 in EtOH); cNile Blue (Φ 0.27 in EtOH). Quantum yields were measured three 
times and averaged. 
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Figure C.2. Normalized fluorescence of acceptor 26 (a) and acceptor 26 (b) 
encapsulated in silica in different solvents. The solvent dependent change in emission is 
much reduced in acceptor encapsulated in silica. Fluorescence was measured after 
matching absorbance intensities for bare and encapsulated cassettes. (c) Comparison of 
solid state emission of acceptor 26 and acceptor 26 encapsulated in silica. 
 
 
 
  211 
c 
 
Figure C.2. Continued 
 
Transmission electron microscopy (TEM) 
Sample preparation and measurement: A few drops of silica nanoparticles in ethanol 
were placed on a TEM grid. The TEM grid is made of copper meshes and covered with a 
thin film of amorphous carbon. The grid is dried and mounted on a specimen holder and 
loaded on to the TEM. Measurements were made on a JEOL 2010 TEM instrument. The 
JEOL 2010 is fitted with a LaB6 thermal emission gun and a Gatan Sc1000 ORIUS 
slow-scan charge-coupled device (CCD) camera (Model 832 with 4008x2672 pixels). 
Bright filed TEM images were obtained with JEOL 2010.  
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Figure C.3. FTIR spectra of cassette 73 doped silica nanoparticles. 
 
 
 
Figure C.4. X-ray photon electron spectroscopy (XPS) whole range spectrum of cassette 
73 doped silica nanoparticles. 
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Photostability Measurement of Silica Nanoparticles 
 
The photostability measurements of the silica nanoparticles were performed in the dry 
state. A few drops of silica nanoparticle suspension (1mg/mL) or dye in ethanol 
(concentration 10-6 M) were placed on a 2cm x 2cm glass slide and air dried. An argon 
ion laser (Spectra-Physics) fitted with a filter to select 488 nm wavelength light was used 
to perform the photostability studies. The 488 nm wavelength light with power density 
of 12W/cm2 within fwhm of beam diameter was focused on the dried sample on the 
glass slide. A biconvex lens was used to concentrate the beam on the sample. The 
fluorescence output form the sample upon irradiation was collected using a microscope 
objective lens. The collected fluorescence output was passed through a filter to remove 
any stray light below 500 nm and to a collimator that was connected to a Peltier-cooled 
charged coupled device (CCD) spectrometer (Ocean Optics, QE65000). 
 
In Vitro Cellular Imaging Studies 
 a Cell culture 
COS-7 cells (American Type Culture Collection) were cultured as subconfluent 
monolayers on 75 cm2 culture flask with vent caps in DMEM supplemented with 10 % 
fetal bovine serum (FBS) in a humidified incubator at 37 ºC with 5 % CO2.  Cells grown 
to subconfluence were enzymatically dissociated from the surface with trypsin and 
plated 2-3 days prior to the experiments in Lab-Tek two well chambered coverglass 
slides (Nunc).  
b Fluorescence microscopy for cassette 1 doped silica nanoparticles (Figure 6a). 
Uptake and subcellular localization of the silica nanoparticles were studied on living 
COS7 cells using a Bio-Rad 2000MP system (Bio-Rad Laboratories, Hercules, CA) 
equipped with a Nikon T300 inverted microscope with a 60x (NA1.2) water immersion 
objective lens and an Argon laser tuned to 488 nm wavelength. Images were collected 
using 488 nm excitation wavelength.  Emission from the donor (GFP analog) was 
collected using a 560 DCLP XR dichroic mirror and a HQ 528/50 –nm emission filter 
whereas emission of the acceptor (BODIPY; FRET channel; acceptor signal) was 
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collected using a HQ 600/50-nm filter. COS7 cells were incubated for 2 hours at 37 ºC 
in ACAS with 0.02 mg/mL of doped nanoparticles (1 mg/mL stock solution in PBS 7.4).  
After the incubation period, the cells were washed with phosphate-buffered saline (PBS, 
pH 7.4) several times before imaging.  
(c) Fluorescence microscopy for cassette 3 (Figure 6b) doped silica nanoparticles. 
Uptake and subcellular localization of the silica nanoparticles were studied on living 
COS7 cells using a Zeiss 510 META NLO Multiphoton Microscope System consisting 
of an Axiovert 200 MOT microscope.  Digital images of BODIPY-Cy3 and Cy3 doped 
nanoparticles were captured with a 40x / 1.3 oil objective with the following filter sets: 
Excitation 488 nm and 543 nm for the cassette and Cy3 alone, respectively; Emission BP 
500-530 for BODIPY; Emission BP 565-615 for Cy3.  COS7 cells were incubated for 2 
hours at 37 ºC in ACAS with 0.01 mg/mL of doped nanoparticles (solution in PBS).  
After the incubation period, the cells were washed with phosphate-buffered saline (PBS, 
pH 7.4) several times before imaging. 
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Figure C.5. Synthesis of calcium phosphate nanoparticles 
 
Synthesis of calcium phosphate nanoparticles was based on a previously reported 
procedure from Adair et al (Figure C.5). Briefly two reverse microemulsions were 
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formed from Igepal CO-520 in cyclohexane and water. 650 µL of freshly prepared 10-2 
M CaCl2 was added to 14 mL of 29 vol % of Igepal CO-520 in cyclohexane under 
constant stirring to form microemulsion A. 650 µL of freshly prepared 6 x 10-3 M 
disodium phosphate and 65 µL 8.3 x 10-4 M of disodium silicate were added sequentially 
under constant stirring to 14 mL of 29 vol % of Igepal CO-520 in cyclohexane to form 
microemulsion B. The dye solution, 1mL of 10-3 M was added to microemulsion B. Both 
microemulsions were stirred at 25 oC for 1 h. Microemulsion A was added drop wise to 
microemulsion B in 10 min and the combined microemulsion C stirred at 25 oC for 24 h. 
The reaction was quenched by addition of 225 µL of 10-3 M sodium citrate at 25 oC and 
stirring for 30 min. 
 
The micelles were broken by addition of 50 mL EtOH and purified via medium pressure 
liquid chromatography (MPLC) using silica microbeads (Stellar phases Inc., Langhorne, 
PA, dimension15 µm average diameter and 59 Angstrom pore size). EtOH was used as 
an eluent to remove any free dye and all reaction precursors. The polarity of the solvent 
was increased to 7/3 EtOH/H2O to elute the calcium phosphate nanoparticles. A portion 
of the collected calcium phosphate nanoparticles were dialyzed against water in a 
Spectra/por molecular membrane tubing MWCO:  6000-8000, flat width: 50 mm and 
diameter: 32 mm (Spectrum LABS, Houston, TX) for 8 h and then for further 8 h against 
pH 7.4 (0.1 M sodium phosphate buffer).  
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APPENDIX D 
 
SYNTHESIS OF CASSETTE WITH A SPACER 
 
As mentioned in the introductory chapter unlike through space systems, through bond 
energy transfer cassettes benefits from both FRET as well as through-bond energy 
transfer (TBET). In order to make sure that through-bond energy transfer predominates 
in such systems, we attempted the synthesis of a cassette with a saturated linker to avoid 
through-bond energy transfer (Figure D.1). We intend to study the fluorescence emission 
of such a system and compare it to a similar through-bond energy transfer cassette. 
 
N
F2B
N
OMe
N
I–
N
1
donor acceptor
spacer to
block TBET
77
 
Figure D.1. Cassette with spacer to block TBET. 
 
Synthesis of the above cassette is shown in scheme D.1. The donor fragment was 
constructed following palladium catalyzed cross coupling reaction of BODIPY 79 (from 
Dr. Yuichiro Ueno) and alkyne 78, which was prepared by following a published 
procedure.206 Deprotection of trimethylsilane using TBAF afforded the donor BODIPY 
80 in 70 % yield. The acceptor fragment iodocyanine was prepared by condensation of 
indole at 120 oC in acetic anhydride with N,N’-diphenylformamidine and treatment of 
the intermediate with iodoindole in pyridine at 25 oC fro 30 min. Standard Sonogashira 
protocol207 was followed to couple the donor and the acceptor fragment to obtain the 
cassette 77. The yield of the reaction is low due to the instability of the acceptor cyanine 
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in DMF for prolonged period. Attempted reaction at 40 oC for 1 h resulted in complete 
decomposition of the acceptor fragment. 
 
Scheme D.1. Synthesis of (a) donor fragment 80 (b) acceptor fragment 82 and (c) 
cassette 76 with spacer. 
a 
TMS
TMSCl, LHMDS
THF, -78 oC, 2 h
78  47 %  
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c 
Pd(PPh3)4, CuI, Et3N
 DMF, 25 oC, 12 h
N
F2B
N
OMe
N
I
I–
N
80 82
 
N
F2B
N
OMe
N
I–
N
77  21 %
 
 
Photophysical properties of the cassette were measured in EtOH. The absorbance of the 
cassette with spacer is similar to absorbance of TBET cassette showing two distinct 
absorbtion corresponding to donor BODIPY and acceptor cyanine Cy5 (Figure D.2a). 
The fluorescence emission of the cassette with spacer was very different from the TBET 
system (Figure D.2b). When excited at the donor absorbance (504 nm), very little 
emission is seen from the acceptor fragment (688 nm) and a huge emission peak 
corresponding to donor fragment is also seen. This is exactly opposite to TBET cassette, 
which upon excitation at donor absorbance (504 nm) shows good energy transfer to the 
acceptor. In order to make sure that the emission seen in cassette with spacer is not 
arising from the acceptor itself, we excited the acceptor Cy5 alone at 504 nm and as 
expected it did not show any emission at 688 nm. This proves that the emission seen in 
cassette with spacer arises from only FRET. The TBET cassette on the other hand shows 
emission, which is a sum of both FRET and TBET. The superior emission observed in 
TBET systems is a great advantage in applications such as multiplexing wherein 
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excitation at a single wavelength is used to observe different fluorescently colored 
regions of the cell or any organelle. 
 
a 
 
b 
 
Figure D.2. (a) Normalized absorbance of cassette with spacer 77 in EtOH (concn: 10-6 
M) (b) comparison of normalized fluorescence intensity of cassette with spacer 77 with 
TBET cassette 44 and Cy5 acceptor in EtOH (concn: 10-7 M). All solutions excited at 
504 nm. 
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APPENDIX E 
 
 
 EXPERIMENTAL FOR APPENDIX D 
 
 
TMS
78  
 
This compound was prepared following a reported procedure.206 1,6-heptadiyne (1 g, 
10.9 mmol) in THF (20 mL) was cooled to -78 oC and LHMDS (1.0 M solution in THF, 
12.0 mL, 13.0 mmol) added. The reaction mixture was stirred for 1 h at -78 oC and 
trimethyl silylchloride (1.65 mL, 13.0 mmol) added. The reaction mixture was further 
stirred at -78 oC for 2 h and saturated ammonium chloride solution (20 mL) was added to 
quench the reaction. The reaction mixture was extracted with CH2Cl2 (20 mL x 2), dried 
over anhydrous sodium sulfate and solvent evaporated at 25 oC. The semisolid obtained 
was purified by flash chromatography using EtOAc/hexanes 1/4 as eluent to afford 78 as 
a yellow semisolid (0.83 g, 47 %) after solvent evaporation and drying for 2 h. Rf = 0.4 
(EtOAc/hexanes 1/4). 1H NMR (300 MHz, CDCl3) δ 2.31 (m, 4H), 1.95 (t, 1H, J = 2.6 
Hz), 1.72 (m, 2H), 0.13 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 105.9, 85.1, 83.4, 68.7, 
27.4, 18.8, 17.4, 0.0. 
1H NMR (CDCl3) 
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13C NMR (CDCl3) 
 
 
N
B
F2
N
OMe
TMS
79a  
BODIPY 79 (100 mg, 0.21 mmol) along with alkyne 78 (171 mg, 1.0 mmol), 
PdCl2(PPh3)2 (15 mg, 0.02 mmol), copper iodide (4 mg, 0.02 mmol), and triethylamine 
(0.3 mL, 2.0 mmol) was dissolved in THF (4 mL) and stirred at 25 oC for 12 h. The 
reaction mixture was filtered through celite to remove solid impurities and filtrate 
obtained evaporated under reduced pressure. The residue obtained was purified via flash 
chromatography using EtOAc/hexanes 3/7 as eluent to afford 79a as an orange solid 
(142 mg, 88 %) after solvent evaporation and drying. Rf  = 0.6 (EtOAc/hexanes 3/7). 1H 
NMR (300 MHz, CDCl3) δ 7.15 (d, 1H, J = 7.6 Hz), 7.07 (s, 1H), 7.03 (d, 1H, J = 7.6 
Hz), 5.97 (s, 2H), 3.77 (s, 3H), 2.55 (s, 6H), 2.44 (t, 2H, J = 7.0 Hz), 1.86 (m, 4H), 1.46 
(s, 6H), 0.17 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 165.1, 156.3, 155.2, 142.6, 131.5, 
129.6, 126.2, 125.0, 123.8, 121.0, 114.3, 106.3, 90.6, 85.5, 80.8, 55.8, 27.8, 19.3, 18.7, 
14.2, 0.3; MS (ESI) m/z 517.26 (M+H)+. 
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1H NMR (CDCl3) 
 
13C NMR (CDCl3) 
 
N
B
F2
N
OMe
80  
BODIPY 79a (150 mg, 0.29 mmol) was dissolved in THF (4 mL) and cooled to -78 oC. 
TBAF (0.3 mL, 0.3 mmol) was added to the above solution and stirred at -78 oC for 30 
min. The reaction was quenched by addition of deionized water (10 mL) and organic 
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layer extracted with CH2Cl2 (5 mL x 3). The CH2Cl2 layer obtained was again washed 
with deionized water (5 mL x 3) and dried over anhydrous sodium sulfate. The solvent 
was evaporated under reduced pressure and residue obtained purified via flash 
chromatography using EtOAc/hexanes 3/7 as eluent to afford 80 as an orange solid (102 
mg, 79%) after solvent evaporation and drying. Rf  = 0.4 (EtOAc/hexanes 3/7).  
1HNMR (300 MHz, CDCl3) δ 7.13 (d, 1H, J = 4.7 Hz), 7.06 (d, 1H, J = 4.7 Hz), 7.02 (s, 
1H), 5.96 (s, 2H), 3.76 (s, 3H), 2.59 (t, 2H, J = 4.2 Hz), 2.55 (s, 6H), 2.41 (m, 2H), 2.01 
(s, 1H), 1.86 (t, 2H, J = 4.2 Hz), 1.46 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 156.2, 
155.1, 142.5, 138.1, 131.8, 129.5, 126.0, 124.9, 123.7, 120.9, 114.1, 90.3, 83.4, 80.8, 
69.1, 55.7, 27.5, 18.5, 17.7, 14.1; MS (ESI) m/z 445.27 (M+H)+. 
1HNMR (CDCl3) 
 
13C NMR (CDCl3) 
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A solution of indolinium salt 81 (200 mg, 0.66 mmol) and N,N’-diphenylformamidine 
(206 mg, 0.80 mmol) in Ac2O (2 mL) was heated at 120 ºC for 30 min.  The reaction 
mixture was cooled to 25 oC and a solution of indolinium iodide 59 (393 mg, 0.92 
mmol) in pyridine (2 mL) was added.  The reaction mixture was stirred at 25 ºC for 30 
min.  Ether (25 mL) was added and the reaction mixture was filtered off to afford as dark 
blue solid.  The residue was purified by flash chromatography eluting with 100 % 
EtOAc and 5 % to 10 % MeOH/CH2Cl2 to afford product 82 as a dark purple solid (189 
mg, 45 %).  Rf  = 0.5 (10 % MeOH/CH2Cl2). 1H NMR (500 MHz, CDCl3) δ 8.18 (br, 
2H), 7.66 (t, 1H, J = 8.5 Hz), 7.60 (br, 1H), 7.49 (s, 1H), 7.40 (t, 1H, J = 8.5 Hz), 7.26 
(br, 1 H), 7.17 (d, 1H, J = 7.6 Hz), 6.86 (br, 2H), 6.47 (d, 1H, J = 12.7 Hz), 6.25 (d, 1H, 
J = 12.7 Hz), 3.77 (s, 3H), 2.19 (s, 3H), 1.76 (br, 12H); 13C NMR (125 MHz, CDCl3) 
δ 174.6, 171.3, 142.3, 141.5, 137.4, 137.1, 131.2, 131.0, 129.5, 128.8, 128.0, 125.8, 
124.8, 122.5, 122.3, 114.0, 111.9, 110.9, 87.8, 49.7, 31.4, 29.7, 27.9, 27.2; MS (ESI) 
m/z 509.14 (M+). 
1H NMR (CDCl3) 
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13C NMR (CDCl3) 
 
N
F2B
N
OMe
N
I–
N
1
77
 
A solution of 5-iodo-Cy5 82  (20 mg, 0.03 mmol), BODIPY 80 (30 mg, 0.07 mmol), 
Pd(PPh3)4 (7 mg, 0.006 mmol), CuI (1 mg, 0.006 mmol) in DMF (1.0 mL) was freeze-
pump-thawed at –78 ºC (x 3 times).  Et3N (42 µL, 0.3 mmol) was added to a solution 
and the reaction mixture was stirred at 25 ºC for 12 h under nitrogen.  Ether (20 mL) was 
added to a reaction mixture and reaction mixture was filtered off to afford product as a 
dark purple solid.  The residue was purified by flash chromatography eluting with 100 % 
EtOAc and 10 to 30 % MeOH/CH2Cl2 to afford 77 as a dark purple solid (6 mg, 21 %) 
in 90 % purity.  Rf 0.7 (10 % MeOH/CH2Cl2). 1H NMR (500 MHz, CDCl3) δ 7.67 (br, 
3H), 7.55 (d, 2H, J = 7.3 Hz), 7.48 (br, 3H), 7.08 (br, 4H), 6.82 (br, 3H), 5.97 (s, 2H), 
3.78 (s, 3H), 3.65 (br, 3H), 2.66 (m, 2H), 2.55 (s, 6H), 2.35 (br, 2H), 2.18 (s, 3H), 1.82 
(br, 2H), 1.71 (br, 12H), 1.47 (s, 6H); could not obtain carbon for this sample. MS 
(MALDI) m/z 825.46 (M+). 
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1H NMR (CDCl3) 
 
 MS (MALDI) 
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